cancer_type	qtl_type	tag_SNP	LD	SNP_id	gene_id	gene_symbol	t-stat	p-value	beta	r	Traits	SNP_position	Gene_position
LUSC	cis	rs75358501	0.636	rs888621	MIMAT0014995	hsa-miR-3130-5p	20.04	4.02e-64	0.83	0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs888621	MIMAT0014995_1	hsa-miR-3130-5p	20.04	4.02e-64	0.83	0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784626	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs2287628	MIMAT0014995	hsa-miR-3130-5p	-20.01	5.66e-64	-0.84	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs2287628	MIMAT0014995_1	hsa-miR-3130-5p	-20.01	5.66e-64	-0.84	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs7576591	MIMAT0014995	hsa-miR-3130-5p	-19.96	1e-63	-0.84	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs7576591	MIMAT0014995_1	hsa-miR-3130-5p	-19.96	1e-63	-0.84	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs2241347	MIMAT0014995	hsa-miR-3130-5p	-19.9	1.79e-63	-0.84	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs2241347	MIMAT0014995_1	hsa-miR-3130-5p	-19.9	1.79e-63	-0.84	-0.69	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs11895370	MIMAT0014995	hsa-miR-3130-5p	-19.71	1.39e-62	-0.83	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs11895370	MIMAT0014995_1	hsa-miR-3130-5p	-19.71	1.39e-62	-0.83	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206789990	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs3815686	MIMAT0014995	hsa-miR-3130-5p	-19.57	6.32e-62	-0.85	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs3815686	MIMAT0014995_1	hsa-miR-3130-5p	-19.57	6.32e-62	-0.85	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206768278	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.688	rs2287629	MIMAT0014995	hsa-miR-3130-5p	19.52	9.88e-62	0.83	0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.688	rs2287629	MIMAT0014995_1	hsa-miR-3130-5p	19.52	9.88e-62	0.83	0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs957414	MIMAT0014995	hsa-miR-3130-5p	-19.38	4.35e-61	-0.85	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs957414	MIMAT0014995_1	hsa-miR-3130-5p	-19.38	4.35e-61	-0.85	-0.68	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206800861	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs4673363	MIMAT0014995	hsa-miR-3130-5p	-18.86	1.05e-58	-0.84	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs4673363	MIMAT0014995_1	hsa-miR-3130-5p	-18.86	1.05e-58	-0.84	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206804687	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs57600974	MIMAT0014995	hsa-miR-3130-5p	-18.86	1.05e-58	-0.84	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs57600974	MIMAT0014995_1	hsa-miR-3130-5p	-18.86	1.05e-58	-0.84	-0.67	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206805471	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs13427002	MIMAT0014995	hsa-miR-3130-5p	-18.76	3.02e-58	-0.82	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs13427002	MIMAT0014995_1	hsa-miR-3130-5p	-18.76	3.02e-58	-0.82	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs725980	MIMAT0014995	hsa-miR-3130-5p	-18.66	8.21e-58	-0.82	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs725980	MIMAT0014995_1	hsa-miR-3130-5p	-18.66	8.21e-58	-0.82	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs10199766	MIMAT0014995	hsa-miR-3130-5p	-18.66	8.21e-58	-0.82	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs10199766	MIMAT0014995_1	hsa-miR-3130-5p	-18.66	8.21e-58	-0.82	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs12471008	MIMAT0014995	hsa-miR-3130-5p	-18.64	1.07e-57	-0.82	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs12471008	MIMAT0014995_1	hsa-miR-3130-5p	-18.64	1.07e-57	-0.82	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs768533	MIMAT0014995	hsa-miR-3130-5p	-18.64	1.07e-57	-0.82	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs768533	MIMAT0014995_1	hsa-miR-3130-5p	-18.64	1.07e-57	-0.82	-0.66	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs12478466	MIMAT0014995	hsa-miR-3130-5p	-18.12	2.49e-55	-0.83	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs12478466	MIMAT0014995_1	hsa-miR-3130-5p	-18.12	2.49e-55	-0.83	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206806288	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.688	rs28365797	MIMAT0014995	hsa-miR-3130-5p	-17.92	2.08e-54	-0.81	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.688	rs28365797	MIMAT0014995_1	hsa-miR-3130-5p	-17.92	2.08e-54	-0.81	-0.65	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765122	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs16838834	MIMAT0014995	hsa-miR-3130-5p	-17.51	1.42e-52	-0.81	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs16838834	MIMAT0014995_1	hsa-miR-3130-5p	-17.51	1.42e-52	-0.81	-0.64	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206765071	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.584	rs11894165	MIMAT0014995	hsa-miR-3130-5p	-16.46	7.57e-48	-0.79	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.584	rs11894165	MIMAT0014995_1	hsa-miR-3130-5p	-16.46	7.57e-48	-0.79	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206759688	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.688	rs1862087	MIMAT0014995	hsa-miR-3130-5p	-16.46	7.57e-48	-0.79	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.688	rs1862087	MIMAT0014995_1	hsa-miR-3130-5p	-16.46	7.57e-48	-0.79	-0.62	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206760843	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs1862089	MIMAT0014995	hsa-miR-3130-5p	-16.1	2.93e-46	-0.78	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs1862089	MIMAT0014995_1	hsa-miR-3130-5p	-16.1	2.93e-46	-0.78	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206755794	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs10932164	MIMAT0014995	hsa-miR-3130-5p	-16.07	4.11e-46	-0.76	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs10932164	MIMAT0014995_1	hsa-miR-3130-5p	-16.07	4.11e-46	-0.76	-0.61	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206751601	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.636	rs7580138	MIMAT0014995	hsa-miR-3130-5p	-15.86	3.19e-45	-0.77	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs7580138	MIMAT0014995_1	hsa-miR-3130-5p	-15.86	3.19e-45	-0.77	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206750560	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.748	rs12470963	MIMAT0014995	hsa-miR-3130-5p	-15.65	2.94e-44	-0.82	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.748	rs12470963	MIMAT0014995_1	hsa-miR-3130-5p	-15.65	2.94e-44	-0.82	-0.6	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206774869	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.901	rs76270461	MIMAT0014995	hsa-miR-3130-5p	-11.46	8.25e-27	-0.8	-0.48	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.901	rs76270461	MIMAT0014995_1	hsa-miR-3130-5p	-11.46	8.25e-27	-0.8	-0.48	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206788929	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.901	rs16838691	MIMAT0014995	hsa-miR-3130-5p	-11.33	2.5e-26	-0.76	-0.47	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.901	rs16838691	MIMAT0014995_1	hsa-miR-3130-5p	-11.33	2.5e-26	-0.76	-0.47	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206718128	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.901	rs79499040	MIMAT0014995	hsa-miR-3130-5p	-10.64	1.02e-23	-0.78	-0.45	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.901	rs79499040	MIMAT0014995_1	hsa-miR-3130-5p	-10.64	1.02e-23	-0.78	-0.45	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776206	chr2:206783246~206783266:+
LUSC	cis	rs6841433	1	rs7677294	MIMAT0003242	hsa-miR-577	9.44	2.15e-19	0.55	0.41	Hemoglobin concentration;	chr4:114633283	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.948	rs35736852	MIMAT0003242	hsa-miR-577	9.22	1.25e-18	0.53	0.4	Hemoglobin concentration;	chr4:114687255	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs34546485	MIMAT0003242	hsa-miR-577	9.21	1.26e-18	0.53	0.4	Hemoglobin concentration;	chr4:114693882	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs13133286	MIMAT0003242	hsa-miR-577	9.18	1.7e-18	0.52	0.4	Hemoglobin concentration;	chr4:114701654	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs34115976	MIMAT0003242	hsa-miR-577	9.13	2.49e-18	0.53	0.4	Hemoglobin concentration;	chr4:114656841	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs13133899	MIMAT0003242	hsa-miR-577	9.13	2.49e-18	0.53	0.4	Hemoglobin concentration;	chr4:114661153	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.948	rs34110012	MIMAT0003242	hsa-miR-577	8.98	7.92e-18	0.51	0.39	Hemoglobin concentration;	chr4:114710498	chr4:114656774~114656794:+
LUSC	cis	rs950880	0.71	rs1474309	MIMAT0019926	hsa-miR-4772-5p	8.94	1.03e-17	0.91	0.39	Serum protein levels (sST2);	chr2:102474542	chr2:102432300~102432321:+
LUSC	cis	rs6841433	0.904	rs4130705	MIMAT0003242	hsa-miR-577	8.91	1.33e-17	0.51	0.39	Hemoglobin concentration;	chr4:114609479	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs6533803	MIMAT0003242	hsa-miR-577	8.72	5.79e-17	0.49	0.38	Hemoglobin concentration;	chr4:114637085	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs10049660	MIMAT0003242	hsa-miR-577	8.72	5.79e-17	0.49	0.38	Hemoglobin concentration;	chr4:114637758	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.948	rs7671477	MIMAT0003242	hsa-miR-577	8.69	7.13e-17	0.49	0.38	Hemoglobin concentration;	chr4:114632518	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs35271056	MIMAT0003242	hsa-miR-577	8.67	8.11e-17	0.49	0.38	Hemoglobin concentration;	chr4:114642195	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.95	rs28696112	MIMAT0003242	hsa-miR-577	8.55	2.04e-16	0.5	0.38	Hemoglobin concentration;	chr4:114601833	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs10008981	MIMAT0003242	hsa-miR-577	8.49	3.15e-16	0.48	0.37	Hemoglobin concentration;	chr4:114650189	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.848	rs13328022	MIMAT0003242	hsa-miR-577	8.39	6.51e-16	0.47	0.37	Hemoglobin concentration;	chr4:114700701	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs55875005	MIMAT0003242	hsa-miR-577	8.39	6.68e-16	0.47	0.37	Hemoglobin concentration;	chr4:114691920	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs10011293	MIMAT0003242	hsa-miR-577	8.35	8.6e-16	0.47	0.37	Hemoglobin concentration;	chr4:114656225	chr4:114656774~114656794:+
LUSC	cis	rs7255436	0.965	rs11666233	MIMAT0021017	hsa-miR-4999-5p	8.31	1.16e-15	0.46	0.37	HDL cholesterol;	chr19:8387161	chr19:8389340~8389360:-
LUSC	cis	rs6841433	0.948	rs9884805	MIMAT0003242	hsa-miR-577	8.28	1.47e-15	0.47	0.37	Hemoglobin concentration;	chr4:114697040	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs6828127	MIMAT0003242	hsa-miR-577	8.28	1.5e-15	0.45	0.37	Hemoglobin concentration;	chr4:114689927	chr4:114656774~114656794:+
LUSC	cis	rs7255436	0.965	rs7254882	MIMAT0021017	hsa-miR-4999-5p	8.26	1.66e-15	0.45	0.37	HDL cholesterol;	chr19:8388938	chr19:8389340~8389360:-
LUSC	cis	rs6841433	1	rs28390138	MIMAT0003242	hsa-miR-577	8.25	1.78e-15	0.46	0.36	Hemoglobin concentration;	chr4:114687320	chr4:114656774~114656794:+
LUSC	cis	rs6841433	1	rs35217170	MIMAT0003242	hsa-miR-577	8.23	2.06e-15	0.47	0.36	Hemoglobin concentration;	chr4:114672701	chr4:114656774~114656794:+
LUSC	cis	rs7255436	0.928	rs7250870	MIMAT0021017	hsa-miR-4999-5p	8.2	2.58e-15	0.45	0.36	HDL cholesterol;	chr19:8388798	chr19:8389340~8389360:-
LUSC	cis	rs6841433	1	rs34403669	MIMAT0003242	hsa-miR-577	8.2	2.69e-15	0.46	0.36	Hemoglobin concentration;	chr4:114703735	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.948	rs13135834	MIMAT0003242	hsa-miR-577	8.19	2.71e-15	0.47	0.36	Hemoglobin concentration;	chr4:114678835	chr4:114656774~114656794:+
LUSC	cis	rs7255436	0.965	rs11668346	MIMAT0021017	hsa-miR-4999-5p	8.15	3.87e-15	0.46	0.36	HDL cholesterol;	chr19:8385970	chr19:8389340~8389360:-
LUSC	cis	rs7255436	0.965	rs12981318	MIMAT0021017	hsa-miR-4999-5p	8.15	3.87e-15	0.46	0.36	HDL cholesterol;	chr19:8386546	chr19:8389340~8389360:-
LUSC	cis	rs7255436	0.965	rs7351098	MIMAT0021017	hsa-miR-4999-5p	8.15	3.87e-15	0.46	0.36	HDL cholesterol;	chr19:8386787	chr19:8389340~8389360:-
LUSC	cis	rs7255436	0.965	rs11666003	MIMAT0021017	hsa-miR-4999-5p	8.14	3.92e-15	0.46	0.36	HDL cholesterol;	chr19:8387218	chr19:8389340~8389360:-
LUSC	cis	rs6841433	1	rs6841433	MIMAT0003242	hsa-miR-577	8.05	7.63e-15	0.47	0.36	Hemoglobin concentration;	chr4:114647874	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.699	rs12643031	MIMAT0003242	hsa-miR-577	7.62	1.59e-13	0.47	0.34	Hemoglobin concentration;	chr4:114541449	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs17047236	MIMAT0003242	hsa-miR-577	7.51	3.32e-13	0.48	0.34	Hemoglobin concentration;	chr4:114564575	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.904	rs11731984	MIMAT0003242	hsa-miR-577	-7.43	5.68e-13	-0.4	-0.33	Hemoglobin concentration;	chr4:114663873	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs12641516	MIMAT0003242	hsa-miR-577	7.22	2.23e-12	0.49	0.32	Hemoglobin concentration;	chr4:114556972	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs7434753	MIMAT0003242	hsa-miR-577	7.19	2.75e-12	0.48	0.32	Hemoglobin concentration;	chr4:114596387	chr4:114656774~114656794:+
LUSC	cis	rs12712135	0.651	rs12712150	MIMAT0019927	hsa-miR-4772-3p	7.18	2.89e-12	0.28	0.32	Blood protein levels;	chr2:102458353	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.677	rs11678721	MIMAT0019927	hsa-miR-4772-3p	7.17	3.13e-12	0.28	0.32	Blood protein levels;	chr2:102456778	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.709	rs11677555	MIMAT0019927	hsa-miR-4772-3p	7.17	3.13e-12	0.28	0.32	Blood protein levels;	chr2:102456833	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.709	rs6705498	MIMAT0019927	hsa-miR-4772-3p	7.17	3.13e-12	0.28	0.32	Blood protein levels;	chr2:102460210	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.709	rs6719196	MIMAT0019927	hsa-miR-4772-3p	7.17	3.13e-12	0.28	0.32	Blood protein levels;	chr2:102460428	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs35252674	MIMAT0003242	hsa-miR-577	7.17	3.16e-12	0.48	0.32	Hemoglobin concentration;	chr4:114556583	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs71606719	MIMAT0003242	hsa-miR-577	7.17	3.16e-12	0.48	0.32	Hemoglobin concentration;	chr4:114557814	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.511	rs13125495	MIMAT0003242	hsa-miR-577	7.17	3.16e-12	0.48	0.32	Hemoglobin concentration;	chr4:114558326	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.571	rs13129837	MIMAT0003242	hsa-miR-577	7.15	3.54e-12	0.48	0.32	Hemoglobin concentration;	chr4:114563925	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs12511581	MIMAT0003242	hsa-miR-577	-7.13	3.99e-12	-0.45	-0.32	Hemoglobin concentration;	chr4:114598400	chr4:114656774~114656794:+
LUSC	cis	rs12712135	0.709	rs4140786	MIMAT0019927	hsa-miR-4772-3p	7.13	4.16e-12	0.28	0.32	Blood protein levels;	chr2:102471716	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.571	rs1903365	MIMAT0003242	hsa-miR-577	7.12	4.25e-12	0.48	0.32	Hemoglobin concentration;	chr4:114561897	chr4:114656774~114656794:+
LUSC	cis	rs12712135	0.709	rs11676236	MIMAT0019927	hsa-miR-4772-3p	7.12	4.26e-12	0.28	0.32	Blood protein levels;	chr2:102465235	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.677	rs11687013	MIMAT0019927	hsa-miR-4772-3p	7.12	4.26e-12	0.28	0.32	Blood protein levels;	chr2:102465261	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs12650115	MIMAT0003242	hsa-miR-577	7.12	4.28e-12	0.48	0.32	Hemoglobin concentration;	chr4:114560232	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs12644238	MIMAT0003242	hsa-miR-577	7.12	4.28e-12	0.48	0.32	Hemoglobin concentration;	chr4:114560598	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs13110751	MIMAT0003242	hsa-miR-577	7.12	4.28e-12	0.48	0.32	Hemoglobin concentration;	chr4:114563572	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs13105144	MIMAT0003242	hsa-miR-577	7.12	4.28e-12	0.48	0.32	Hemoglobin concentration;	chr4:114563873	chr4:114656774~114656794:+
LUSC	cis	rs12712135	0.709	rs10201184	MIMAT0019927	hsa-miR-4772-3p	-7.12	4.41e-12	-0.28	-0.32	Blood protein levels;	chr2:102472618	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs1380932	MIMAT0003242	hsa-miR-577	7.09	5.45e-12	0.48	0.32	Hemoglobin concentration;	chr4:114565923	chr4:114656774~114656794:+
LUSC	cis	rs12712135	0.677	rs6705385	MIMAT0019927	hsa-miR-4772-3p	7.07	6.22e-12	0.27	0.32	Blood protein levels;	chr2:102460109	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.967	rs3744208	MIMAT0017994	hsa-miR-3615	-7.06	6.64e-12	-0.29	-0.32	Monocyte count;	chr17:74771426	chr17:74748663~74748683:+
LUSC	cis	rs6543140	0.964	rs1523206	MIMAT0019927	hsa-miR-4772-3p	-7.03	7.64e-12	-0.3	-0.32	Blood protein levels;	chr2:102453715	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs1523205	MIMAT0019927	hsa-miR-4772-3p	-7.03	7.64e-12	-0.3	-0.32	Blood protein levels;	chr2:102453716	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs6543138	MIMAT0019927	hsa-miR-4772-3p	-7.03	8.02e-12	-0.3	-0.32	Blood protein levels;	chr2:102449672	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.709	rs12463588	MIMAT0019927	hsa-miR-4772-3p	7.02	8.43e-12	0.27	0.32	Blood protein levels;	chr2:102468797	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.709	rs2310302	MIMAT0019927	hsa-miR-4772-3p	7.02	8.43e-12	0.27	0.32	Blood protein levels;	chr2:102469589	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.709	rs12469887	MIMAT0019927	hsa-miR-4772-3p	7.02	8.43e-12	0.27	0.32	Blood protein levels;	chr2:102470298	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.709	rs10195075	MIMAT0019927	hsa-miR-4772-3p	7.02	8.43e-12	0.27	0.32	Blood protein levels;	chr2:102471192	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.709	rs1403553	MIMAT0019927	hsa-miR-4772-3p	7.02	8.43e-12	0.27	0.32	Blood protein levels;	chr2:102471202	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs79776742	MIMAT0003242	hsa-miR-577	7	9.53e-12	0.47	0.32	Hemoglobin concentration;	chr4:114550195	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs57059575	MIMAT0003242	hsa-miR-577	7	9.53e-12	0.47	0.32	Hemoglobin concentration;	chr4:114551237	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs13147106	MIMAT0003242	hsa-miR-577	7	9.53e-12	0.47	0.32	Hemoglobin concentration;	chr4:114552206	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs13147485	MIMAT0003242	hsa-miR-577	7	9.53e-12	0.47	0.32	Hemoglobin concentration;	chr4:114552321	chr4:114656774~114656794:+
LUSC	cis	rs75358501	0.636	rs12473690	MIMAT0014995	hsa-miR-3130-5p	6.99	1.04e-11	0.41	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.636	rs12473690	MIMAT0014995_1	hsa-miR-3130-5p	6.99	1.04e-11	0.41	0.31	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206734939	chr2:206783246~206783266:+
LUSC	cis	rs6841433	0.615	rs17047198	MIMAT0003242	hsa-miR-577	6.98	1.1e-11	0.46	0.31	Hemoglobin concentration;	chr4:114544338	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs79261962	MIMAT0003242	hsa-miR-577	6.98	1.11e-11	0.46	0.31	Hemoglobin concentration;	chr4:114539953	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs77422558	MIMAT0003242	hsa-miR-577	6.98	1.11e-11	0.46	0.31	Hemoglobin concentration;	chr4:114540944	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.571	rs12649041	MIMAT0003242	hsa-miR-577	6.98	1.11e-11	0.46	0.31	Hemoglobin concentration;	chr4:114541220	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs12649963	MIMAT0003242	hsa-miR-577	6.98	1.11e-11	0.46	0.31	Hemoglobin concentration;	chr4:114542537	chr4:114656774~114656794:+
LUSC	cis	rs12712135	0.709	rs11465730	MIMAT0019927	hsa-miR-4772-3p	6.97	1.13e-11	0.27	0.31	Blood protein levels;	chr2:102450398	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs34685786	MIMAT0003242	hsa-miR-577	6.97	1.15e-11	0.46	0.31	Hemoglobin concentration;	chr4:114549280	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs13120552	MIMAT0003242	hsa-miR-577	6.97	1.15e-11	0.46	0.31	Hemoglobin concentration;	chr4:114552518	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs13101831	MIMAT0003242	hsa-miR-577	6.97	1.15e-11	0.46	0.31	Hemoglobin concentration;	chr4:114552771	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.66	rs13127941	MIMAT0003242	hsa-miR-577	6.97	1.15e-11	0.46	0.31	Hemoglobin concentration;	chr4:114553520	chr4:114656774~114656794:+
LUSC	cis	rs6543140	0.964	rs6543136	MIMAT0019927	hsa-miR-4772-3p	-6.97	1.16e-11	-0.3	-0.31	Blood protein levels;	chr2:102449087	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs35082726	MIMAT0003242	hsa-miR-577	6.97	1.16e-11	0.47	0.31	Hemoglobin concentration;	chr4:114566777	chr4:114656774~114656794:+
LUSC	cis	rs6543140	0.964	rs918000	MIMAT0019927	hsa-miR-4772-3p	-6.97	1.16e-11	-0.3	-0.31	Blood protein levels;	chr2:102451402	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.927	rs917999	MIMAT0019927	hsa-miR-4772-3p	-6.97	1.16e-11	-0.3	-0.31	Blood protein levels;	chr2:102451409	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs13136602	MIMAT0003242	hsa-miR-577	6.96	1.2e-11	0.46	0.31	Hemoglobin concentration;	chr4:114541864	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs12649943	MIMAT0003242	hsa-miR-577	6.96	1.2e-11	0.46	0.31	Hemoglobin concentration;	chr4:114542460	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs13147198	MIMAT0003242	hsa-miR-577	6.96	1.27e-11	0.46	0.31	Hemoglobin concentration;	chr4:114553935	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs34403145	MIMAT0003242	hsa-miR-577	6.96	1.27e-11	0.46	0.31	Hemoglobin concentration;	chr4:114554629	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs12643074	MIMAT0003242	hsa-miR-577	6.96	1.27e-11	0.46	0.31	Hemoglobin concentration;	chr4:114555226	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs2100783	MIMAT0003242	hsa-miR-577	6.96	1.27e-11	0.46	0.31	Hemoglobin concentration;	chr4:114555821	chr4:114656774~114656794:+
LUSC	cis	rs6543140	0.964	rs13393175	MIMAT0019927	hsa-miR-4772-3p	-6.94	1.39e-11	-0.3	-0.31	Blood protein levels;	chr2:102462389	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.865	rs6760275	MIMAT0019927	hsa-miR-4772-3p	-6.94	1.39e-11	-0.3	-0.31	Blood protein levels;	chr2:102463147	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs6734203	MIMAT0019927	hsa-miR-4772-3p	-6.94	1.39e-11	-0.3	-0.31	Blood protein levels;	chr2:102463606	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs17047201	MIMAT0003242	hsa-miR-577	6.94	1.42e-11	0.45	0.31	Hemoglobin concentration;	chr4:114544945	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs10516604	MIMAT0003242	hsa-miR-577	6.93	1.5e-11	0.45	0.31	Hemoglobin concentration;	chr4:114546112	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs13135560	MIMAT0003242	hsa-miR-577	6.92	1.63e-11	0.45	0.31	Hemoglobin concentration;	chr4:114547331	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs35777558	MIMAT0003242	hsa-miR-577	6.92	1.63e-11	0.45	0.31	Hemoglobin concentration;	chr4:114548111	chr4:114656774~114656794:+
LUSC	cis	rs6543140	0.964	rs6736135	MIMAT0019927	hsa-miR-4772-3p	-6.91	1.68e-11	-0.3	-0.31	Blood protein levels;	chr2:102448464	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs6543142	MIMAT0019927	hsa-miR-4772-3p	-6.91	1.73e-11	-0.3	-0.31	Blood protein levels;	chr2:102465546	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.929	rs6742530	MIMAT0019927	hsa-miR-4772-3p	-6.91	1.73e-11	-0.3	-0.31	Blood protein levels;	chr2:102465820	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs13127912	MIMAT0003242	hsa-miR-577	6.9	1.8e-11	0.45	0.31	Hemoglobin concentration;	chr4:114546019	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs10516603	MIMAT0003242	hsa-miR-577	6.9	1.8e-11	0.45	0.31	Hemoglobin concentration;	chr4:114546303	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs6849357	MIMAT0003242	hsa-miR-577	-6.9	1.84e-11	-0.43	-0.31	Hemoglobin concentration;	chr4:114598115	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs13112553	MIMAT0003242	hsa-miR-577	-6.9	1.84e-11	-0.43	-0.31	Hemoglobin concentration;	chr4:114598194	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs13114989	MIMAT0003242	hsa-miR-577	6.89	1.86e-11	0.45	0.31	Hemoglobin concentration;	chr4:114538869	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs35594431	MIMAT0003242	hsa-miR-577	6.89	1.88e-11	0.46	0.31	Hemoglobin concentration;	chr4:114554497	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs33914856	MIMAT0003242	hsa-miR-577	6.89	1.92e-11	0.45	0.31	Hemoglobin concentration;	chr4:114564668	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.607	rs34695716	MIMAT0003242	hsa-miR-577	-6.87	2.21e-11	-0.35	-0.31	Hemoglobin concentration;	chr4:114658285	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.571	rs17047238	MIMAT0003242	hsa-miR-577	6.86	2.25e-11	0.46	0.31	Hemoglobin concentration;	chr4:114568870	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs7437576	MIMAT0003242	hsa-miR-577	6.86	2.28e-11	0.45	0.31	Hemoglobin concentration;	chr4:114595467	chr4:114656774~114656794:+
LUSC	cis	rs6543140	0.964	rs4851592	MIMAT0019927	hsa-miR-4772-3p	-6.86	2.37e-11	-0.3	-0.31	Blood protein levels;	chr2:102471181	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.967	rs880827	MIMAT0017994	hsa-miR-3615	6.85	2.54e-11	0.28	0.31	Monocyte count;	chr17:74771296	chr17:74748663~74748683:+
LUSC	cis	rs6543140	0.964	rs2141781	MIMAT0019927	hsa-miR-4772-3p	-6.84	2.61e-11	-0.3	-0.31	Blood protein levels;	chr2:102466446	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.652	rs11465727	MIMAT0019927	hsa-miR-4772-3p	6.82	2.97e-11	0.27	0.31	Blood protein levels;	chr2:102448043	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.709	rs11465729	MIMAT0019927	hsa-miR-4772-3p	6.82	2.97e-11	0.27	0.31	Blood protein levels;	chr2:102448052	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs12648803	MIMAT0003242	hsa-miR-577	-6.82	2.97e-11	-0.44	-0.31	Hemoglobin concentration;	chr4:114546228	chr4:114656774~114656794:+
LUSC	cis	rs6543140	0.855	rs4851591	MIMAT0019927	hsa-miR-4772-3p	-6.82	3.03e-11	-0.3	-0.31	Blood protein levels;	chr2:102460963	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs7561351	MIMAT0019927	hsa-miR-4772-3p	-6.82	3.03e-11	-0.3	-0.31	Blood protein levels;	chr2:102461320	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs6748390	MIMAT0019927	hsa-miR-4772-3p	-6.79	3.61e-11	-0.29	-0.31	Blood protein levels;	chr2:102445715	chr2:102432336~102432357:+
LUSC	cis	rs12712135	0.709	rs11465728	MIMAT0019927	hsa-miR-4772-3p	6.79	3.62e-11	0.27	0.31	Blood protein levels;	chr2:102448051	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.687	rs12640227	MIMAT0003242	hsa-miR-577	-6.78	3.83e-11	-0.35	-0.31	Hemoglobin concentration;	chr4:114700788	chr4:114656774~114656794:+
LUSC	cis	rs6543140	0.964	rs10169192	MIMAT0019927	hsa-miR-4772-3p	-6.78	3.93e-11	-0.29	-0.31	Blood protein levels;	chr2:102455751	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs11886793	MIMAT0019927	hsa-miR-4772-3p	-6.78	3.93e-11	-0.29	-0.31	Blood protein levels;	chr2:102455760	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs2310301	MIMAT0019927	hsa-miR-4772-3p	-6.78	3.93e-11	-0.29	-0.31	Blood protein levels;	chr2:102456475	chr2:102432336~102432357:+
LUSC	cis	rs6543140	1	rs6543140	MIMAT0019927	hsa-miR-4772-3p	-6.78	3.93e-11	-0.29	-0.31	Blood protein levels;	chr2:102457814	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs13390895	MIMAT0019927	hsa-miR-4772-3p	-6.78	3.93e-11	-0.29	-0.31	Blood protein levels;	chr2:102459039	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.718	rs7656139	MIMAT0003242	hsa-miR-577	-6.77	4e-11	-0.34	-0.31	Hemoglobin concentration;	chr4:114672622	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.75	rs6857337	MIMAT0003242	hsa-miR-577	6.75	4.66e-11	0.34	0.31	Hemoglobin concentration;	chr4:114667805	chr4:114656774~114656794:+
LUSC	cis	rs6543140	0.964	rs11903551	MIMAT0019927	hsa-miR-4772-3p	-6.74	4.8e-11	-0.3	-0.3	Blood protein levels;	chr2:102467721	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs6543143	MIMAT0019927	hsa-miR-4772-3p	-6.74	4.8e-11	-0.3	-0.3	Blood protein levels;	chr2:102468960	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs13383602	MIMAT0019927	hsa-miR-4772-3p	-6.74	4.8e-11	-0.3	-0.3	Blood protein levels;	chr2:102469502	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.929	rs11465700	MIMAT0019927	hsa-miR-4772-3p	-6.7	6.16e-11	-0.29	-0.3	Blood protein levels;	chr2:102441208	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs62154972	MIMAT0019927	hsa-miR-4772-3p	-6.7	6.42e-11	-0.29	-0.3	Blood protein levels;	chr2:102432278	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs17047239	MIMAT0003242	hsa-miR-577	6.7	6.46e-11	0.45	0.3	Hemoglobin concentration;	chr4:114570559	chr4:114656774~114656794:+
LUSC	cis	rs12712135	0.709	rs55664618	MIMAT0019927	hsa-miR-4772-3p	6.7	6.47e-11	0.26	0.3	Blood protein levels;	chr2:102399756	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs10193485	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.66e-11	-0.29	-0.3	Blood protein levels;	chr2:102473114	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs10196334	MIMAT0019927	hsa-miR-4772-3p	-6.63	9.66e-11	-0.29	-0.3	Blood protein levels;	chr2:102473582	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs4851593	MIMAT0019927	hsa-miR-4772-3p	6.61	1.07e-10	0.3	0.3	Blood protein levels;	chr2:102472767	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.601	rs6543135	MIMAT0019927	hsa-miR-4772-3p	-6.61	1.11e-10	-0.32	-0.3	Blood protein levels;	chr2:102445946	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs10200081	MIMAT0019927	hsa-miR-4772-3p	-6.6	1.14e-10	-0.29	-0.3	Blood protein levels;	chr2:102475097	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.934	rs895692	MIMAT0017994	hsa-miR-3615	-6.6	1.14e-10	-0.28	-0.3	Monocyte count;	chr17:74770113	chr17:74748663~74748683:+
LUSC	cis	rs6841433	0.615	rs13144260	MIMAT0003242	hsa-miR-577	6.6	1.18e-10	0.44	0.3	Hemoglobin concentration;	chr4:114573271	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs34948407	MIMAT0003242	hsa-miR-577	6.6	1.18e-10	0.44	0.3	Hemoglobin concentration;	chr4:114575280	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.571	rs17047244	MIMAT0003242	hsa-miR-577	6.59	1.21e-10	0.44	0.3	Hemoglobin concentration;	chr4:114571532	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs17047246	MIMAT0003242	hsa-miR-577	6.59	1.21e-10	0.44	0.3	Hemoglobin concentration;	chr4:114571876	chr4:114656774~114656794:+
LUSC	cis	rs17027258	0.609	rs4851005	MIMAT0019926	hsa-miR-4772-5p	6.59	1.24e-10	0.37	0.3	White blood cell types;	chr2:102395092	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.706	rs10194822	MIMAT0019926	hsa-miR-4772-5p	-6.58	1.29e-10	-0.34	-0.3	Serum protein levels (sST2);	chr2:102549045	chr2:102432300~102432321:+
LUSC	cis	rs6543140	0.964	rs4851010	MIMAT0019927	hsa-miR-4772-3p	6.57	1.45e-10	0.29	0.3	Blood protein levels;	chr2:102439667	chr2:102432336~102432357:+
LUSC	cis	rs1014286	0.641	rs10172553	MIMAT0019926	hsa-miR-4772-5p	6.54	1.67e-10	0.34	0.3	Serum protein levels (sST2);	chr2:102536516	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.706	rs6761291	MIMAT0019926	hsa-miR-4772-5p	6.54	1.72e-10	0.34	0.3	Serum protein levels (sST2);	chr2:102538610	chr2:102432300~102432321:+
LUSC	cis	rs6841433	0.516	rs11098259	MIMAT0003242	hsa-miR-577	-6.53	1.83e-10	-0.41	-0.3	Hemoglobin concentration;	chr4:114598669	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.56	rs11098260	MIMAT0003242	hsa-miR-577	-6.53	1.83e-10	-0.41	-0.3	Hemoglobin concentration;	chr4:114598670	chr4:114656774~114656794:+
LUSC	cis	rs1014286	0.706	rs2216000	MIMAT0019926	hsa-miR-4772-5p	6.52	1.87e-10	0.34	0.3	Serum protein levels (sST2);	chr2:102516181	chr2:102432300~102432321:+
LUSC	cis	rs6543140	0.572	rs17027173	MIMAT0019927	hsa-miR-4772-3p	-6.52	1.97e-10	-0.32	-0.3	Blood protein levels;	chr2:102440583	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs4851011	MIMAT0019927	hsa-miR-4772-3p	-6.5	2.17e-10	-0.3	-0.29	Serum protein levels (sST2);	chr2:102473219	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs1035126	MIMAT0019927	hsa-miR-4772-3p	-6.48	2.41e-10	-0.28	-0.29	Blood protein levels;	chr2:102403521	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs6761350	MIMAT0019927	hsa-miR-4772-3p	-6.48	2.46e-10	-0.28	-0.29	Blood protein levels;	chr2:102414316	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.929	rs7602207	MIMAT0019927	hsa-miR-4772-3p	-6.48	2.46e-10	-0.28	-0.29	Blood protein levels;	chr2:102415906	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs2160200	MIMAT0019927	hsa-miR-4772-3p	-6.48	2.46e-10	-0.28	-0.29	Blood protein levels;	chr2:102417503	chr2:102432336~102432357:+
LUSC	cis	rs75358501	0.551	rs16838710	MIMAT0014995	hsa-miR-3130-5p	6.46	2.83e-10	0.34	0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.551	rs16838710	MIMAT0014995_1	hsa-miR-3130-5p	6.46	2.83e-10	0.34	0.29	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206724196	chr2:206783246~206783266:+
LUSC	cis	rs6841433	0.615	rs34001486	MIMAT0003242	hsa-miR-577	6.45	2.85e-10	0.44	0.29	Hemoglobin concentration;	chr4:114594792	chr4:114656774~114656794:+
LUSC	cis	rs1712517	0.566	rs1163073	MIMAT0022727	hsa-miR-1307-5p	6.44	3.19e-10	0.22	0.29	Migraine;	chr10:103263177	chr10:103394341~103394361:-
LUSC	cis	rs6543140	0.964	rs4851578	MIMAT0019927	hsa-miR-4772-3p	-6.43	3.22e-10	-0.28	-0.29	Blood protein levels;	chr2:102412491	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.693	rs7579737	MIMAT0019927	hsa-miR-4772-3p	-6.43	3.27e-10	-0.28	-0.29	Blood protein levels;	chr2:102370901	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.503	rs72846198	MIMAT0022727	hsa-miR-1307-5p	-6.43	3.31e-10	-0.23	-0.29	Migraine;	chr10:103338267	chr10:103394341~103394361:-
LUSC	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	-6.43	3.37e-10	-0.52	-0.29	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
LUSC	cis	rs1014286	0.73	rs2215998	MIMAT0019926	hsa-miR-4772-5p	6.42	3.52e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102549584	chr2:102432300~102432321:+
LUSC	cis	rs6841433	0.615	rs35789595	MIMAT0003242	hsa-miR-577	6.41	3.67e-10	0.44	0.29	Hemoglobin concentration;	chr4:114594055	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.571	rs35578985	MIMAT0003242	hsa-miR-577	6.41	3.67e-10	0.44	0.29	Hemoglobin concentration;	chr4:114594500	chr4:114656774~114656794:+
LUSC	cis	rs6543140	0.964	rs2080288	MIMAT0019927	hsa-miR-4772-3p	-6.38	4.37e-10	-0.28	-0.29	Blood protein levels;	chr2:102405706	chr2:102432336~102432357:+
LUSC	cis	rs1163656	0.502	rs10862209	MIMAT0003287	hsa-miR-618	-6.38	4.4e-10	-0.48	-0.29	Dental caries;	chr12:80933176	chr12:80935796~80935818:-
LUSC	cis	rs1163656	0.502	rs7310000	MIMAT0003287	hsa-miR-618	-6.38	4.49e-10	-0.48	-0.29	Dental caries;	chr12:80933498	chr12:80935796~80935818:-
LUSC	cis	rs1014286	0.66	rs1476999	MIMAT0019926	hsa-miR-4772-5p	6.37	4.71e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102515220	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.706	rs4851608	MIMAT0019926	hsa-miR-4772-5p	6.37	4.75e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102509525	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.706	rs2058656	MIMAT0019926	hsa-miR-4772-5p	6.37	4.75e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102520567	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.706	rs4851612	MIMAT0019926	hsa-miR-4772-5p	6.37	4.75e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102521421	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.665	rs1523204	MIMAT0019926	hsa-miR-4772-5p	6.37	4.77e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102519178	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.706	rs4851615	MIMAT0019926	hsa-miR-4772-5p	-6.37	4.85e-10	-0.32	-0.29	Serum protein levels (sST2);	chr2:102530540	chr2:102432300~102432321:+
LUSC	cis	rs1163656	0.502	rs17007704	MIMAT0003287	hsa-miR-618	-6.36	4.96e-10	-0.48	-0.29	Dental caries;	chr12:80932218	chr12:80935796~80935818:-
LUSC	cis	rs1014286	0.706	rs10196579	MIMAT0019926	hsa-miR-4772-5p	6.35	5.33e-10	0.33	0.29	Serum protein levels (sST2);	chr2:102553722	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.706	rs4851019	MIMAT0019926	hsa-miR-4772-5p	6.35	5.44e-10	0.32	0.29	Serum protein levels (sST2);	chr2:102561106	chr2:102432300~102432321:+
LUSC	cis	rs6543140	0.89	rs61122764	MIMAT0019927	hsa-miR-4772-3p	-6.32	6.48e-10	-0.27	-0.29	Blood protein levels;	chr2:102383060	chr2:102432336~102432357:+
LUSC	cis	rs1014286	0.706	rs10202404	MIMAT0019926	hsa-miR-4772-5p	-6.3	7.2e-10	-0.33	-0.29	Serum protein levels (sST2);	chr2:102560955	chr2:102432300~102432321:+
LUSC	cis	rs1163656	0.502	rs11114658	MIMAT0003287	hsa-miR-618	-6.3	7.38e-10	-0.47	-0.29	Dental caries;	chr12:80933378	chr12:80935796~80935818:-
LUSC	cis	rs6841433	0.615	rs56149980	MIMAT0003242	hsa-miR-577	6.29	7.6e-10	0.42	0.29	Hemoglobin concentration;	chr4:114576580	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs12642541	MIMAT0003242	hsa-miR-577	6.29	7.6e-10	0.42	0.29	Hemoglobin concentration;	chr4:114579576	chr4:114656774~114656794:+
LUSC	cis	rs6543140	0.601	rs7558013	MIMAT0019927	hsa-miR-4772-3p	-6.28	7.92e-10	-0.31	-0.29	Blood protein levels;	chr2:102376346	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.615	rs6813283	MIMAT0003242	hsa-miR-577	6.28	8.2e-10	0.43	0.29	Hemoglobin concentration;	chr4:114582806	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs35732213	MIMAT0003242	hsa-miR-577	6.27	8.58e-10	0.43	0.29	Hemoglobin concentration;	chr4:114581427	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.511	rs36078253	MIMAT0003242	hsa-miR-577	6.27	8.74e-10	0.39	0.29	Hemoglobin concentration;	chr4:114538112	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs57930571	MIMAT0003242	hsa-miR-577	6.26	8.86e-10	0.43	0.28	Hemoglobin concentration;	chr4:114580433	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.511	rs34534063	MIMAT0003242	hsa-miR-577	6.26	9.04e-10	0.39	0.28	Hemoglobin concentration;	chr4:114538077	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs35936834	MIMAT0003242	hsa-miR-577	6.25	9.56e-10	0.43	0.28	Hemoglobin concentration;	chr4:114581520	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.615	rs6813229	MIMAT0003242	hsa-miR-577	6.25	9.56e-10	0.43	0.28	Hemoglobin concentration;	chr4:114582721	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.571	rs6839189	MIMAT0003242	hsa-miR-577	6.25	9.56e-10	0.43	0.28	Hemoglobin concentration;	chr4:114582848	chr4:114656774~114656794:+
LUSC	cis	rs1014286	0.706	rs2310295	MIMAT0019926	hsa-miR-4772-5p	6.24	9.95e-10	0.32	0.28	Serum protein levels (sST2);	chr2:102554607	chr2:102432300~102432321:+
LUSC	cis	rs6543140	0.601	rs78178597	MIMAT0019927	hsa-miR-4772-3p	-6.24	1.01e-09	-0.3	-0.28	Blood protein levels;	chr2:102407136	chr2:102432336~102432357:+
LUSC	cis	rs1014286	0.706	rs10171438	MIMAT0019926	hsa-miR-4772-5p	-6.24	1.04e-09	-0.32	-0.28	Serum protein levels (sST2);	chr2:102558917	chr2:102432300~102432321:+
LUSC	cis	rs75358501	0.551	rs12471939	MIMAT0014995	hsa-miR-3130-5p	-6.23	1.09e-09	-0.36	-0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.551	rs12471939	MIMAT0014995_1	hsa-miR-3130-5p	-6.23	1.09e-09	-0.36	-0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206723545	chr2:206783246~206783266:+
LUSC	cis	rs1712517	0.526	rs113528138	MIMAT0022727	hsa-miR-1307-5p	-6.18	1.46e-09	-0.21	-0.28	Migraine;	chr10:103365694	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.525	rs11191667	MIMAT0022727	hsa-miR-1307-5p	-6.18	1.46e-09	-0.21	-0.28	Migraine;	chr10:103369141	chr10:103394341~103394361:-
LUSC	cis	rs75358501	0.551	rs13394079	MIMAT0014995	hsa-miR-3130-5p	-6.15	1.74e-09	-0.36	-0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.551	rs13394079	MIMAT0014995_1	hsa-miR-3130-5p	-6.15	1.74e-09	-0.36	-0.28	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206729470	chr2:206783246~206783266:+
LUSC	cis	rs1712517	0.525	rs2271751	MIMAT0022727	hsa-miR-1307-5p	-6.15	1.78e-09	-0.21	-0.28	Migraine;	chr10:103415374	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.566	rs7076274	MIMAT0022727	hsa-miR-1307-5p	-6.11	2.24e-09	-0.21	-0.28	Migraine;	chr10:103286250	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.545	rs3740381	MIMAT0022727	hsa-miR-1307-5p	-6.11	2.24e-09	-0.21	-0.28	Migraine;	chr10:103286932	chr10:103394341~103394361:-
LUSC	cis	rs8064299	0.655	rs12797	MIMAT0017994	hsa-miR-3615	-6.1	2.29e-09	-0.26	-0.28	Monocyte count;	chr17:74770854	chr17:74748663~74748683:+
LUSC	cis	rs1712517	0.588	rs12220267	MIMAT0022727	hsa-miR-1307-5p	-6.1	2.35e-09	-0.21	-0.28	Migraine;	chr10:103315955	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.525	rs7911488	MIMAT0022727	hsa-miR-1307-5p	-6.08	2.65e-09	-0.21	-0.28	Migraine;	chr10:103394332	chr10:103394341~103394361:-
LUSC	cis	rs1163656	0.534	rs17007709	MIMAT0003287	hsa-miR-618	-6.08	2.67e-09	-0.4	-0.28	Dental caries;	chr12:80934267	chr12:80935796~80935818:-
LUSC	cis	rs950880	0.71	rs3771171	MIMAT0019927	hsa-miR-4772-3p	6.07	2.68e-09	0.28	0.28	Serum protein levels (sST2);	chr2:102369490	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs17027230	MIMAT0019927	hsa-miR-4772-3p	6.07	2.69e-09	0.28	0.28	Serum protein levels (sST2);	chr2:102462870	chr2:102432336~102432357:+
LUSC	cis	rs1163656	0.502	rs17007711	MIMAT0003287	hsa-miR-618	6.07	2.71e-09	0.46	0.28	Dental caries;	chr12:80934305	chr12:80935796~80935818:-
LUSC	cis	rs950880	0.71	rs873022	MIMAT0019927	hsa-miR-4772-3p	6.06	2.85e-09	0.28	0.28	Serum protein levels (sST2);	chr2:102339223	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs12905	MIMAT0019927	hsa-miR-4772-3p	6.05	3.05e-09	0.28	0.28	Serum protein levels (sST2);	chr2:102343547	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.566	rs7917388	MIMAT0022727	hsa-miR-1307-5p	-6.05	3.08e-09	-0.21	-0.28	Migraine;	chr10:103295206	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.525	rs11191642	MIMAT0022727	hsa-miR-1307-5p	-6.05	3.08e-09	-0.21	-0.28	Migraine;	chr10:103296155	chr10:103394341~103394361:-
LUSC	cis	rs950880	0.71	rs55927292	MIMAT0019927	hsa-miR-4772-3p	6.03	3.39e-09	0.27	0.28	Serum protein levels (sST2);	chr2:102348401	chr2:102432336~102432357:+
LUSC	cis	rs6543140	0.964	rs4851589	MIMAT0019927	hsa-miR-4772-3p	-6	4.07e-09	-0.26	-0.27	Blood protein levels;	chr2:102460685	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs3771177	MIMAT0019927	hsa-miR-4772-3p	6	4.19e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102339400	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs3771172	MIMAT0019927	hsa-miR-4772-3p	6	4.2e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102369352	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs2160202	MIMAT0019927	hsa-miR-4772-3p	6	4.2e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102369694	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs67723747	MIMAT0019927	hsa-miR-4772-3p	5.98	4.68e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102353347	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs56386507	MIMAT0019927	hsa-miR-4772-3p	5.98	4.68e-09	0.28	0.27	Serum protein levels (sST2);	chr2:102354705	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs56117144	MIMAT0019927	hsa-miR-4772-3p	5.97	4.78e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102458191	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs57081652	MIMAT0019927	hsa-miR-4772-3p	5.97	4.78e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102458921	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs3821204	MIMAT0019927	hsa-miR-4772-3p	5.95	5.45e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102343821	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs12469506	MIMAT0019927	hsa-miR-4772-3p	5.95	5.45e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102349411	chr2:102432336~102432357:+
LUSC	cis	rs75358501	0.551	rs28619220	MIMAT0014995	hsa-miR-3130-5p	-5.95	5.49e-09	-0.35	-0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.551	rs28619220	MIMAT0014995_1	hsa-miR-3130-5p	-5.95	5.49e-09	-0.35	-0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206720891	chr2:206783246~206783266:+
LUSC	cis	rs75358501	0.551	rs79761690	MIMAT0014995	hsa-miR-3130-5p	-5.93	6.14e-09	-0.35	-0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.551	rs79761690	MIMAT0014995_1	hsa-miR-3130-5p	-5.93	6.14e-09	-0.35	-0.27	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206717731	chr2:206783246~206783266:+
LUSC	cis	rs950880	0.71	rs3732129	MIMAT0019927	hsa-miR-4772-3p	5.92	6.28e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102341072	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.614	rs60038017	MIMAT0019927	hsa-miR-4772-3p	5.92	6.57e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102459541	chr2:102432336~102432357:+
LUSC	cis	rs3771180	0.505	rs2160203	MIMAT0019926	hsa-miR-4772-5p	5.9	7.37e-09	0.35	0.27	Asthma;	chr2:102344364	chr2:102432300~102432321:+
LUSC	cis	rs950880	0.71	rs4140785	MIMAT0019927	hsa-miR-4772-3p	5.87	8.43e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102472057	chr2:102432336~102432357:+
LUSC	cis	rs1163656	0.534	rs11114656	MIMAT0003287	hsa-miR-618	-5.87	8.77e-09	-0.39	-0.27	Dental caries;	chr12:80925906	chr12:80935796~80935818:-
LUSC	cis	rs950880	0.71	rs1474309	MIMAT0019927	hsa-miR-4772-3p	5.85	9.42e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102474542	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs17027255	MIMAT0019927	hsa-miR-4772-3p	5.85	9.5e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102473668	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs11683700	MIMAT0019927	hsa-miR-4772-3p	5.85	9.59e-09	0.27	0.27	Serum protein levels (sST2);	chr2:102380345	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.967	rs7420	MIMAT0017994	hsa-miR-3615	5.84	1e-08	0.25	0.27	Monocyte count;	chr17:74769076	chr17:74748663~74748683:+
LUSC	cis	rs950880	0.56	rs59247511	MIMAT0019927	hsa-miR-4772-3p	5.84	1.01e-08	0.23	0.27	Serum protein levels (sST2);	chr2:102337730	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs11678975	MIMAT0019927	hsa-miR-4772-3p	5.83	1.06e-08	0.27	0.27	Serum protein levels (sST2);	chr2:102427279	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs11681718	MIMAT0019927	hsa-miR-4772-3p	5.82	1.14e-08	0.27	0.27	Serum protein levels (sST2);	chr2:102434684	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.632	rs35717197	MIMAT0003242	hsa-miR-577	-5.81	1.18e-08	-0.28	-0.27	Hemoglobin concentration;	chr4:114639584	chr4:114656774~114656794:+
LUSC	cis	rs950880	0.71	rs17027258	MIMAT0019927	hsa-miR-4772-3p	5.81	1.2e-08	0.26	0.27	Serum protein levels (sST2);	chr2:102475081	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.632	rs13106767	MIMAT0003242	hsa-miR-577	-5.81	1.21e-08	-0.28	-0.27	Hemoglobin concentration;	chr4:114635719	chr4:114656774~114656794:+
LUSC	cis	rs950880	0.71	rs56258475	MIMAT0019927	hsa-miR-4772-3p	5.8	1.24e-08	0.27	0.27	Serum protein levels (sST2);	chr2:102382852	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs56043441	MIMAT0019927	hsa-miR-4772-3p	5.8	1.25e-08	0.26	0.27	Serum protein levels (sST2);	chr2:102470923	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs17026974	MIMAT0019927	hsa-miR-4772-3p	-5.8	1.27e-08	-0.27	-0.27	Serum protein levels (sST2);	chr2:102335900	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs56331791	MIMAT0019927	hsa-miR-4772-3p	5.78	1.44e-08	0.27	0.26	Serum protein levels (sST2);	chr2:102431697	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs11693204	MIMAT0019927	hsa-miR-4772-3p	5.77	1.45e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102319514	chr2:102432336~102432357:+
LUSC	cis	rs1163656	0.534	rs12311427	MIMAT0003287	hsa-miR-618	-5.77	1.46e-08	-0.37	-0.26	Dental caries;	chr12:80934053	chr12:80935796~80935818:-
LUSC	cis	rs1163656	0.536	rs4261347	MIMAT0003287	hsa-miR-618	-5.77	1.5e-08	-0.42	-0.26	Dental caries;	chr12:80921546	chr12:80935796~80935818:-
LUSC	cis	rs950880	0.668	rs3732126	MIMAT0019927	hsa-miR-4772-3p	5.76	1.54e-08	0.27	0.26	Serum protein levels (sST2);	chr2:102397502	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs3732125	MIMAT0019927	hsa-miR-4772-3p	5.76	1.54e-08	0.27	0.26	Serum protein levels (sST2);	chr2:102397503	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.597	rs2166703	MIMAT0017994	hsa-miR-3615	-5.76	1.6e-08	-0.25	-0.26	Monocyte count;	chr17:74785673	chr17:74748663~74748683:+
LUSC	cis	rs6841433	0.632	rs6533807	MIMAT0003242	hsa-miR-577	-5.75	1.71e-08	-0.28	-0.26	Hemoglobin concentration;	chr4:114699454	chr4:114656774~114656794:+
LUSC	cis	rs6841433	0.632	rs7679995	MIMAT0003242	hsa-miR-577	-5.74	1.77e-08	-0.28	-0.26	Hemoglobin concentration;	chr4:114665137	chr4:114656774~114656794:+
LUSC	cis	rs950880	0.71	rs10490204	MIMAT0019927	hsa-miR-4772-3p	5.73	1.82e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102440074	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.744	rs3771156	MIMAT0019927	hsa-miR-4772-3p	5.73	1.83e-08	0.27	0.26	Serum protein levels (sST2);	chr2:102420217	chr2:102432336~102432357:+
LUSC	cis	rs1163656	0.536	rs7306751	MIMAT0003287	hsa-miR-618	-5.72	1.92e-08	-0.41	-0.26	Dental caries;	chr12:80922459	chr12:80935796~80935818:-
LUSC	cis	rs950880	0.71	rs17027006	MIMAT0019927	hsa-miR-4772-3p	-5.71	2.05e-08	-0.26	-0.26	Serum protein levels (sST2);	chr2:102348872	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.597	rs9944506	MIMAT0017994	hsa-miR-3615	-5.71	2.07e-08	-0.25	-0.26	Monocyte count;	chr17:74786587	chr17:74748663~74748683:+
LUSC	cis	rs6841433	0.561	rs13148598	MIMAT0003242	hsa-miR-577	-5.7	2.13e-08	-0.28	-0.26	Hemoglobin concentration;	chr4:114676939	chr4:114656774~114656794:+
LUSC	cis	rs950880	0.593	rs887972	MIMAT0019927	hsa-miR-4772-3p	5.69	2.33e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102424485	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.645	rs56044378	MIMAT0019927	hsa-miR-4772-3p	5.69	2.37e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102448907	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.524	rs4917384	MIMAT0022727	hsa-miR-1307-5p	5.68	2.41e-08	0.2	0.26	Migraine;	chr10:103236031	chr10:103394341~103394361:-
LUSC	cis	rs950880	0.71	rs3771150	MIMAT0019927	hsa-miR-4772-3p	5.68	2.43e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102444391	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs11123929	MIMAT0019927	hsa-miR-4772-3p	5.68	2.49e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102450683	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.524	rs1712509	MIMAT0022727	hsa-miR-1307-5p	-5.67	2.51e-08	-0.2	-0.26	Migraine;	chr10:103254113	chr10:103394341~103394361:-
LUSC	cis	rs950880	0.71	rs11123928	MIMAT0019927	hsa-miR-4772-3p	5.67	2.53e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102444826	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.632	rs4834428	MIMAT0003242	hsa-miR-577	-5.67	2.57e-08	-0.28	-0.26	Hemoglobin concentration;	chr4:114683908	chr4:114656774~114656794:+
LUSC	cis	rs950880	0.71	rs17027071	MIMAT0019927	hsa-miR-4772-3p	5.67	2.58e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102396214	chr2:102432336~102432357:+
LUSC	cis	rs4917385	1	rs4917385	MIMAT0022727	hsa-miR-1307-5p	5.65	2.92e-08	0.2	0.26	Systemic lupus erythematosus;	chr10:103243964	chr10:103394341~103394361:-
LUSC	cis	rs950880	0.71	rs4851582	MIMAT0019927	hsa-miR-4772-3p	5.64	2.96e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102435098	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.645	rs11679889	MIMAT0019927	hsa-miR-4772-3p	5.63	3.27e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102324549	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs66566526	MIMAT0019927	hsa-miR-4772-3p	5.62	3.37e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102431342	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.597	rs4789098	MIMAT0017994	hsa-miR-3615	-5.62	3.4e-08	-0.25	-0.26	Monocyte count;	chr17:74785153	chr17:74748663~74748683:+
LUSC	cis	rs950880	0.71	rs2270298	MIMAT0019927	hsa-miR-4772-3p	5.61	3.51e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102375619	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs17027037	MIMAT0019927	hsa-miR-4772-3p	5.61	3.51e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102378424	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs2080289	MIMAT0019927	hsa-miR-4772-3p	5.61	3.51e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102378560	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs3821203	MIMAT0019927	hsa-miR-4772-3p	5.61	3.51e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102380412	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs3771162	MIMAT0019927	hsa-miR-4772-3p	5.61	3.51e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102380714	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs11465633	MIMAT0019927	hsa-miR-4772-3p	5.61	3.51e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102381273	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs1035130	MIMAT0019927	hsa-miR-4772-3p	5.61	3.61e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102384942	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.645	rs4851006	MIMAT0019927	hsa-miR-4772-3p	5.6	3.7e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102408278	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs11693955	MIMAT0019927	hsa-miR-4772-3p	5.6	3.81e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102412705	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs7597017	MIMAT0019927	hsa-miR-4772-3p	5.6	3.84e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102445656	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs55645612	MIMAT0019927	hsa-miR-4772-3p	5.59	3.93e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102439201	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs56166614	MIMAT0019927	hsa-miR-4772-3p	5.59	3.93e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102439636	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs17027179	MIMAT0019927	hsa-miR-4772-3p	5.59	3.93e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102440699	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs17027060	MIMAT0019927	hsa-miR-4772-3p	5.59	3.93e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102391107	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs66919607	MIMAT0019927	hsa-miR-4772-3p	5.59	3.93e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102392509	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.677	rs17027087	MIMAT0019927	hsa-miR-4772-3p	5.59	4.04e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102399458	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs55883125	MIMAT0019927	hsa-miR-4772-3p	5.58	4.09e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102407871	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs1135354	MIMAT0019927	hsa-miR-4772-3p	5.57	4.47e-08	0.26	0.26	Serum protein levels (sST2);	chr2:102397842	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs11123927	MIMAT0019927	hsa-miR-4772-3p	5.55	4.91e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102442343	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs10490203	MIMAT0019927	hsa-miR-4772-3p	5.55	4.91e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102442777	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs4851583	MIMAT0019927	hsa-miR-4772-3p	5.55	4.91e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102443840	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs11694360	MIMAT0019927	hsa-miR-4772-3p	5.55	4.91e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102444687	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.677	rs4851585	MIMAT0019927	hsa-miR-4772-3p	5.55	4.91e-08	0.25	0.25	Serum protein levels (sST2);	chr2:102446294	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs3732123	MIMAT0019927	hsa-miR-4772-3p	5.55	5.02e-08	0.26	0.25	Serum protein levels (sST2);	chr2:102401617	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs55742125	MIMAT0019927	hsa-miR-4772-3p	5.55	5.02e-08	0.26	0.25	Serum protein levels (sST2);	chr2:102403322	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs12712140	MIMAT0019927	hsa-miR-4772-3p	5.54	5.18e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102334602	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.58	rs1997467	MIMAT0019927	hsa-miR-4772-3p	5.54	5.18e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102334613	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.565	rs12453550	MIMAT0017994	hsa-miR-3615	-5.53	5.45e-08	-0.24	-0.25	Monocyte count;	chr17:74789947	chr17:74748663~74748683:+
LUSC	cis	rs950880	0.56	rs66780767	MIMAT0019927	hsa-miR-4772-3p	5.5	6.33e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102323249	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs4851570	MIMAT0019927	hsa-miR-4772-3p	5.5	6.53e-08	0.26	0.25	Serum protein levels (sST2);	chr2:102389927	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs2287034	MIMAT0019927	hsa-miR-4772-3p	-5.49	6.68e-08	-0.25	-0.25	Serum protein levels (sST2);	chr2:102394128	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs971764	MIMAT0019927	hsa-miR-4772-3p	5.49	6.81e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102321875	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs6706844	MIMAT0019927	hsa-miR-4772-3p	5.49	6.81e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102323952	chr2:102432336~102432357:+
LUSC	cis	rs6841433	0.632	rs13152031	MIMAT0003242	hsa-miR-577	-5.49	6.9e-08	-0.26	-0.25	Hemoglobin concentration;	chr4:114644503	chr4:114656774~114656794:+
LUSC	cis	rs950880	0.56	rs1362350	MIMAT0019927	hsa-miR-4772-3p	5.48	7.21e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102335338	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.597	rs7210318	MIMAT0017994	hsa-miR-3615	-5.47	7.37e-08	-0.24	-0.25	Monocyte count;	chr17:74787246	chr17:74748663~74748683:+
LUSC	cis	rs8064299	0.597	rs4789097	MIMAT0017994	hsa-miR-3615	5.47	7.48e-08	0.24	0.25	Monocyte count;	chr17:74785069	chr17:74748663~74748683:+
LUSC	cis	rs950880	0.56	rs10189711	MIMAT0019927	hsa-miR-4772-3p	5.47	7.49e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102314421	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.597	rs6501736	MIMAT0017994	hsa-miR-3615	-5.46	7.87e-08	-0.24	-0.25	Monocyte count;	chr17:74779219	chr17:74748663~74748683:+
LUSC	cis	rs950880	0.553	rs2241116	MIMAT0019927	hsa-miR-4772-3p	5.46	8.15e-08	0.29	0.25	Serum protein levels (sST2);	chr2:102386805	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs11690443	MIMAT0019927	hsa-miR-4772-3p	5.45	8.36e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102319671	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.536	rs2290038	MIMAT0017994	hsa-miR-3615	5.45	8.48e-08	0.25	0.25	Monocyte count;	chr17:74790472	chr17:74748663~74748683:+
LUSC	cis	rs76886731	1	rs76886731	MIMAT0019927	hsa-miR-4772-3p	5.45	8.55e-08	0.22	0.25	Leprosy;	chr2:102328956	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.542	rs12996505	MIMAT0019927	hsa-miR-4772-3p	5.44	8.69e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102315342	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs12712136	MIMAT0019927	hsa-miR-4772-3p	5.44	8.73e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102319906	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs4142132	MIMAT0019927	hsa-miR-4772-3p	5.44	8.73e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102321022	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.517	rs1420088	MIMAT0019927	hsa-miR-4772-3p	5.44	8.73e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102322974	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs11123920	MIMAT0019927	hsa-miR-4772-3p	5.44	8.73e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102323373	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs11676075	MIMAT0019927	hsa-miR-4772-3p	5.44	8.73e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102324755	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.518	rs12996772	MIMAT0019927	hsa-miR-4772-3p	5.44	8.73e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102330741	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs12466380	MIMAT0019927	hsa-miR-4772-3p	5.44	8.73e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102332479	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs10183388	MIMAT0019927	hsa-miR-4772-3p	5.44	8.89e-08	0.21	0.25	Serum protein levels (sST2);	chr2:102315787	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs1997466	MIMAT0019927	hsa-miR-4772-3p	5.44	8.96e-08	0.22	0.25	Serum protein levels (sST2);	chr2:102335007	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.56	rs11077763	MIMAT0017994	hsa-miR-3615	-5.43	9.22e-08	-0.24	-0.25	Monocyte count;	chr17:74789890	chr17:74748663~74748683:+
LUSC	cis	rs8064299	0.597	rs2016126	MIMAT0017994	hsa-miR-3615	-5.41	1.02e-07	-0.24	-0.25	Monocyte count;	chr17:74788793	chr17:74748663~74748683:+
LUSC	cis	rs8064299	0.597	rs2053748	MIMAT0017994	hsa-miR-3615	5.4	1.11e-07	0.24	0.25	Monocyte count;	chr17:74779772	chr17:74748663~74748683:+
LUSC	cis	rs1014286	1	rs2015478	MIMAT0019926	hsa-miR-4772-5p	5.39	1.16e-07	0.28	0.25	Serum protein levels (sST2);	chr2:102524988	chr2:102432300~102432321:+
LUSC	cis	rs75358501	0.551	rs10171736	MIMAT0014995	hsa-miR-3130-5p	-5.39	1.17e-07	-0.29	-0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206728167	chr2:206783276~206783296:-
LUSC	cis	rs75358501	0.551	rs10171736	MIMAT0014995_1	hsa-miR-3130-5p	-5.39	1.17e-07	-0.29	-0.25	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206728167	chr2:206783246~206783266:+
LUSC	cis	rs1014286	1	rs4851614	MIMAT0019926	hsa-miR-4772-5p	5.38	1.18e-07	0.28	0.25	Serum protein levels (sST2);	chr2:102523939	chr2:102432300~102432321:+
LUSC	cis	rs8064299	0.597	rs9893035	MIMAT0017994	hsa-miR-3615	-5.38	1.21e-07	-0.24	-0.25	Monocyte count;	chr17:74787659	chr17:74748663~74748683:+
LUSC	cis	rs1014286	1	rs6737119	MIMAT0019926	hsa-miR-4772-5p	5.38	1.21e-07	0.28	0.25	Serum protein levels (sST2);	chr2:102534650	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.965	rs6709284	MIMAT0019926	hsa-miR-4772-5p	5.38	1.23e-07	0.28	0.25	Serum protein levels (sST2);	chr2:102534705	chr2:102432300~102432321:+
LUSC	cis	rs1014286	1	rs1014286	MIMAT0019926	hsa-miR-4772-5p	5.37	1.25e-07	0.28	0.25	Serum protein levels (sST2);	chr2:102532641	chr2:102432300~102432321:+
LUSC	cis	rs950880	0.542	rs6543118	MIMAT0019927	hsa-miR-4772-3p	5.37	1.27e-07	0.21	0.25	Serum protein levels (sST2);	chr2:102313009	chr2:102432336~102432357:+
LUSC	cis	rs1014286	1	rs1357471	MIMAT0019926	hsa-miR-4772-5p	5.36	1.31e-07	0.28	0.25	Serum protein levels (sST2);	chr2:102524013	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.964	rs1003431	MIMAT0019926	hsa-miR-4772-5p	5.36	1.31e-07	0.27	0.25	Serum protein levels (sST2);	chr2:102530797	chr2:102432300~102432321:+
LUSC	cis	rs1014286	1	rs741285	MIMAT0019926	hsa-miR-4772-5p	5.36	1.31e-07	0.27	0.25	Serum protein levels (sST2);	chr2:102531710	chr2:102432300~102432321:+
LUSC	cis	rs950880	0.56	rs974389	MIMAT0019927	hsa-miR-4772-3p	-5.36	1.31e-07	-0.21	-0.25	Serum protein levels (sST2);	chr2:102320521	chr2:102432336~102432357:+
LUSC	cis	rs9663711	1	rs9663711	MIMAT0022727	hsa-miR-1307-5p	5.36	1.31e-07	0.18	0.25	Carotid plaque burden;	chr10:102787871	chr10:103394341~103394361:-
LUSC	cis	rs1014286	1	rs2008157	MIMAT0019926	hsa-miR-4772-5p	5.36	1.32e-07	0.28	0.25	Serum protein levels (sST2);	chr2:102532723	chr2:102432300~102432321:+
LUSC	cis	rs8064299	0.597	rs3785539	MIMAT0017994	hsa-miR-3615	-5.36	1.35e-07	-0.24	-0.25	Monocyte count;	chr17:74778960	chr17:74748663~74748683:+
LUSC	cis	rs950880	0.56	rs12712141	MIMAT0019927	hsa-miR-4772-3p	5.35	1.4e-07	0.21	0.25	Serum protein levels (sST2);	chr2:102336607	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs1558622	MIMAT0019927	hsa-miR-4772-3p	5.34	1.46e-07	0.21	0.25	Serum protein levels (sST2);	chr2:102313687	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs10189202	MIMAT0019927	hsa-miR-4772-3p	5.34	1.46e-07	0.21	0.25	Serum protein levels (sST2);	chr2:102313920	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs10191914	MIMAT0019927	hsa-miR-4772-3p	5.34	1.46e-07	0.21	0.25	Serum protein levels (sST2);	chr2:102314197	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs1420102	MIMAT0019927	hsa-miR-4772-3p	5.34	1.48e-07	0.21	0.25	Serum protein levels (sST2);	chr2:102332359	chr2:102432336~102432357:+
LUSC	cis	rs7072216	0.763	rs4475861	MIMAT0005878	hsa-miR-1287-5p	5.34	1.48e-07	0.27	0.25	Metabolite levels;	chr10:98405232	chr10:98395271~98395292:-
LUSC	cis	rs950880	0.56	rs1558620	MIMAT0019927	hsa-miR-4772-3p	5.33	1.54e-07	0.21	0.25	Serum protein levels (sST2);	chr2:102314935	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.517	rs1968170	MIMAT0019927	hsa-miR-4772-3p	5.33	1.56e-07	0.21	0.25	Serum protein levels (sST2);	chr2:102317342	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs11123918	MIMAT0019927	hsa-miR-4772-3p	5.33	1.56e-07	0.21	0.25	Serum protein levels (sST2);	chr2:102318777	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs13020793	MIMAT0019927	hsa-miR-4772-3p	5.33	1.57e-07	0.21	0.25	Serum protein levels (sST2);	chr2:102315466	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs10182639	MIMAT0019927	hsa-miR-4772-3p	5.33	1.57e-07	0.21	0.25	Serum protein levels (sST2);	chr2:102319345	chr2:102432336~102432357:+
LUSC	cis	rs1014286	1	rs4851018	MIMAT0019926	hsa-miR-4772-5p	5.32	1.64e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102530156	chr2:102432300~102432321:+
LUSC	cis	rs1014286	1	rs2008159	MIMAT0019926	hsa-miR-4772-5p	5.31	1.7e-07	0.28	0.24	Serum protein levels (sST2);	chr2:102532703	chr2:102432300~102432321:+
LUSC	cis	rs950880	0.542	rs12712135	MIMAT0019927	hsa-miR-4772-3p	5.31	1.7e-07	0.21	0.24	Serum protein levels (sST2);	chr2:102314488	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs6733174	MIMAT0019927	hsa-miR-4772-3p	5.31	1.76e-07	0.21	0.24	Serum protein levels (sST2);	chr2:102312552	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs17027166	MIMAT0019927	hsa-miR-4772-3p	5.3	1.78e-07	0.25	0.24	Serum protein levels (sST2);	chr2:102438960	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.542	rs1558621	MIMAT0019927	hsa-miR-4772-3p	5.3	1.79e-07	0.21	0.24	Serum protein levels (sST2);	chr2:102313847	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs1362349	MIMAT0019927	hsa-miR-4772-3p	5.3	1.81e-07	0.21	0.24	Serum protein levels (sST2);	chr2:102335512	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.597	rs6501737	MIMAT0017994	hsa-miR-3615	5.3	1.85e-07	0.23	0.24	Monocyte count;	chr17:74784691	chr17:74748663~74748683:+
LUSC	cis	rs1014286	1	rs4241211	MIMAT0019926	hsa-miR-4772-5p	5.3	1.87e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102526700	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.965	rs12712156	MIMAT0019926	hsa-miR-4772-5p	5.3	1.87e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102527561	chr2:102432300~102432321:+
LUSC	cis	rs1014286	1	rs3849364	MIMAT0019926	hsa-miR-4772-5p	5.3	1.87e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102527783	chr2:102432300~102432321:+
LUSC	cis	rs1014286	0.965	rs3849365	MIMAT0019926	hsa-miR-4772-5p	5.3	1.87e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102527932	chr2:102432300~102432321:+
LUSC	cis	rs1014286	1	rs3849366	MIMAT0019926	hsa-miR-4772-5p	5.3	1.87e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102528441	chr2:102432300~102432321:+
LUSC	cis	rs1014286	1	rs6739236	MIMAT0019926	hsa-miR-4772-5p	5.3	1.87e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102528485	chr2:102432300~102432321:+
LUSC	cis	rs1014286	1	rs6712696	MIMAT0019926	hsa-miR-4772-5p	5.3	1.87e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102528542	chr2:102432300~102432321:+
LUSC	cis	rs1014286	1	rs1005042	MIMAT0019926	hsa-miR-4772-5p	5.3	1.87e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102528900	chr2:102432300~102432321:+
LUSC	cis	rs8064299	0.655	rs895691	MIMAT0017994	hsa-miR-3615	-5.29	1.88e-07	-0.22	-0.24	Monocyte count;	chr17:74770161	chr17:74748663~74748683:+
LUSC	cis	rs12712135	0.706	rs6543114	MIMAT0019927	hsa-miR-4772-3p	5.29	1.9e-07	0.25	0.24	Blood protein levels;	chr2:102309534	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.71	rs12470867	MIMAT0019927	hsa-miR-4772-3p	5.29	1.94e-07	0.25	0.24	Serum protein levels (sST2);	chr2:102309906	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.584	rs2384957	MIMAT0017994	hsa-miR-3615	-5.28	1.98e-07	-0.23	-0.24	Monocyte count;	chr17:74788491	chr17:74748663~74748683:+
LUSC	cis	rs1163656	0.572	rs1402348	MIMAT0003287	hsa-miR-618	-5.28	2e-07	-0.34	-0.24	Dental caries;	chr12:80919695	chr12:80935796~80935818:-
LUSC	cis	rs950880	0.677	rs56224165	MIMAT0019927	hsa-miR-4772-3p	5.28	2.03e-07	0.25	0.24	Serum protein levels (sST2);	chr2:102308763	chr2:102432336~102432357:+
LUSC	cis	rs74233809	0.748	rs10786736	MIMAT0022727	hsa-miR-1307-5p	-5.28	2.05e-07	-0.32	-0.24	Birth weight;	chr10:103089359	chr10:103394341~103394361:-
LUSC	cis	rs8064299	0.574	rs1879455	MIMAT0017994	hsa-miR-3615	-5.27	2.14e-07	-0.24	-0.24	Monocyte count;	chr17:74778599	chr17:74748663~74748683:+
LUSC	cis	rs950880	0.56	rs11685480	MIMAT0019927	hsa-miR-4772-3p	5.26	2.23e-07	0.21	0.24	Serum protein levels (sST2);	chr2:102310626	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.553	rs3755272	MIMAT0019927	hsa-miR-4772-3p	5.26	2.29e-07	0.28	0.24	Serum protein levels (sST2);	chr2:102417365	chr2:102432336~102432357:+
LUSC	cis	rs7072216	0.726	rs4474372	MIMAT0005878	hsa-miR-1287-5p	5.25	2.37e-07	0.27	0.24	Metabolite levels;	chr10:98404814	chr10:98395271~98395292:-
LUSC	cis	rs7851726	0.966	rs7019822	MIMAT0019208	hsa-miR-3074-5p	-5.25	2.42e-07	-0.24	-0.24	Urinary albumin-to-creatinine ratio;	chr9:94720609	chr9:95086063~95086083:-
LUSC	cis	rs950880	0.542	rs953934	MIMAT0019927	hsa-miR-4772-3p	5.24	2.45e-07	0.21	0.24	Serum protein levels (sST2);	chr2:102315833	chr2:102432336~102432357:+
LUSC	cis	rs1018697	0.966	rs6584526	MIMAT0022727	hsa-miR-1307-5p	5.23	2.57e-07	0.17	0.24	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394341~103394361:-
LUSC	cis	rs950880	0.553	rs2293225	MIMAT0019927	hsa-miR-4772-3p	5.23	2.66e-07	0.28	0.24	Serum protein levels (sST2);	chr2:102419429	chr2:102432336~102432357:+
LUSC	cis	rs1014286	1	rs4292112	MIMAT0019926	hsa-miR-4772-5p	5.21	2.84e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102537321	chr2:102432300~102432321:+
LUSC	cis	rs950880	0.542	rs7568913	MIMAT0019927	hsa-miR-4772-3p	5.19	3.21e-07	0.21	0.24	Serum protein levels (sST2);	chr2:102303577	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.542	rs10179654	MIMAT0019927	hsa-miR-4772-3p	5.19	3.21e-07	0.21	0.24	Serum protein levels (sST2);	chr2:102305323	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs1558619	MIMAT0019927	hsa-miR-4772-3p	5.18	3.36e-07	0.21	0.24	Serum protein levels (sST2);	chr2:102315090	chr2:102432336~102432357:+
LUSC	cis	rs7072216	0.69	rs113195335	MIMAT0005878	hsa-miR-1287-5p	5.16	3.67e-07	0.26	0.24	Metabolite levels;	chr10:98415775	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.727	rs3750603	MIMAT0005878	hsa-miR-1287-5p	5.16	3.67e-07	0.26	0.24	Metabolite levels;	chr10:98415779	chr10:98395271~98395292:-
LUSC	cis	rs950880	0.56	rs10178436	MIMAT0019927	hsa-miR-4772-3p	5.16	3.69e-07	0.2	0.24	Serum protein levels (sST2);	chr2:102310051	chr2:102432336~102432357:+
LUSC	cis	rs7072216	0.763	rs10732782	MIMAT0005878	hsa-miR-1287-5p	5.16	3.74e-07	0.26	0.24	Metabolite levels;	chr10:98406749	chr10:98395271~98395292:-
LUSC	cis	rs1014286	1	rs1005043	MIMAT0019926	hsa-miR-4772-5p	-5.16	3.76e-07	-0.27	-0.24	Serum protein levels (sST2);	chr2:102528967	chr2:102432300~102432321:+
LUSC	cis	rs1014286	1	rs10193009	MIMAT0019926	hsa-miR-4772-5p	5.16	3.78e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102552518	chr2:102432300~102432321:+
LUSC	cis	rs950880	0.56	rs11685424	MIMAT0019927	hsa-miR-4772-3p	5.15	3.84e-07	0.2	0.24	Serum protein levels (sST2);	chr2:102310521	chr2:102432336~102432357:+
LUSC	cis	rs7072216	0.763	rs942804	MIMAT0005878	hsa-miR-1287-5p	5.15	3.88e-07	0.26	0.24	Metabolite levels;	chr10:98408742	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs6584205	MIMAT0005878	hsa-miR-1287-5p	5.15	3.97e-07	0.26	0.24	Metabolite levels;	chr10:98414049	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs3750601	MIMAT0005878	hsa-miR-1287-5p	5.15	3.97e-07	0.26	0.24	Metabolite levels;	chr10:98414804	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs2147900	MIMAT0005878	hsa-miR-1287-5p	5.15	3.97e-07	0.26	0.24	Metabolite levels;	chr10:98414964	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs2274246	MIMAT0005878	hsa-miR-1287-5p	5.15	3.97e-07	0.26	0.24	Metabolite levels;	chr10:98415303	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs2274245	MIMAT0005878	hsa-miR-1287-5p	5.15	3.97e-07	0.26	0.24	Metabolite levels;	chr10:98415325	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs2274244	MIMAT0005878	hsa-miR-1287-5p	5.15	3.97e-07	0.26	0.24	Metabolite levels;	chr10:98415461	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs2274243	MIMAT0005878	hsa-miR-1287-5p	5.15	3.97e-07	0.26	0.24	Metabolite levels;	chr10:98415510	chr10:98395271~98395292:-
LUSC	cis	rs1014286	1	rs10490202	MIMAT0019926	hsa-miR-4772-5p	5.14	4.15e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102544373	chr2:102432300~102432321:+
LUSC	cis	rs1018697	0.966	rs10748831	MIMAT0022727	hsa-miR-1307-5p	5.14	4.19e-07	0.17	0.24	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs7909612	MIMAT0022727	hsa-miR-1307-5p	5.14	4.2e-07	0.17	0.24	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.763	rs7914401	MIMAT0005878	hsa-miR-1287-5p	5.14	4.22e-07	0.25	0.24	Metabolite levels;	chr10:98404171	chr10:98395271~98395292:-
LUSC	cis	rs1018697	0.966	rs1953930	MIMAT0022727	hsa-miR-1307-5p	5.13	4.26e-07	0.17	0.24	Colorectal adenoma (advanced);	chr10:102789704	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.763	rs942803	MIMAT0005878	hsa-miR-1287-5p	5.13	4.28e-07	0.26	0.24	Metabolite levels;	chr10:98408874	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.691	rs7910973	MIMAT0005878	hsa-miR-1287-5p	5.13	4.36e-07	0.26	0.24	Metabolite levels;	chr10:98406975	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs7911036	MIMAT0005878	hsa-miR-1287-5p	5.13	4.36e-07	0.26	0.24	Metabolite levels;	chr10:98407258	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs10883090	MIMAT0005878	hsa-miR-1287-5p	5.13	4.36e-07	0.26	0.24	Metabolite levels;	chr10:98407479	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs45523432	MIMAT0005878	hsa-miR-1287-5p	5.13	4.36e-07	0.26	0.24	Metabolite levels;	chr10:98407679	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs12763044	MIMAT0005878	hsa-miR-1287-5p	5.13	4.36e-07	0.26	0.24	Metabolite levels;	chr10:98407694	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.727	rs942808	MIMAT0005878	hsa-miR-1287-5p	5.13	4.36e-07	0.26	0.24	Metabolite levels;	chr10:98408345	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs942805	MIMAT0005878	hsa-miR-1287-5p	5.13	4.36e-07	0.26	0.24	Metabolite levels;	chr10:98408615	chr10:98395271~98395292:-
LUSC	cis	rs950880	0.56	rs4399750	MIMAT0019927	hsa-miR-4772-3p	5.12	4.67e-07	0.2	0.24	Serum protein levels (sST2);	chr2:102301328	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs1420090	MIMAT0019927	hsa-miR-4772-3p	5.12	4.67e-07	0.2	0.24	Serum protein levels (sST2);	chr2:102302845	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs7565653	MIMAT0019927	hsa-miR-4772-3p	5.12	4.67e-07	0.2	0.24	Serum protein levels (sST2);	chr2:102302966	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.56	rs4090473	MIMAT0019927	hsa-miR-4772-3p	5.12	4.67e-07	0.2	0.24	Serum protein levels (sST2);	chr2:102306527	chr2:102432336~102432357:+
LUSC	cis	rs1014286	1	rs2177317	MIMAT0019926	hsa-miR-4772-5p	5.11	4.9e-07	0.27	0.24	Serum protein levels (sST2);	chr2:102534860	chr2:102432300~102432321:+
LUSC	cis	rs950880	0.56	rs2110660	MIMAT0019927	hsa-miR-4772-3p	5.11	4.91e-07	0.2	0.24	Serum protein levels (sST2);	chr2:102302141	chr2:102432336~102432357:+
LUSC	cis	rs7072216	0.763	rs7923729	MIMAT0005878	hsa-miR-1287-5p	5.1	5.05e-07	0.26	0.24	Metabolite levels;	chr10:98409708	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs6584198	MIMAT0005878	hsa-miR-1287-5p	5.1	5.05e-07	0.26	0.24	Metabolite levels;	chr10:98410149	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.727	rs6584199	MIMAT0005878	hsa-miR-1287-5p	5.1	5.05e-07	0.26	0.24	Metabolite levels;	chr10:98410226	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs6584201	MIMAT0005878	hsa-miR-1287-5p	5.1	5.05e-07	0.26	0.24	Metabolite levels;	chr10:98410452	chr10:98395271~98395292:-
LUSC	cis	rs950880	0.56	rs12476968	MIMAT0019927	hsa-miR-4772-3p	5.1	5.09e-07	0.2	0.24	Serum protein levels (sST2);	chr2:102308202	chr2:102432336~102432357:+
LUSC	cis	rs7072216	0.763	rs3814140	MIMAT0005878	hsa-miR-1287-5p	5.1	5.16e-07	0.26	0.24	Metabolite levels;	chr10:98411005	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs6584200	MIMAT0005878	hsa-miR-1287-5p	5.08	5.43e-07	0.26	0.23	Metabolite levels;	chr10:98410280	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs7910014	MIMAT0005878	hsa-miR-1287-5p	5.08	5.57e-07	0.26	0.23	Metabolite levels;	chr10:98412353	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs7910247	MIMAT0005878	hsa-miR-1287-5p	5.08	5.57e-07	0.26	0.23	Metabolite levels;	chr10:98412495	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.727	rs7913541	MIMAT0005878	hsa-miR-1287-5p	5.08	5.57e-07	0.26	0.23	Metabolite levels;	chr10:98412722	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs6584204	MIMAT0005878	hsa-miR-1287-5p	5.08	5.57e-07	0.26	0.23	Metabolite levels;	chr10:98413823	chr10:98395271~98395292:-
LUSC	cis	rs1014286	1	rs7581853	MIMAT0019926	hsa-miR-4772-5p	5.08	5.63e-07	0.26	0.23	Serum protein levels (sST2);	chr2:102551265	chr2:102432300~102432321:+
LUSC	cis	rs6681460	0.565	rs1536112	MIMAT0014979	hsa-miR-3117-3p	5.08	5.69e-07	0.25	0.23	Presence of antiphospholipid antibodies;	chr1:66641542	chr1:66628485~66628505:+
LUSC	cis	rs7072216	0.763	rs3814142	MIMAT0005878	hsa-miR-1287-5p	5.07	5.77e-07	0.26	0.23	Metabolite levels;	chr10:98411347	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.691	rs3829853	MIMAT0005878	hsa-miR-1287-5p	5.07	5.77e-07	0.26	0.23	Metabolite levels;	chr10:98411417	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.727	rs10748728	MIMAT0005878	hsa-miR-1287-5p	5.07	5.77e-07	0.26	0.23	Metabolite levels;	chr10:98411441	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs10748729	MIMAT0005878	hsa-miR-1287-5p	5.07	5.77e-07	0.26	0.23	Metabolite levels;	chr10:98411614	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs10748730	MIMAT0005878	hsa-miR-1287-5p	5.07	5.77e-07	0.26	0.23	Metabolite levels;	chr10:98411683	chr10:98395271~98395292:-
LUSC	cis	rs950880	0.56	rs12476925	MIMAT0019927	hsa-miR-4772-3p	5.07	5.84e-07	0.2	0.23	Serum protein levels (sST2);	chr2:102308089	chr2:102432336~102432357:+
LUSC	cis	rs7072216	0.587	rs3814141	MIMAT0005878	hsa-miR-1287-5p	5.07	5.89e-07	0.28	0.23	Metabolite levels;	chr10:98411271	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs733345	MIMAT0005878	hsa-miR-1287-5p	5.06	6.06e-07	0.26	0.23	Metabolite levels;	chr10:98404458	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs733346	MIMAT0005878	hsa-miR-1287-5p	5.06	6.06e-07	0.26	0.23	Metabolite levels;	chr10:98404568	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs942803	MIMAT0026738	hsa-miR-1287-3p	5.05	6.36e-07	0.22	0.23	Metabolite levels;	chr10:98408874	chr10:98395232~98395253:-
LUSC	cis	rs1163656	0.819	rs1716537	MIMAT0003287	hsa-miR-618	5.05	6.55e-07	0.32	0.23	Dental caries;	chr12:80940959	chr12:80935796~80935818:-
LUSC	cis	rs950880	0.56	rs6721346	MIMAT0019927	hsa-miR-4772-3p	5.05	6.57e-07	0.2	0.23	Serum protein levels (sST2);	chr2:102309860	chr2:102432336~102432357:+
LUSC	cis	rs1867631	1	rs11208927	MIMAT0014979	hsa-miR-3117-3p	-5.05	6.6e-07	-0.27	-0.23	Menopause (age at onset);	chr1:66623878	chr1:66628485~66628505:+
LUSC	cis	rs7072216	0.806	rs9804285	MIMAT0005878	hsa-miR-1287-5p	5.04	6.64e-07	0.26	0.23	Metabolite levels;	chr10:98409715	chr10:98395271~98395292:-
LUSC	cis	rs950880	0.542	rs1420091	MIMAT0019927	hsa-miR-4772-3p	5.04	6.71e-07	0.2	0.23	Serum protein levels (sST2);	chr2:102300774	chr2:102432336~102432357:+
LUSC	cis	rs7072216	0.763	rs10736129	MIMAT0026738	hsa-miR-1287-3p	-5.04	6.88e-07	-0.22	-0.23	Metabolite levels;	chr10:98411814	chr10:98395232~98395253:-
LUSC	cis	rs950880	0.56	rs11679191	MIMAT0019927	hsa-miR-4772-3p	5.04	6.89e-07	0.2	0.23	Serum protein levels (sST2);	chr2:102310340	chr2:102432336~102432357:+
LUSC	cis	rs1018697	1	rs7896903	MIMAT0022727	hsa-miR-1307-5p	5.03	6.99e-07	0.16	0.23	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.904	rs7905968	MIMAT0022727	hsa-miR-1307-5p	-5.03	7.06e-07	-0.16	-0.23	Migraine;	chr10:103375562	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.763	rs10736129	MIMAT0005878	hsa-miR-1287-5p	-5.03	7.11e-07	-0.26	-0.23	Metabolite levels;	chr10:98411814	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs942804	MIMAT0026738	hsa-miR-1287-3p	5.02	7.35e-07	0.22	0.23	Metabolite levels;	chr10:98408742	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs3814142	MIMAT0026738	hsa-miR-1287-3p	5.02	7.38e-07	0.22	0.23	Metabolite levels;	chr10:98411347	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.691	rs3829853	MIMAT0026738	hsa-miR-1287-3p	5.02	7.38e-07	0.22	0.23	Metabolite levels;	chr10:98411417	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.727	rs10748728	MIMAT0026738	hsa-miR-1287-3p	5.02	7.38e-07	0.22	0.23	Metabolite levels;	chr10:98411441	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs10748729	MIMAT0026738	hsa-miR-1287-3p	5.02	7.38e-07	0.22	0.23	Metabolite levels;	chr10:98411614	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs10748730	MIMAT0026738	hsa-miR-1287-3p	5.02	7.38e-07	0.22	0.23	Metabolite levels;	chr10:98411683	chr10:98395232~98395253:-
LUSC	cis	rs1018697	1	rs7092051	MIMAT0022727	hsa-miR-1307-5p	5.02	7.41e-07	0.16	0.23	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.587	rs3814141	MIMAT0026738	hsa-miR-1287-3p	5.02	7.42e-07	0.24	0.23	Metabolite levels;	chr10:98411271	chr10:98395232~98395253:-
LUSC	cis	rs1018697	1	rs7092346	MIMAT0022727	hsa-miR-1307-5p	5.02	7.42e-07	0.17	0.23	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394341~103394361:-
LUSC	cis	rs950880	0.71	rs2287035	MIMAT0019927	hsa-miR-4772-3p	5.02	7.51e-07	0.23	0.23	Serum protein levels (sST2);	chr2:102394070	chr2:102432336~102432357:+
LUSC	cis	rs8064299	0.655	rs734232	MIMAT0017994	hsa-miR-3615	-5.02	7.54e-07	-0.22	-0.23	Monocyte count;	chr17:74769592	chr17:74748663~74748683:+
LUSC	cis	rs7072216	0.763	rs7910014	MIMAT0026738	hsa-miR-1287-3p	5.01	7.74e-07	0.22	0.23	Metabolite levels;	chr10:98412353	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs7910247	MIMAT0026738	hsa-miR-1287-3p	5.01	7.74e-07	0.22	0.23	Metabolite levels;	chr10:98412495	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.727	rs7913541	MIMAT0026738	hsa-miR-1287-3p	5.01	7.74e-07	0.22	0.23	Metabolite levels;	chr10:98412722	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs6584204	MIMAT0026738	hsa-miR-1287-3p	5.01	7.74e-07	0.22	0.23	Metabolite levels;	chr10:98413823	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs10732782	MIMAT0026738	hsa-miR-1287-3p	5.01	7.76e-07	0.22	0.23	Metabolite levels;	chr10:98406749	chr10:98395232~98395253:-
LUSC	cis	rs1018697	1	rs10786710	MIMAT0022727	hsa-miR-1307-5p	5.01	7.8e-07	0.17	0.23	Colorectal adenoma (advanced);	chr10:102788982	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs11191397	MIMAT0022727	hsa-miR-1307-5p	5.01	7.9e-07	0.16	0.23	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs7073114	MIMAT0022727	hsa-miR-1307-5p	5.01	7.97e-07	0.16	0.23	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394341~103394361:-
LUSC	cis	rs1014286	1	rs997056	MIMAT0019926	hsa-miR-4772-5p	5.01	8.03e-07	0.26	0.23	Serum protein levels (sST2);	chr2:102554460	chr2:102432300~102432321:+
LUSC	cis	rs7072216	0.727	rs942807	MIMAT0005878	hsa-miR-1287-5p	5.01	8.04e-07	0.25	0.23	Metabolite levels;	chr10:98408462	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs3814140	MIMAT0026738	hsa-miR-1287-3p	5	8.11e-07	0.22	0.23	Metabolite levels;	chr10:98411005	chr10:98395232~98395253:-
LUSC	cis	rs1018697	1	rs7086400	MIMAT0022727	hsa-miR-1307-5p	5	8.21e-07	0.17	0.23	Colorectal adenoma (advanced);	chr10:102802340	chr10:103394341~103394361:-
LUSC	cis	rs1018697	0.966	rs1475643	MIMAT0022727	hsa-miR-1307-5p	5	8.34e-07	0.17	0.23	Colorectal adenoma (advanced);	chr10:102786710	chr10:103394341~103394361:-
LUSC	cis	rs6681460	0.625	rs6680364	MIMAT0014979	hsa-miR-3117-3p	-5	8.41e-07	-0.25	-0.23	Presence of antiphospholipid antibodies;	chr1:66639151	chr1:66628485~66628505:+
LUSC	cis	rs1712517	0.836	rs7093039	MIMAT0022727	hsa-miR-1307-5p	-4.99	8.49e-07	-0.16	-0.23	Migraine;	chr10:103389790	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.691	rs7910973	MIMAT0026738	hsa-miR-1287-3p	4.99	8.59e-07	0.22	0.23	Metabolite levels;	chr10:98406975	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs7911036	MIMAT0026738	hsa-miR-1287-3p	4.99	8.59e-07	0.22	0.23	Metabolite levels;	chr10:98407258	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs10883090	MIMAT0026738	hsa-miR-1287-3p	4.99	8.59e-07	0.22	0.23	Metabolite levels;	chr10:98407479	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs45523432	MIMAT0026738	hsa-miR-1287-3p	4.99	8.59e-07	0.22	0.23	Metabolite levels;	chr10:98407679	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs12763044	MIMAT0026738	hsa-miR-1287-3p	4.99	8.59e-07	0.22	0.23	Metabolite levels;	chr10:98407694	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.727	rs942808	MIMAT0026738	hsa-miR-1287-3p	4.99	8.59e-07	0.22	0.23	Metabolite levels;	chr10:98408345	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs942805	MIMAT0026738	hsa-miR-1287-3p	4.99	8.59e-07	0.22	0.23	Metabolite levels;	chr10:98408615	chr10:98395232~98395253:-
LUSC	cis	rs1018697	1	rs1018696	MIMAT0022727	hsa-miR-1307-5p	4.97	9.62e-07	0.16	0.23	Colorectal adenoma (advanced);	chr10:102789309	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.763	rs12763326	MIMAT0005878	hsa-miR-1287-5p	-4.96	9.9e-07	-0.25	-0.23	Metabolite levels;	chr10:98407639	chr10:98395271~98395292:-
LUSC	cis	rs1355223	0.583	rs2941057	MIMAT0019776	hsa-miR-1343-3p	4.96	1e-06	0.21	0.23	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34860673	chr11:34941888~34941909:+
LUSC	cis	rs1018697	1	rs7088711	MIMAT0022727	hsa-miR-1307-5p	-4.96	1.01e-06	-0.16	-0.23	Colorectal adenoma (advanced);	chr10:102799509	chr10:103394341~103394361:-
LUSC	cis	rs2229238	0.911	rs7526293	MIMAT0022491	hsa-miR-5698	-4.96	1.02e-06	-0.31	-0.23	Coronary heart disease;	chr1:154471733	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.824	rs6669229	MIMAT0022491	hsa-miR-5698	-4.96	1.02e-06	-0.31	-0.23	Coronary heart disease;	chr1:154472115	chr1:154104562~154104583:-
LUSC	cis	rs7072216	0.763	rs4475861	MIMAT0026738	hsa-miR-1287-3p	4.96	1.02e-06	0.22	0.23	Metabolite levels;	chr10:98405232	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs7923729	MIMAT0026738	hsa-miR-1287-3p	4.96	1.03e-06	0.22	0.23	Metabolite levels;	chr10:98409708	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs6584198	MIMAT0026738	hsa-miR-1287-3p	4.96	1.03e-06	0.22	0.23	Metabolite levels;	chr10:98410149	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.727	rs6584199	MIMAT0026738	hsa-miR-1287-3p	4.96	1.03e-06	0.22	0.23	Metabolite levels;	chr10:98410226	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs6584201	MIMAT0026738	hsa-miR-1287-3p	4.96	1.03e-06	0.22	0.23	Metabolite levels;	chr10:98410452	chr10:98395232~98395253:-
LUSC	cis	rs1018697	1	rs2150928	MIMAT0022727	hsa-miR-1307-5p	4.96	1.03e-06	0.16	0.23	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs6584525	MIMAT0022727	hsa-miR-1307-5p	4.96	1.03e-06	0.16	0.23	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.763	rs6584205	MIMAT0026738	hsa-miR-1287-3p	4.95	1.04e-06	0.22	0.23	Metabolite levels;	chr10:98414049	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs3750601	MIMAT0026738	hsa-miR-1287-3p	4.95	1.04e-06	0.22	0.23	Metabolite levels;	chr10:98414804	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs2147900	MIMAT0026738	hsa-miR-1287-3p	4.95	1.04e-06	0.22	0.23	Metabolite levels;	chr10:98414964	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs2274246	MIMAT0026738	hsa-miR-1287-3p	4.95	1.04e-06	0.22	0.23	Metabolite levels;	chr10:98415303	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs2274245	MIMAT0026738	hsa-miR-1287-3p	4.95	1.04e-06	0.22	0.23	Metabolite levels;	chr10:98415325	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs2274244	MIMAT0026738	hsa-miR-1287-3p	4.95	1.04e-06	0.22	0.23	Metabolite levels;	chr10:98415461	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs2274243	MIMAT0026738	hsa-miR-1287-3p	4.95	1.04e-06	0.22	0.23	Metabolite levels;	chr10:98415510	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs6584200	MIMAT0026738	hsa-miR-1287-3p	4.95	1.04e-06	0.22	0.23	Metabolite levels;	chr10:98410280	chr10:98395232~98395253:-
LUSC	cis	rs1018697	0.966	rs11191396	MIMAT0022727	hsa-miR-1307-5p	4.95	1.05e-06	0.16	0.23	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs4919677	MIMAT0022727	hsa-miR-1307-5p	4.95	1.05e-06	0.16	0.23	Colorectal adenoma (advanced);	chr10:102794547	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs4919678	MIMAT0022727	hsa-miR-1307-5p	4.95	1.05e-06	0.16	0.23	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.726	rs4474372	MIMAT0026738	hsa-miR-1287-3p	4.95	1.06e-06	0.22	0.23	Metabolite levels;	chr10:98404814	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs12763326	MIMAT0026738	hsa-miR-1287-3p	-4.94	1.1e-06	-0.22	-0.23	Metabolite levels;	chr10:98407639	chr10:98395232~98395253:-
LUSC	cis	rs74233809	1	rs11191580	MIMAT0022727	hsa-miR-1307-5p	4.93	1.15e-06	0.32	0.23	Birth weight;	chr10:103146454	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.69	rs113195335	MIMAT0026738	hsa-miR-1287-3p	4.93	1.16e-06	0.22	0.23	Metabolite levels;	chr10:98415775	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.727	rs3750603	MIMAT0026738	hsa-miR-1287-3p	4.93	1.16e-06	0.22	0.23	Metabolite levels;	chr10:98415779	chr10:98395232~98395253:-
LUSC	cis	rs1163656	0.819	rs1795515	MIMAT0003287	hsa-miR-618	4.93	1.17e-06	0.31	0.23	Dental caries;	chr12:80941888	chr12:80935796~80935818:-
LUSC	cis	rs1355223	0.552	rs2421743	MIMAT0019776	hsa-miR-1343-3p	4.93	1.19e-06	0.21	0.23	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34861293	chr11:34941888~34941909:+
LUSC	cis	rs1867631	1	rs11208928	MIMAT0014979	hsa-miR-3117-3p	-4.92	1.24e-06	-0.27	-0.23	Menopause (age at onset);	chr1:66623879	chr1:66628485~66628505:+
LUSC	cis	rs1014286	0.892	rs2110737	MIMAT0019926	hsa-miR-4772-5p	-4.91	1.28e-06	-0.25	-0.23	Serum protein levels (sST2);	chr2:102555804	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.699	rs4792717	MIMAT0005942	hsa-miR-1288-3p	4.91	1.3e-06	0.26	0.23	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16045116	chr17:16282058~16282078:+
LUSC	cis	rs6681460	0.625	rs12138066	MIMAT0014979	hsa-miR-3117-3p	-4.91	1.31e-06	-0.25	-0.23	Presence of antiphospholipid antibodies;	chr1:66638133	chr1:66628485~66628505:+
LUSC	cis	rs9663711	1	rs9663711	MIMAT0005951	hsa-miR-1307-3p	4.9	1.33e-06	0.17	0.23	Carotid plaque burden;	chr10:102787871	chr10:103394301~103394322:-
LUSC	cis	rs7072216	0.806	rs9804285	MIMAT0026738	hsa-miR-1287-3p	4.9	1.34e-06	0.22	0.23	Metabolite levels;	chr10:98409715	chr10:98395232~98395253:-
LUSC	cis	rs7477	0.557	rs2109262	MIMAT0005942	hsa-miR-1288-3p	4.9	1.34e-06	0.25	0.23	Amyotrophic lateral sclerosis;	chr17:16281315	chr17:16282058~16282078:+
LUSC	cis	rs6681460	0.604	rs7546825	MIMAT0014979	hsa-miR-3117-3p	-4.9	1.35e-06	-0.25	-0.23	Presence of antiphospholipid antibodies;	chr1:66636119	chr1:66628485~66628505:+
LUSC	cis	rs6681460	0.625	rs12127199	MIMAT0014979	hsa-miR-3117-3p	-4.9	1.35e-06	-0.25	-0.23	Presence of antiphospholipid antibodies;	chr1:66638059	chr1:66628485~66628505:+
LUSC	cis	rs1355223	0.583	rs2941058	MIMAT0019776	hsa-miR-1343-3p	4.9	1.35e-06	0.21	0.23	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34858698	chr11:34941888~34941909:+
LUSC	cis	rs7477	0.647	rs3112511	MIMAT0005942	hsa-miR-1288-3p	-4.89	1.43e-06	-0.25	-0.23	Amyotrophic lateral sclerosis;	chr17:16304212	chr17:16282058~16282078:+
LUSC	cis	rs1018697	1	rs7911528	MIMAT0022727	hsa-miR-1307-5p	4.88	1.47e-06	0.16	0.23	Colorectal adenoma (advanced);	chr10:102791810	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.727	rs942807	MIMAT0026738	hsa-miR-1287-3p	4.87	1.53e-06	0.21	0.23	Metabolite levels;	chr10:98408462	chr10:98395232~98395253:-
LUSC	cis	rs7477	0.557	rs3785626	MIMAT0005942	hsa-miR-1288-3p	-4.86	1.61e-06	-0.25	-0.22	Amyotrophic lateral sclerosis;	chr17:16281934	chr17:16282058~16282078:+
LUSC	cis	rs1867631	0.876	rs10889637	MIMAT0014979	hsa-miR-3117-3p	-4.86	1.61e-06	-0.26	-0.22	Menopause (age at onset);	chr1:66631782	chr1:66628485~66628505:+
LUSC	cis	rs1018697	1	rs10748830	MIMAT0022727	hsa-miR-1307-5p	4.86	1.64e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102788625	chr10:103394341~103394361:-
LUSC	cis	rs7210990	0.724	rs4435297	MIMAT0005942	hsa-miR-1288-3p	4.86	1.64e-06	0.25	0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16043903	chr17:16282058~16282078:+
LUSC	cis	rs7072216	0.763	rs12259939	MIMAT0005878	hsa-miR-1287-5p	4.85	1.69e-06	0.25	0.22	Metabolite levels;	chr10:98409264	chr10:98395271~98395292:-
LUSC	cis	rs1867631	0.958	rs7536188	MIMAT0014979	hsa-miR-3117-3p	4.84	1.82e-06	0.26	0.22	Menopause (age at onset);	chr1:66622243	chr1:66628485~66628505:+
LUSC	cis	rs1014286	1	rs10210658	MIMAT0019926	hsa-miR-4772-5p	4.83	1.86e-06	0.25	0.22	Serum protein levels (sST2);	chr2:102559290	chr2:102432300~102432321:+
LUSC	cis	rs1355223	0.583	rs2941041	MIMAT0019776	hsa-miR-1343-3p	4.83	1.87e-06	0.21	0.22	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34853187	chr11:34941888~34941909:+
LUSC	cis	rs1014286	1	rs1829849	MIMAT0019926	hsa-miR-4772-5p	4.83	1.88e-06	0.26	0.22	Serum protein levels (sST2);	chr2:102533239	chr2:102432300~102432321:+
LUSC	cis	rs7477	0.557	rs4792728	MIMAT0005942	hsa-miR-1288-3p	4.82	1.94e-06	0.24	0.22	Amyotrophic lateral sclerosis;	chr17:16283501	chr17:16282058~16282078:+
LUSC	cis	rs1014286	1	rs11123937	MIMAT0019926	hsa-miR-4772-5p	4.81	2.02e-06	0.25	0.22	Serum protein levels (sST2);	chr2:102553223	chr2:102432300~102432321:+
LUSC	cis	rs1014286	1	rs12712159	MIMAT0019926	hsa-miR-4772-5p	4.81	2.02e-06	0.25	0.22	Serum protein levels (sST2);	chr2:102553523	chr2:102432300~102432321:+
LUSC	cis	rs1355223	0.583	rs1396880	MIMAT0019776	hsa-miR-1343-3p	-4.81	2.04e-06	-0.2	-0.22	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34849005	chr11:34941888~34941909:+
LUSC	cis	rs7072216	0.763	rs12259939	MIMAT0026738	hsa-miR-1287-3p	4.81	2.09e-06	0.21	0.22	Metabolite levels;	chr10:98409264	chr10:98395232~98395253:-
LUSC	cis	rs6681460	0.625	rs6696812	MIMAT0014979	hsa-miR-3117-3p	-4.8	2.19e-06	-0.24	-0.22	Presence of antiphospholipid antibodies;	chr1:66634626	chr1:66628485~66628505:+
LUSC	cis	rs7072216	0.763	rs1061437	MIMAT0005878	hsa-miR-1287-5p	4.79	2.23e-06	0.24	0.22	Metabolite levels;	chr10:98416397	chr10:98395271~98395292:-
LUSC	cis	rs1018697	0.897	rs2150929	MIMAT0022727	hsa-miR-1307-5p	4.79	2.26e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102791180	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.763	rs9787550	MIMAT0005878	hsa-miR-1287-5p	4.79	2.27e-06	0.25	0.22	Metabolite levels;	chr10:98409294	chr10:98395271~98395292:-
LUSC	cis	rs1163656	0.605	rs10778771	MIMAT0003287	hsa-miR-618	-4.79	2.3e-06	-0.34	-0.22	Dental caries;	chr12:80924235	chr12:80935796~80935818:-
LUSC	cis	rs7072216	0.727	rs7915108	MIMAT0005878	hsa-miR-1287-5p	4.79	2.32e-06	0.25	0.22	Metabolite levels;	chr10:98404684	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.727	rs7901577	MIMAT0005878	hsa-miR-1287-5p	4.79	2.32e-06	0.25	0.22	Metabolite levels;	chr10:98404685	chr10:98395271~98395292:-
LUSC	cis	rs1712517	0.904	rs6584547	MIMAT0022727	hsa-miR-1307-5p	-4.77	2.54e-06	-0.16	-0.22	Migraine;	chr10:103305652	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs9633712	MIMAT0022727	hsa-miR-1307-5p	-4.75	2.76e-06	-0.32	-0.22	Birth weight;	chr10:103114004	chr10:103394341~103394361:-
LUSC	cis	rs74233809	0.786	rs11191564	MIMAT0022727	hsa-miR-1307-5p	-4.75	2.76e-06	-0.32	-0.22	Birth weight;	chr10:103118786	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs1060240	MIMAT0022727	hsa-miR-1307-5p	-4.75	2.76e-06	-0.32	-0.22	Birth weight;	chr10:103123580	chr10:103394341~103394361:-
LUSC	cis	rs1163656	0.559	rs17007693	MIMAT0003287	hsa-miR-618	-4.75	2.78e-06	-0.41	-0.22	Dental caries;	chr12:80925305	chr12:80935796~80935818:-
LUSC	cis	rs1018697	0.966	rs1953930	MIMAT0005951	hsa-miR-1307-3p	4.75	2.8e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102789704	chr10:103394301~103394322:-
LUSC	cis	rs2229238	0.911	rs7556449	MIMAT0022491	hsa-miR-5698	-4.75	2.81e-06	-0.3	-0.22	Coronary heart disease;	chr1:154533410	chr1:154104562~154104583:-
LUSC	cis	rs74233809	1	rs10883835	MIMAT0022727	hsa-miR-1307-5p	-4.74	2.88e-06	-0.31	-0.22	Birth weight;	chr10:103124451	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.763	rs733345	MIMAT0026738	hsa-miR-1287-3p	4.73	2.99e-06	0.21	0.22	Metabolite levels;	chr10:98404458	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs733346	MIMAT0026738	hsa-miR-1287-3p	4.73	2.99e-06	0.21	0.22	Metabolite levels;	chr10:98404568	chr10:98395232~98395253:-
LUSC	cis	rs7477	0.557	rs11654658	MIMAT0005942	hsa-miR-1288-3p	-4.73	3.07e-06	-0.24	-0.22	Amyotrophic lateral sclerosis;	chr17:16304141	chr17:16282058~16282078:+
LUSC	cis	rs7072216	0.763	rs9787550	MIMAT0026738	hsa-miR-1287-3p	4.71	3.25e-06	0.21	0.22	Metabolite levels;	chr10:98409294	chr10:98395232~98395253:-
LUSC	cis	rs74233809	1	rs79082900	MIMAT0022727	hsa-miR-1307-5p	-4.69	3.62e-06	-0.31	-0.22	Birth weight;	chr10:103117545	chr10:103394341~103394361:-
LUSC	cis	rs1355223	0.583	rs2116085	MIMAT0019776	hsa-miR-1343-3p	4.69	3.7e-06	0.2	0.22	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34862454	chr11:34941888~34941909:+
LUSC	cis	rs1355223	0.583	rs2915238	MIMAT0019776	hsa-miR-1343-3p	4.69	3.7e-06	0.2	0.22	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34862858	chr11:34941888~34941909:+
LUSC	cis	rs74233809	1	rs11191551	MIMAT0022727	hsa-miR-1307-5p	-4.68	3.88e-06	-0.33	-0.22	Birth weight;	chr10:103091078	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs17094683	MIMAT0022727	hsa-miR-1307-5p	-4.68	3.88e-06	-0.33	-0.22	Birth weight;	chr10:103091544	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs12220743	MIMAT0022727	hsa-miR-1307-5p	-4.68	3.88e-06	-0.33	-0.22	Birth weight;	chr10:103092155	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs12412038	MIMAT0022727	hsa-miR-1307-5p	-4.68	3.9e-06	-0.33	-0.22	Birth weight;	chr10:103096405	chr10:103394341~103394361:-
LUSC	cis	rs2229238	0.911	rs4379670	MIMAT0022491	hsa-miR-5698	-4.67	4.06e-06	-0.3	-0.22	Coronary heart disease;	chr1:154467389	chr1:154104562~154104583:-
LUSC	cis	rs7072216	0.763	rs7914401	MIMAT0026738	hsa-miR-1287-3p	4.66	4.13e-06	0.2	0.22	Metabolite levels;	chr10:98404171	chr10:98395232~98395253:-
LUSC	cis	rs7210990	0.699	rs2285583	MIMAT0005942	hsa-miR-1288-3p	-4.66	4.21e-06	-0.24	-0.22	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16064829	chr17:16282058~16282078:+
LUSC	cis	rs1355223	0.583	rs2915177	MIMAT0019776	hsa-miR-1343-3p	4.66	4.23e-06	0.2	0.22	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34858719	chr11:34941888~34941909:+
LUSC	cis	rs1712517	0.771	rs11191666	MIMAT0022727	hsa-miR-1307-5p	-4.66	4.26e-06	-0.15	-0.22	Migraine;	chr10:103367521	chr10:103394341~103394361:-
LUSC	cis	rs1018697	0.966	rs10748831	MIMAT0005951	hsa-miR-1307-3p	4.66	4.28e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102798986	chr10:103394301~103394322:-
LUSC	cis	rs1163656	0.592	rs1795514	MIMAT0003287	hsa-miR-618	4.65	4.3e-06	0.38	0.22	Dental caries;	chr12:80939088	chr12:80935796~80935818:-
LUSC	cis	rs1867631	1	rs10889636	MIMAT0014979	hsa-miR-3117-3p	4.65	4.4e-06	0.25	0.22	Menopause (age at onset);	chr1:66624241	chr1:66628485~66628505:+
LUSC	cis	rs2229238	0.868	rs73018293	MIMAT0022491	hsa-miR-5698	4.65	4.41e-06	0.29	0.22	Coronary heart disease;	chr1:154493101	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs59838898	MIMAT0022491	hsa-miR-5698	4.65	4.41e-06	0.29	0.22	Coronary heart disease;	chr1:154493825	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs10047079	MIMAT0022491	hsa-miR-5698	4.65	4.41e-06	0.29	0.22	Coronary heart disease;	chr1:154495659	chr1:154104562~154104583:-
LUSC	cis	rs1712517	0.771	rs10883858	MIMAT0022727	hsa-miR-1307-5p	-4.65	4.42e-06	-0.15	-0.22	Migraine;	chr10:103367951	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.771	rs61871160	MIMAT0022727	hsa-miR-1307-5p	-4.65	4.44e-06	-0.15	-0.22	Migraine;	chr10:103384531	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.771	rs11191664	MIMAT0022727	hsa-miR-1307-5p	-4.65	4.48e-06	-0.15	-0.22	Migraine;	chr10:103358719	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs7909612	MIMAT0005951	hsa-miR-1307-3p	4.64	4.55e-06	0.16	0.22	Colorectal adenoma (advanced);	chr10:102801699	chr10:103394301~103394322:-
LUSC	cis	rs17027258	0.697	rs1468789	MIMAT0019927	hsa-miR-4772-3p	4.64	4.6e-06	0.23	0.22	White blood cell types;	chr2:102476044	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.771	rs7921655	MIMAT0022727	hsa-miR-1307-5p	-4.64	4.66e-06	-0.15	-0.21	Migraine;	chr10:103353944	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.771	rs7074749	MIMAT0022727	hsa-miR-1307-5p	-4.64	4.66e-06	-0.15	-0.21	Migraine;	chr10:103356299	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.74	rs11191663	MIMAT0022727	hsa-miR-1307-5p	-4.64	4.66e-06	-0.15	-0.21	Migraine;	chr10:103358705	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.566	rs1163073	MIMAT0005951	hsa-miR-1307-3p	4.64	4.67e-06	0.17	0.21	Migraine;	chr10:103263177	chr10:103394301~103394322:-
LUSC	cis	rs1355223	0.583	rs2941043	MIMAT0019776	hsa-miR-1343-3p	-4.63	4.71e-06	-0.2	-0.21	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34849447	chr11:34941888~34941909:+
LUSC	cis	rs1018697	1	rs1018696	MIMAT0005951	hsa-miR-1307-3p	4.63	4.77e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102789309	chr10:103394301~103394322:-
LUSC	cis	rs1163656	0.559	rs17007699	MIMAT0003287	hsa-miR-618	-4.63	4.87e-06	-0.4	-0.21	Dental caries;	chr12:80930007	chr12:80935796~80935818:-
LUSC	cis	rs1018697	0.966	rs6584526	MIMAT0005951	hsa-miR-1307-3p	4.63	4.89e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102806484	chr10:103394301~103394322:-
LUSC	cis	rs950880	1	rs13001325	MIMAT0019927	hsa-miR-4772-3p	4.62	5.02e-06	0.2	0.21	Serum protein levels (sST2);	chr2:102322576	chr2:102432336~102432357:+
LUSC	cis	rs74233809	1	rs12217501	MIMAT0022727	hsa-miR-1307-5p	-4.62	5.1e-06	-0.33	-0.21	Birth weight;	chr10:103092132	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs10786710	MIMAT0005951	hsa-miR-1307-3p	4.61	5.17e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102788982	chr10:103394301~103394322:-
LUSC	cis	rs74233809	1	rs12413046	MIMAT0022727	hsa-miR-1307-5p	-4.61	5.23e-06	-0.31	-0.21	Birth weight;	chr10:103111447	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs10883832	MIMAT0022727	hsa-miR-1307-5p	-4.61	5.23e-06	-0.31	-0.21	Birth weight;	chr10:103111522	chr10:103394341~103394361:-
LUSC	cis	rs950880	1	rs12479210	MIMAT0019927	hsa-miR-4772-3p	4.61	5.23e-06	0.2	0.21	Serum protein levels (sST2);	chr2:102332701	chr2:102432336~102432357:+
LUSC	cis	rs74233809	1	rs10883806	MIMAT0022727	hsa-miR-1307-5p	-4.61	5.31e-06	-0.31	-0.21	Birth weight;	chr10:102953319	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.771	rs59744322	MIMAT0022727	hsa-miR-1307-5p	-4.61	5.35e-06	-0.15	-0.21	Migraine;	chr10:103386935	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.771	rs11191676	MIMAT0022727	hsa-miR-1307-5p	-4.61	5.35e-06	-0.15	-0.21	Migraine;	chr10:103395309	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.771	rs2292807	MIMAT0022727	hsa-miR-1307-5p	-4.6	5.4e-06	-0.15	-0.21	Migraine;	chr10:103395888	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs10509759	MIMAT0022727	hsa-miR-1307-5p	-4.6	5.48e-06	-0.31	-0.21	Birth weight;	chr10:102929908	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs5011520	MIMAT0022727	hsa-miR-1307-5p	-4.6	5.48e-06	-0.31	-0.21	Birth weight;	chr10:102937759	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs10883808	MIMAT0022727	hsa-miR-1307-5p	-4.6	5.48e-06	-0.31	-0.21	Birth weight;	chr10:102961369	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs78260931	MIMAT0022727	hsa-miR-1307-5p	-4.6	5.48e-06	-0.31	-0.21	Birth weight;	chr10:102962205	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs11191479	MIMAT0022727	hsa-miR-1307-5p	-4.6	5.48e-06	-0.31	-0.21	Birth weight;	chr10:102963863	chr10:103394341~103394361:-
LUSC	cis	rs1018697	0.966	rs1475643	MIMAT0005951	hsa-miR-1307-3p	4.6	5.58e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102786710	chr10:103394301~103394322:-
LUSC	cis	rs2229238	0.911	rs73020232	MIMAT0022491	hsa-miR-5698	4.59	5.71e-06	0.29	0.21	Coronary heart disease;	chr1:154510193	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs73020234	MIMAT0022491	hsa-miR-5698	4.59	5.71e-06	0.29	0.21	Coronary heart disease;	chr1:154510291	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs73020246	MIMAT0022491	hsa-miR-5698	4.59	5.71e-06	0.29	0.21	Coronary heart disease;	chr1:154513164	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs6674171	MIMAT0022491	hsa-miR-5698	4.59	5.71e-06	0.29	0.21	Coronary heart disease;	chr1:154519207	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs77184252	MIMAT0022491	hsa-miR-5698	4.59	5.71e-06	0.29	0.21	Coronary heart disease;	chr1:154520057	chr1:154104562~154104583:-
LUSC	cis	rs1712517	0.771	rs11191672	MIMAT0022727	hsa-miR-1307-5p	-4.59	5.77e-06	-0.15	-0.21	Migraine;	chr10:103379204	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs10748830	MIMAT0005951	hsa-miR-1307-3p	4.59	5.82e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102788625	chr10:103394301~103394322:-
LUSC	cis	rs950880	1	rs13019081	MIMAT0019927	hsa-miR-4772-3p	-4.58	6.07e-06	-0.19	-0.21	Serum protein levels (sST2);	chr2:102334362	chr2:102432336~102432357:+
LUSC	cis	rs7210990	0.661	rs1079534	MIMAT0005942	hsa-miR-1288-3p	4.58	6.15e-06	0.24	0.21	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16045819	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.687	rs2078050	MIMAT0005942	hsa-miR-1288-3p	4.58	6.16e-06	0.24	0.21	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16091574	chr17:16282058~16282078:+
LUSC	cis	rs2229238	0.78	rs61698846	MIMAT0022491	hsa-miR-5698	4.57	6.22e-06	0.29	0.21	Coronary heart disease;	chr1:154532378	chr1:154104562~154104583:-
LUSC	cis	rs950880	1	rs1420101	MIMAT0019927	hsa-miR-4772-3p	4.57	6.25e-06	0.19	0.21	Serum protein levels (sST2);	chr2:102341256	chr2:102432336~102432357:+
LUSC	cis	rs1867631	1	rs6665859	MIMAT0014979	hsa-miR-3117-3p	-4.57	6.45e-06	-0.25	-0.21	Menopause (age at onset);	chr1:66611872	chr1:66628485~66628505:+
LUSC	cis	rs74233809	1	rs11191555	MIMAT0022727	hsa-miR-1307-5p	-4.56	6.51e-06	-0.31	-0.21	Birth weight;	chr10:103097766	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs11191557	MIMAT0022727	hsa-miR-1307-5p	-4.56	6.51e-06	-0.31	-0.21	Birth weight;	chr10:103104857	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs11191558	MIMAT0022727	hsa-miR-1307-5p	-4.56	6.51e-06	-0.31	-0.21	Birth weight;	chr10:103104921	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs7092051	MIMAT0005951	hsa-miR-1307-3p	4.56	6.7e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102799720	chr10:103394301~103394322:-
LUSC	cis	rs1014286	0.505	rs1030026	MIMAT0019926	hsa-miR-4772-5p	4.56	6.78e-06	0.24	0.21	Serum protein levels (sST2);	chr2:102481719	chr2:102432300~102432321:+
LUSC	cis	rs4851016	0.506	rs2140316	MIMAT0019926	hsa-miR-4772-5p	4.56	6.78e-06	0.24	0.21	Blood protein levels;	chr2:102482217	chr2:102432300~102432321:+
LUSC	cis	rs1712517	0.74	rs4917387	MIMAT0022727	hsa-miR-1307-5p	-4.55	6.78e-06	-0.15	-0.21	Migraine;	chr10:103348698	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs2150928	MIMAT0005951	hsa-miR-1307-3p	4.55	6.8e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102791228	chr10:103394301~103394322:-
LUSC	cis	rs1018697	1	rs6584525	MIMAT0005951	hsa-miR-1307-3p	4.55	6.8e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102792224	chr10:103394301~103394322:-
LUSC	cis	rs1018697	0.966	rs11191396	MIMAT0005951	hsa-miR-1307-3p	4.55	6.82e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102793108	chr10:103394301~103394322:-
LUSC	cis	rs1018697	1	rs4919677	MIMAT0005951	hsa-miR-1307-3p	4.55	6.82e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102794547	chr10:103394301~103394322:-
LUSC	cis	rs1018697	1	rs4919678	MIMAT0005951	hsa-miR-1307-3p	4.55	6.82e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102794606	chr10:103394301~103394322:-
LUSC	cis	rs1018697	1	rs7086400	MIMAT0005951	hsa-miR-1307-3p	4.55	6.96e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102802340	chr10:103394301~103394322:-
LUSC	cis	rs2229238	0.911	rs11490956	MIMAT0022491	hsa-miR-5698	4.55	7.05e-06	0.29	0.21	Coronary heart disease;	chr1:154514782	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs111600849	MIMAT0022491	hsa-miR-5698	4.55	7.05e-06	0.29	0.21	Coronary heart disease;	chr1:154515013	chr1:154104562~154104583:-
LUSC	cis	rs1018697	1	rs7073114	MIMAT0005951	hsa-miR-1307-3p	4.54	7.1e-06	0.15	0.21	Colorectal adenoma (advanced);	chr10:102795894	chr10:103394301~103394322:-
LUSC	cis	rs1018697	1	rs7092346	MIMAT0005951	hsa-miR-1307-3p	4.54	7.11e-06	0.16	0.21	Colorectal adenoma (advanced);	chr10:102800007	chr10:103394301~103394322:-
LUSC	cis	rs1018697	1	rs11191397	MIMAT0005951	hsa-miR-1307-3p	4.54	7.11e-06	0.15	0.21	Colorectal adenoma (advanced);	chr10:102798517	chr10:103394301~103394322:-
LUSC	cis	rs74233809	1	rs11191472	MIMAT0022727	hsa-miR-1307-5p	-4.54	7.13e-06	-0.31	-0.21	Birth weight;	chr10:102947259	chr10:103394341~103394361:-
LUSC	cis	rs1867631	1	rs7546090	MIMAT0014979	hsa-miR-3117-3p	-4.54	7.19e-06	-0.24	-0.21	Menopause (age at onset);	chr1:66618298	chr1:66628485~66628505:+
LUSC	cis	rs950880	0.767	rs11123923	MIMAT0019927	hsa-miR-4772-3p	4.54	7.2e-06	0.19	0.21	Serum protein levels (sST2);	chr2:102351384	chr2:102432336~102432357:+
LUSC	cis	rs1163656	0.559	rs1163657	MIMAT0003287	hsa-miR-618	4.54	7.21e-06	0.39	0.21	Dental caries;	chr12:80943890	chr12:80935796~80935818:-
LUSC	cis	rs7210990	0.724	rs2285580	MIMAT0005942	hsa-miR-1288-3p	4.54	7.26e-06	0.23	0.21	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16101873	chr17:16282058~16282078:+
LUSC	cis	rs950880	0.767	rs13017455	MIMAT0019927	hsa-miR-4772-3p	4.54	7.28e-06	0.19	0.21	Serum protein levels (sST2);	chr2:102348282	chr2:102432336~102432357:+
LUSC	cis	rs74233809	1	rs11191575	MIMAT0022727	hsa-miR-1307-5p	-4.54	7.36e-06	-0.29	-0.21	Birth weight;	chr10:103138580	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs79993475	MIMAT0022727	hsa-miR-1307-5p	-4.54	7.36e-06	-0.29	-0.21	Birth weight;	chr10:103141274	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs77860422	MIMAT0022727	hsa-miR-1307-5p	-4.54	7.38e-06	-0.31	-0.21	Birth weight;	chr10:102988252	chr10:103394341~103394361:-
LUSC	cis	rs2229238	0.911	rs7551873	MIMAT0022491	hsa-miR-5698	-4.53	7.5e-06	-0.29	-0.21	Coronary heart disease;	chr1:154533381	chr1:154104562~154104583:-
LUSC	cis	rs950880	0.767	rs6543119	MIMAT0019927	hsa-miR-4772-3p	4.53	7.57e-06	0.19	0.21	Serum protein levels (sST2);	chr2:102346612	chr2:102432336~102432357:+
LUSC	cis	rs205611	0.825	rs11685111	MIMAT0021020	hsa-miR-5000-3p	-4.53	7.6e-06	-0.35	-0.21	Iris characteristics;	chr2:74768774	chr2:75090873~75090894:+
LUSC	cis	rs4851016	0.506	rs6543146	MIMAT0019926	hsa-miR-4772-5p	4.52	7.77e-06	0.24	0.21	Blood protein levels;	chr2:102480236	chr2:102432300~102432321:+
LUSC	cis	rs1867631	0.958	rs7520226	MIMAT0014979	hsa-miR-3117-3p	-4.52	7.84e-06	-0.25	-0.21	Menopause (age at onset);	chr1:66615312	chr1:66628485~66628505:+
LUSC	cis	rs7477	0.647	rs2014604	MIMAT0005942	hsa-miR-1288-3p	-4.52	7.97e-06	-0.23	-0.21	Amyotrophic lateral sclerosis;	chr17:16273569	chr17:16282058~16282078:+
LUSC	cis	rs7072216	0.763	rs1061437	MIMAT0026738	hsa-miR-1287-3p	4.52	8.01e-06	0.2	0.21	Metabolite levels;	chr10:98416397	chr10:98395232~98395253:-
LUSC	cis	rs74233809	1	rs10883815	MIMAT0022727	hsa-miR-1307-5p	-4.51	8.36e-06	-0.31	-0.21	Birth weight;	chr10:102979422	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs112390216	MIMAT0022727	hsa-miR-1307-5p	-4.51	8.36e-06	-0.31	-0.21	Birth weight;	chr10:102981274	chr10:103394341~103394361:-
LUSC	cis	rs7210990	0.724	rs2157990	MIMAT0005942	hsa-miR-1288-3p	4.5	8.52e-06	0.23	0.21	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16058679	chr17:16282058~16282078:+
LUSC	cis	rs74233809	1	rs12219304	MIMAT0022727	hsa-miR-1307-5p	-4.5	8.58e-06	-0.31	-0.21	Birth weight;	chr10:103171827	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs732998	MIMAT0022727	hsa-miR-1307-5p	4.5	8.6e-06	0.27	0.21	Birth weight;	chr10:103138144	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs7911528	MIMAT0005951	hsa-miR-1307-3p	4.5	8.64e-06	0.15	0.21	Colorectal adenoma (advanced);	chr10:102791810	chr10:103394301~103394322:-
LUSC	cis	rs1018697	0.897	rs2150929	MIMAT0005951	hsa-miR-1307-3p	4.5	8.67e-06	0.15	0.21	Colorectal adenoma (advanced);	chr10:102791180	chr10:103394301~103394322:-
LUSC	cis	rs950880	1	rs950880	MIMAT0019927	hsa-miR-4772-3p	4.5	8.73e-06	0.19	0.21	Serum protein levels (sST2);	chr2:102316102	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.525	rs2271751	MIMAT0005951	hsa-miR-1307-3p	-4.49	8.92e-06	-0.16	-0.21	Migraine;	chr10:103415374	chr10:103394301~103394322:-
LUSC	cis	rs3824488	0.599	rs16909859	MIMAT0019208	hsa-miR-3074-5p	-4.49	9e-06	-0.36	-0.21	Neuroticism;	chr9:95442510	chr9:95086063~95086083:-
LUSC	cis	rs950880	0.767	rs13001714	MIMAT0019927	hsa-miR-4772-3p	4.49	9.21e-06	0.19	0.21	Serum protein levels (sST2);	chr2:102344025	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.767	rs12999364	MIMAT0019927	hsa-miR-4772-3p	4.49	9.24e-06	0.19	0.21	Serum protein levels (sST2);	chr2:102357669	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.767	rs12998521	MIMAT0019927	hsa-miR-4772-3p	4.49	9.24e-06	0.19	0.21	Serum protein levels (sST2);	chr2:102357957	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.796	rs12987977	MIMAT0019927	hsa-miR-4772-3p	4.49	9.24e-06	0.19	0.21	Serum protein levels (sST2);	chr2:102358876	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.771	rs2008530	MIMAT0022727	hsa-miR-1307-5p	-4.48	9.3e-06	-0.15	-0.21	Migraine;	chr10:103299082	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.836	rs11191649	MIMAT0022727	hsa-miR-1307-5p	-4.48	9.32e-06	-0.15	-0.21	Migraine;	chr10:103307280	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs12220375	MIMAT0022727	hsa-miR-1307-5p	-4.48	9.51e-06	-0.29	-0.21	Birth weight;	chr10:103141734	chr10:103394341~103394361:-
LUSC	cis	rs205611	0.769	rs34790684	MIMAT0021020	hsa-miR-5000-3p	-4.48	9.61e-06	-0.35	-0.21	Iris characteristics;	chr2:74768622	chr2:75090873~75090894:+
LUSC	cis	rs1712517	0.503	rs72846198	MIMAT0005951	hsa-miR-1307-3p	-4.48	9.68e-06	-0.17	-0.21	Migraine;	chr10:103338267	chr10:103394301~103394322:-
LUSC	cis	rs1355223	0.583	rs2941044	MIMAT0019776	hsa-miR-1343-3p	4.47	9.76e-06	0.19	0.21	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34845897	chr11:34941888~34941909:+
LUSC	cis	rs7072216	0.727	rs7915108	MIMAT0026738	hsa-miR-1287-3p	4.47	9.84e-06	0.2	0.21	Metabolite levels;	chr10:98404684	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.727	rs7901577	MIMAT0026738	hsa-miR-1287-3p	4.47	9.84e-06	0.2	0.21	Metabolite levels;	chr10:98404685	chr10:98395232~98395253:-
LUSC	cis	rs1712517	0.904	rs4918007	MIMAT0022727	hsa-miR-1307-5p	4.47	1.01e-05	0.15	0.21	Migraine;	chr10:103347713	chr10:103394341~103394361:-
LUSC	cis	rs546131	0.642	rs537873	MIMAT0019776	hsa-miR-1343-3p	4.46	1.03e-05	0.22	0.21	Lung disease severity in cystic fibrosis;	chr11:34813574	chr11:34941888~34941909:+
LUSC	cis	rs7072216	0.763	rs8181292	MIMAT0005878	hsa-miR-1287-5p	4.46	1.04e-05	0.23	0.21	Metabolite levels;	chr10:98415720	chr10:98395271~98395292:-
LUSC	cis	rs7210990	0.75	rs4566208	MIMAT0005942	hsa-miR-1288-3p	4.45	1.06e-05	0.23	0.21	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16107606	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.724	rs2157991	MIMAT0005942	hsa-miR-1288-3p	4.45	1.09e-05	0.23	0.21	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16058637	chr17:16282058~16282078:+
LUSC	cis	rs2229238	0.911	rs59239860	MIMAT0022491	hsa-miR-5698	4.45	1.11e-05	0.29	0.21	Coronary heart disease;	chr1:154519631	chr1:154104562~154104583:-
LUSC	cis	rs1355223	0.583	rs2941060	MIMAT0019776	hsa-miR-1343-3p	4.44	1.12e-05	0.19	0.21	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34857607	chr11:34941888~34941909:+
LUSC	cis	rs4851016	0.506	rs2310303	MIMAT0019926	hsa-miR-4772-5p	4.44	1.16e-05	0.24	0.21	Blood protein levels;	chr2:102487420	chr2:102432300~102432321:+
LUSC	cis	rs1355223	0.583	rs2915178	MIMAT0019776	hsa-miR-1343-3p	4.43	1.18e-05	0.19	0.21	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34856504	chr11:34941888~34941909:+
LUSC	cis	rs950880	0.767	rs12712142	MIMAT0019927	hsa-miR-4772-3p	-4.42	1.22e-05	-0.18	-0.21	Serum protein levels (sST2);	chr2:102344124	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.524	rs4917384	MIMAT0005951	hsa-miR-1307-3p	4.42	1.25e-05	0.16	0.21	Migraine;	chr10:103236031	chr10:103394301~103394322:-
LUSC	cis	rs2229238	0.911	rs58348886	MIMAT0022491	hsa-miR-5698	4.42	1.25e-05	0.29	0.21	Coronary heart disease;	chr1:154473722	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs60760897	MIMAT0022491	hsa-miR-5698	4.41	1.27e-05	0.28	0.21	Coronary heart disease;	chr1:154532373	chr1:154104562~154104583:-
LUSC	cis	rs1712517	0.74	rs11191643	MIMAT0022727	hsa-miR-1307-5p	-4.41	1.32e-05	-0.15	-0.2	Migraine;	chr10:103297804	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs7896903	MIMAT0005951	hsa-miR-1307-3p	4.41	1.32e-05	0.15	0.2	Colorectal adenoma (advanced);	chr10:102806660	chr10:103394301~103394322:-
LUSC	cis	rs2229238	0.911	rs73023331	MIMAT0022491	hsa-miR-5698	4.41	1.32e-05	0.28	0.2	Coronary heart disease;	chr1:154535734	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.826	rs111742980	MIMAT0022491	hsa-miR-5698	4.41	1.32e-05	0.28	0.2	Coronary heart disease;	chr1:154536288	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs4639752	MIMAT0022491	hsa-miR-5698	4.41	1.32e-05	0.28	0.2	Coronary heart disease;	chr1:154536498	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs60368585	MIMAT0022491	hsa-miR-5698	4.41	1.32e-05	0.28	0.2	Coronary heart disease;	chr1:154536864	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs73023339	MIMAT0022491	hsa-miR-5698	4.41	1.32e-05	0.28	0.2	Coronary heart disease;	chr1:154538376	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs4633282	MIMAT0022491	hsa-miR-5698	4.41	1.32e-05	0.28	0.2	Coronary heart disease;	chr1:154535423	chr1:154104562~154104583:-
LUSC	cis	rs74233809	1	rs12219027	MIMAT0022727	hsa-miR-1307-5p	-4.41	1.32e-05	-0.3	-0.2	Birth weight;	chr10:103051446	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.763	rs7909822	MIMAT0005878	hsa-miR-1287-5p	4.4	1.33e-05	0.23	0.2	Metabolite levels;	chr10:98412278	chr10:98395271~98395292:-
LUSC	cis	rs546131	0.642	rs523246	MIMAT0019776	hsa-miR-1343-3p	4.4	1.33e-05	0.21	0.2	Lung disease severity in cystic fibrosis;	chr11:34823464	chr11:34941888~34941909:+
LUSC	cis	rs74233809	1	rs11191560	MIMAT0022727	hsa-miR-1307-5p	-4.4	1.34e-05	-0.3	-0.2	Birth weight;	chr10:103109281	chr10:103394341~103394361:-
LUSC	cis	rs2229238	0.868	rs12408461	MIMAT0022491	hsa-miR-5698	4.4	1.37e-05	0.28	0.2	Coronary heart disease;	chr1:154540234	chr1:154104562~154104583:-
LUSC	cis	rs6681460	0.546	rs1998716	MIMAT0014979	hsa-miR-3117-3p	-4.4	1.37e-05	-0.22	-0.2	Presence of antiphospholipid antibodies;	chr1:66651423	chr1:66628485~66628505:+
LUSC	cis	rs2229238	0.955	rs4072391	MIMAT0022491	hsa-miR-5698	-4.4	1.38e-05	-0.27	-0.2	Coronary heart disease;	chr1:154466404	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.915	rs7514452	MIMAT0022491	hsa-miR-5698	-4.4	1.38e-05	-0.28	-0.2	Coronary heart disease;	chr1:154465608	chr1:154104562~154104583:-
LUSC	cis	rs1712517	0.771	rs61350103	MIMAT0022727	hsa-miR-1307-5p	-4.39	1.4e-05	-0.15	-0.2	Migraine;	chr10:103309363	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs11191454	MIMAT0022727	hsa-miR-1307-5p	-4.39	1.41e-05	-0.28	-0.2	Birth weight;	chr10:102900247	chr10:103394341~103394361:-
LUSC	cis	rs2229238	0.866	rs59741504	MIMAT0022491	hsa-miR-5698	4.39	1.42e-05	0.28	0.2	Coronary heart disease;	chr1:154532125	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.823	rs61275241	MIMAT0022491	hsa-miR-5698	4.39	1.42e-05	0.28	0.2	Coronary heart disease;	chr1:154532411	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.866	rs61403567	MIMAT0022491	hsa-miR-5698	4.39	1.42e-05	0.28	0.2	Coronary heart disease;	chr1:154532451	chr1:154104562~154104583:-
LUSC	cis	rs1712517	0.771	rs11191645	MIMAT0022727	hsa-miR-1307-5p	-4.39	1.43e-05	-0.15	-0.2	Migraine;	chr10:103299551	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.666	rs11598689	MIMAT0026738	hsa-miR-1287-3p	4.39	1.43e-05	0.21	0.2	Metabolite levels;	chr10:98396270	chr10:98395232~98395253:-
LUSC	cis	rs2229238	0.868	rs41308419	MIMAT0022491	hsa-miR-5698	4.39	1.44e-05	0.28	0.2	Coronary heart disease;	chr1:154534721	chr1:154104562~154104583:-
LUSC	cis	rs950880	0.961	rs13020553	MIMAT0019927	hsa-miR-4772-3p	4.39	1.45e-05	0.19	0.2	Serum protein levels (sST2);	chr2:102315366	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.771	rs11191654	MIMAT0022727	hsa-miR-1307-5p	-4.39	1.45e-05	-0.15	-0.2	Migraine;	chr10:103317367	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.771	rs61869827	MIMAT0022727	hsa-miR-1307-5p	-4.39	1.45e-05	-0.15	-0.2	Migraine;	chr10:103319682	chr10:103394341~103394361:-
LUSC	cis	rs4851016	0.553	rs4851602	MIMAT0019926	hsa-miR-4772-5p	-4.38	1.46e-05	-0.23	-0.2	Blood protein levels;	chr2:102499846	chr2:102432300~102432321:+
LUSC	cis	rs1712517	0.771	rs10883857	MIMAT0022727	hsa-miR-1307-5p	4.38	1.48e-05	0.14	0.2	Migraine;	chr10:103367830	chr10:103394341~103394361:-
LUSC	cis	rs1355223	0.583	rs2956076	MIMAT0019776	hsa-miR-1343-3p	4.37	1.52e-05	0.19	0.2	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34852577	chr11:34941888~34941909:+
LUSC	cis	rs1355223	0.583	rs2915179	MIMAT0019776	hsa-miR-1343-3p	4.36	1.62e-05	0.19	0.2	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34850396	chr11:34941888~34941909:+
LUSC	cis	rs2229238	0.911	rs4390168	MIMAT0022491	hsa-miR-5698	4.36	1.62e-05	0.28	0.2	Coronary heart disease;	chr1:154536620	chr1:154104562~154104583:-
LUSC	cis	rs6681460	0.565	rs6689755	MIMAT0014979	hsa-miR-3117-3p	-4.36	1.62e-05	-0.21	-0.2	Presence of antiphospholipid antibodies;	chr1:66647367	chr1:66628485~66628505:+
LUSC	cis	rs2229238	0.911	rs6681207	MIMAT0022491	hsa-miR-5698	4.36	1.62e-05	0.28	0.2	Coronary heart disease;	chr1:154544741	chr1:154104562~154104583:-
LUSC	cis	rs7072216	0.763	rs6584202	MIMAT0005878	hsa-miR-1287-5p	4.36	1.64e-05	0.22	0.2	Metabolite levels;	chr10:98410626	chr10:98395271~98395292:-
LUSC	cis	rs2229238	0.911	rs3811449	MIMAT0022491	hsa-miR-5698	4.35	1.67e-05	0.28	0.2	Coronary heart disease;	chr1:154545028	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs61559765	MIMAT0022491	hsa-miR-5698	4.35	1.67e-05	0.28	0.2	Coronary heart disease;	chr1:154545873	chr1:154104562~154104583:-
LUSC	cis	rs1712517	0.904	rs10883863	MIMAT0022727	hsa-miR-1307-5p	4.35	1.67e-05	0.14	0.2	Migraine;	chr10:103402122	chr10:103394341~103394361:-
LUSC	cis	rs2229238	0.911	rs12405637	MIMAT0022491	hsa-miR-5698	4.34	1.73e-05	0.28	0.2	Coronary heart disease;	chr1:154528809	chr1:154104562~154104583:-
LUSC	cis	rs74233809	1	rs11191502	MIMAT0022727	hsa-miR-1307-5p	-4.34	1.74e-05	-0.29	-0.2	Birth weight;	chr10:103005737	chr10:103394341~103394361:-
LUSC	cis	rs6681460	0.604	rs11208920	MIMAT0014979	hsa-miR-3117-3p	-4.34	1.76e-05	-0.22	-0.2	Presence of antiphospholipid antibodies;	chr1:66609629	chr1:66628485~66628505:+
LUSC	cis	rs7072216	0.763	rs7909822	MIMAT0026738	hsa-miR-1287-3p	4.34	1.77e-05	0.19	0.2	Metabolite levels;	chr10:98412278	chr10:98395232~98395253:-
LUSC	cis	rs7851726	0.585	rs7870160	MIMAT0019208	hsa-miR-3074-5p	-4.33	1.82e-05	-0.2	-0.2	Urinary albumin-to-creatinine ratio;	chr9:94950249	chr9:95086063~95086083:-
LUSC	cis	rs7210990	0.724	rs2285579	MIMAT0005942	hsa-miR-1288-3p	4.33	1.85e-05	0.23	0.2	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16143531	chr17:16282058~16282078:+
LUSC	cis	rs74233809	1	rs11191505	MIMAT0022727	hsa-miR-1307-5p	-4.33	1.87e-05	-0.29	-0.2	Birth weight;	chr10:103007134	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs11191593	MIMAT0022727	hsa-miR-1307-5p	-4.33	1.87e-05	-0.29	-0.2	Birth weight;	chr10:103179458	chr10:103394341~103394361:-
LUSC	cis	rs79387448	0.638	rs74731686	MIMAT0019926	hsa-miR-4772-5p	-4.32	1.9e-05	-0.34	-0.2	Gut microbiota (bacterial taxa);	chr2:102427521	chr2:102432300~102432321:+
LUSC	cis	rs2229238	0.911	rs6672087	MIMAT0022491	hsa-miR-5698	4.31	1.99e-05	0.28	0.2	Coronary heart disease;	chr1:154543646	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs3811448	MIMAT0022491	hsa-miR-5698	4.31	1.99e-05	0.28	0.2	Coronary heart disease;	chr1:154544102	chr1:154104562~154104583:-
LUSC	cis	rs74233809	1	rs12221193	MIMAT0022727	hsa-miR-1307-5p	-4.31	1.99e-05	-0.3	-0.2	Birth weight;	chr10:102905510	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs77180047	MIMAT0022727	hsa-miR-1307-5p	-4.31	1.99e-05	-0.3	-0.2	Birth weight;	chr10:102907000	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs12221064	MIMAT0022727	hsa-miR-1307-5p	-4.31	1.99e-05	-0.3	-0.2	Birth weight;	chr10:102917369	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs17115213	MIMAT0022727	hsa-miR-1307-5p	-4.31	1.99e-05	-0.3	-0.2	Birth weight;	chr10:102921386	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs77602510	MIMAT0022727	hsa-miR-1307-5p	-4.31	1.99e-05	-0.3	-0.2	Birth weight;	chr10:102922845	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs78821730	MIMAT0022727	hsa-miR-1307-5p	-4.31	1.99e-05	-0.3	-0.2	Birth weight;	chr10:102924787	chr10:103394341~103394361:-
LUSC	cis	rs2229238	0.868	rs72999415	MIMAT0022491	hsa-miR-5698	4.31	2.02e-05	0.27	0.2	Coronary heart disease;	chr1:154541236	chr1:154104562~154104583:-
LUSC	cis	rs1163656	0.559	rs12228291	MIMAT0003287	hsa-miR-618	-4.31	2.06e-05	-0.4	-0.2	Dental caries;	chr12:80918034	chr12:80935796~80935818:-
LUSC	cis	rs2229238	0.911	rs57783436	MIMAT0022491	hsa-miR-5698	4.31	2.06e-05	0.28	0.2	Coronary heart disease;	chr1:154539233	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs112394421	MIMAT0022491	hsa-miR-5698	4.31	2.06e-05	0.28	0.2	Coronary heart disease;	chr1:154539532	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs73023346	MIMAT0022491	hsa-miR-5698	4.31	2.06e-05	0.28	0.2	Coronary heart disease;	chr1:154539601	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.868	rs73023348	MIMAT0022491	hsa-miR-5698	4.31	2.06e-05	0.28	0.2	Coronary heart disease;	chr1:154540942	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.868	rs72999419	MIMAT0022491	hsa-miR-5698	4.31	2.06e-05	0.28	0.2	Coronary heart disease;	chr1:154541616	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs41313910	MIMAT0022491	hsa-miR-5698	4.31	2.06e-05	0.28	0.2	Coronary heart disease;	chr1:154541727	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.868	rs72999422	MIMAT0022491	hsa-miR-5698	4.31	2.06e-05	0.28	0.2	Coronary heart disease;	chr1:154542466	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs58881140	MIMAT0022491	hsa-miR-5698	4.31	2.06e-05	0.28	0.2	Coronary heart disease;	chr1:154542717	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.911	rs41269915	MIMAT0022491	hsa-miR-5698	4.3	2.06e-05	0.28	0.2	Coronary heart disease;	chr1:154549108	chr1:154104562~154104583:-
LUSC	cis	rs17639215	0.55	rs9679297	MIMAT0019927	hsa-miR-4772-3p	-4.3	2.11e-05	-0.2	-0.2	Serum protein levels (sST2);	chr2:102298109	chr2:102432336~102432357:+
LUSC	cis	rs74233809	1	rs11191587	MIMAT0022727	hsa-miR-1307-5p	-4.3	2.12e-05	-0.28	-0.2	Birth weight;	chr10:103169959	chr10:103394341~103394361:-
LUSC	cis	rs546131	0.642	rs566798	MIMAT0019776	hsa-miR-1343-3p	-4.29	2.18e-05	-0.21	-0.2	Lung disease severity in cystic fibrosis;	chr11:34830730	chr11:34941888~34941909:+
LUSC	cis	rs1712517	1	rs3123794	MIMAT0022727	hsa-miR-1307-5p	-4.29	2.19e-05	-0.14	-0.2	Migraine;	chr10:103273985	chr10:103394341~103394361:-
LUSC	cis	rs6681460	0.565	rs2147776	MIMAT0014979	hsa-miR-3117-3p	-4.29	2.21e-05	-0.21	-0.2	Presence of antiphospholipid antibodies;	chr1:66641720	chr1:66628485~66628505:+
LUSC	cis	rs2229238	0.911	rs73023349	MIMAT0022491	hsa-miR-5698	4.29	2.23e-05	0.27	0.2	Coronary heart disease;	chr1:154540964	chr1:154104562~154104583:-
LUSC	cis	rs6681460	0.584	rs7528182	MIMAT0014979	hsa-miR-3117-3p	-4.28	2.25e-05	-0.21	-0.2	Presence of antiphospholipid antibodies;	chr1:66601686	chr1:66628485~66628505:+
LUSC	cis	rs6584202	0.589	rs10883094	MIMAT0005878	hsa-miR-1287-5p	4.28	2.27e-05	0.22	0.2	Obesity-related traits;	chr10:98428349	chr10:98395271~98395292:-
LUSC	cis	rs1163656	0.559	rs1183656	MIMAT0003287	hsa-miR-618	4.28	2.27e-05	0.38	0.2	Dental caries;	chr12:80944131	chr12:80935796~80935818:-
LUSC	cis	rs74233809	1	rs74444347	MIMAT0022727	hsa-miR-1307-5p	-4.28	2.28e-05	-0.28	-0.2	Birth weight;	chr10:103009518	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs12221335	MIMAT0022727	hsa-miR-1307-5p	-4.28	2.28e-05	-0.28	-0.2	Birth weight;	chr10:103009635	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.873	rs7894240	MIMAT0022727	hsa-miR-1307-5p	4.28	2.32e-05	0.14	0.2	Migraine;	chr10:103240612	chr10:103394341~103394361:-
LUSC	cis	rs1018697	1	rs7088711	MIMAT0005951	hsa-miR-1307-3p	-4.28	2.33e-05	-0.15	-0.2	Colorectal adenoma (advanced);	chr10:102799509	chr10:103394301~103394322:-
LUSC	cis	rs74233809	1	rs79237883	MIMAT0022727	hsa-miR-1307-5p	-4.27	2.41e-05	-0.28	-0.2	Birth weight;	chr10:103181189	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs34747231	MIMAT0022727	hsa-miR-1307-5p	-4.27	2.41e-05	-0.28	-0.2	Birth weight;	chr10:103182487	chr10:103394341~103394361:-
LUSC	cis	rs1712517	1	rs1163084	MIMAT0022727	hsa-miR-1307-5p	-4.27	2.42e-05	-0.14	-0.2	Migraine;	chr10:103279291	chr10:103394341~103394361:-
LUSC	cis	rs546131	0.642	rs568529	MIMAT0019776	hsa-miR-1343-3p	4.27	2.43e-05	0.21	0.2	Lung disease severity in cystic fibrosis;	chr11:34820959	chr11:34941888~34941909:+
LUSC	cis	rs74233809	1	rs12411886	MIMAT0022727	hsa-miR-1307-5p	-4.26	2.45e-05	-0.3	-0.2	Birth weight;	chr10:102925542	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.526	rs113528138	MIMAT0005951	hsa-miR-1307-3p	-4.26	2.46e-05	-0.15	-0.2	Migraine;	chr10:103365694	chr10:103394301~103394322:-
LUSC	cis	rs1712517	0.525	rs11191667	MIMAT0005951	hsa-miR-1307-3p	-4.26	2.46e-05	-0.15	-0.2	Migraine;	chr10:103369141	chr10:103394301~103394322:-
LUSC	cis	rs1712517	0.588	rs12220267	MIMAT0005951	hsa-miR-1307-3p	-4.26	2.47e-05	-0.16	-0.2	Migraine;	chr10:103315955	chr10:103394301~103394322:-
LUSC	cis	rs1712517	0.873	rs7903004	MIMAT0022727	hsa-miR-1307-5p	4.26	2.48e-05	0.14	0.2	Migraine;	chr10:103244344	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.763	rs8181292	MIMAT0026738	hsa-miR-1287-3p	4.26	2.49e-05	0.19	0.2	Metabolite levels;	chr10:98415720	chr10:98395232~98395253:-
LUSC	cis	rs1712517	0.566	rs7076274	MIMAT0005951	hsa-miR-1307-3p	-4.26	2.49e-05	-0.16	-0.2	Migraine;	chr10:103286250	chr10:103394301~103394322:-
LUSC	cis	rs1712517	0.545	rs3740381	MIMAT0005951	hsa-miR-1307-3p	-4.26	2.49e-05	-0.16	-0.2	Migraine;	chr10:103286932	chr10:103394301~103394322:-
LUSC	cis	rs990171	0.687	rs6724213	MIMAT0019926	hsa-miR-4772-5p	4.26	2.52e-05	0.26	0.2	Lymphocyte counts;	chr2:102534760	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.548	rs2871474	MIMAT0019926	hsa-miR-4772-5p	4.26	2.52e-05	0.26	0.2	Lymphocyte counts;	chr2:102534982	chr2:102432300~102432321:+
LUSC	cis	rs2229238	0.866	rs112231452	MIMAT0022491	hsa-miR-5698	4.26	2.52e-05	0.27	0.2	Coronary heart disease;	chr1:154532424	chr1:154104562~154104583:-
LUSC	cis	rs546131	0.642	rs512013	MIMAT0019776	hsa-miR-1343-3p	4.26	2.55e-05	0.21	0.2	Lung disease severity in cystic fibrosis;	chr11:34820678	chr11:34941888~34941909:+
LUSC	cis	rs1867631	1	rs10889640	MIMAT0014979	hsa-miR-3117-3p	-4.25	2.62e-05	-0.23	-0.2	Menopause (age at onset);	chr1:66662168	chr1:66628485~66628505:+
LUSC	cis	rs1712517	0.566	rs7917388	MIMAT0005951	hsa-miR-1307-3p	-4.25	2.62e-05	-0.16	-0.2	Migraine;	chr10:103295206	chr10:103394301~103394322:-
LUSC	cis	rs1712517	0.525	rs11191642	MIMAT0005951	hsa-miR-1307-3p	-4.25	2.62e-05	-0.16	-0.2	Migraine;	chr10:103296155	chr10:103394301~103394322:-
LUSC	cis	rs990171	1	rs2058623	MIMAT0019926	hsa-miR-4772-5p	4.25	2.64e-05	0.25	0.2	Lymphocyte counts;	chr2:102369710	chr2:102432300~102432321:+
LUSC	cis	rs1355223	0.583	rs1828298	MIMAT0019776	hsa-miR-1343-3p	4.25	2.65e-05	0.18	0.2	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34848892	chr11:34941888~34941909:+
LUSC	cis	rs1355223	0.583	rs1396881	MIMAT0019776	hsa-miR-1343-3p	4.25	2.65e-05	0.18	0.2	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34848959	chr11:34941888~34941909:+
LUSC	cis	rs7072216	0.763	rs6584202	MIMAT0026738	hsa-miR-1287-3p	4.25	2.65e-05	0.19	0.2	Metabolite levels;	chr10:98410626	chr10:98395232~98395253:-
LUSC	cis	rs950880	0.767	rs1420098	MIMAT0019927	hsa-miR-4772-3p	4.24	2.68e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102367819	chr2:102432336~102432357:+
LUSC	cis	rs950880	0.699	rs1882348	MIMAT0019927	hsa-miR-4772-3p	4.24	2.68e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102368211	chr2:102432336~102432357:+
LUSC	cis	rs7210990	0.724	rs9896441	MIMAT0005942	hsa-miR-1288-3p	4.24	2.69e-05	0.22	0.2	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16073729	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.724	rs11078331	MIMAT0005942	hsa-miR-1288-3p	4.24	2.69e-05	0.22	0.2	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16074555	chr17:16282058~16282078:+
LUSC	cis	rs7072216	0.763	rs7091709	MIMAT0005878	hsa-miR-1287-5p	4.24	2.69e-05	0.22	0.2	Metabolite levels;	chr10:98407848	chr10:98395271~98395292:-
LUSC	cis	rs4921799	0.64	rs28716839	MIMAT0015020	hsa-miR-548v	-4.24	2.73e-05	-0.23	-0.2	Lung cancer;Adenocarcinoma;	chr8:17680463	chr8:17681588~17681609:-
LUSC	cis	rs9807989	0.507	rs6734762	MIMAT0019927	hsa-miR-4772-3p	-4.24	2.75e-05	-0.17	-0.2	Asthma;	chr2:102446466	chr2:102432336~102432357:+
LUSC	cis	rs950880	1	rs12470864	MIMAT0019927	hsa-miR-4772-3p	4.24	2.76e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102309902	chr2:102432336~102432357:+
LUSC	cis	rs7072216	0.763	rs10883091	MIMAT0005878	hsa-miR-1287-5p	4.24	2.77e-05	0.22	0.2	Metabolite levels;	chr10:98407482	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.763	rs10883092	MIMAT0005878	hsa-miR-1287-5p	4.24	2.77e-05	0.22	0.2	Metabolite levels;	chr10:98407519	chr10:98395271~98395292:-
LUSC	cis	rs7072216	0.727	rs942809	MIMAT0005878	hsa-miR-1287-5p	4.24	2.77e-05	0.22	0.2	Metabolite levels;	chr10:98408244	chr10:98395271~98395292:-
LUSC	cis	rs4921799	0.662	rs17690083	MIMAT0015020	hsa-miR-548v	-4.23	2.79e-05	-0.23	-0.2	Lung cancer;Adenocarcinoma;	chr8:17680756	chr8:17681588~17681609:-
LUSC	cis	rs74233809	1	rs11191514	MIMAT0022727	hsa-miR-1307-5p	-4.23	2.8e-05	-0.28	-0.2	Birth weight;	chr10:103013607	chr10:103394341~103394361:-
LUSC	cis	rs79387448	0.638	rs11465670	MIMAT0019926	hsa-miR-4772-5p	-4.23	2.83e-05	-0.33	-0.2	Gut microbiota (bacterial taxa);	chr2:102417980	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.724	rs10451230	MIMAT0005942	hsa-miR-1288-3p	4.23	2.83e-05	0.22	0.2	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16131911	chr17:16282058~16282078:+
LUSC	cis	rs4917385	1	rs4917385	MIMAT0005951	hsa-miR-1307-3p	4.23	2.85e-05	0.16	0.2	Systemic lupus erythematosus;	chr10:103243964	chr10:103394301~103394322:-
LUSC	cis	rs4921799	0.662	rs17125108	MIMAT0015020	hsa-miR-548v	-4.23	2.85e-05	-0.23	-0.2	Lung cancer;Adenocarcinoma;	chr8:17680832	chr8:17681588~17681609:-
LUSC	cis	rs1867631	1	rs10789212	MIMAT0014979	hsa-miR-3117-3p	-4.23	2.86e-05	-0.23	-0.2	Menopause (age at onset);	chr1:66662472	chr1:66628485~66628505:+
LUSC	cis	rs1867631	1	rs10789213	MIMAT0014979	hsa-miR-3117-3p	-4.23	2.86e-05	-0.23	-0.2	Menopause (age at onset);	chr1:66662518	chr1:66628485~66628505:+
LUSC	cis	rs950880	0.767	rs4851569	MIMAT0019927	hsa-miR-4772-3p	4.22	2.96e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102366787	chr2:102432336~102432357:+
LUSC	cis	rs205611	1	rs205611	MIMAT0021020	hsa-miR-5000-3p	4.22	3.01e-05	0.3	0.2	Iris characteristics;	chr2:74744954	chr2:75090873~75090894:+
LUSC	cis	rs546131	0.642	rs2956073	MIMAT0019776	hsa-miR-1343-3p	4.21	3.07e-05	0.2	0.2	Lung disease severity in cystic fibrosis;	chr11:34821336	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.642	rs508062	MIMAT0019776	hsa-miR-1343-3p	4.21	3.07e-05	0.2	0.2	Lung disease severity in cystic fibrosis;	chr11:34822273	chr11:34941888~34941909:+
LUSC	cis	rs7072216	0.763	rs7091709	MIMAT0026738	hsa-miR-1287-3p	4.21	3.1e-05	0.19	0.2	Metabolite levels;	chr10:98407848	chr10:98395232~98395253:-
LUSC	cis	rs950880	0.767	rs2287037	MIMAT0019927	hsa-miR-4772-3p	4.21	3.14e-05	0.18	0.2	Serum protein levels (sST2);	chr2:102362568	chr2:102432336~102432357:+
LUSC	cis	rs990171	1	rs3771170	MIMAT0019926	hsa-miR-4772-5p	4.2	3.17e-05	0.25	0.2	Lymphocyte counts;	chr2:102369520	chr2:102432300~102432321:+
LUSC	cis	rs6681460	0.625	rs4488004	MIMAT0014979	hsa-miR-3117-3p	-4.2	3.18e-05	-0.21	-0.2	Presence of antiphospholipid antibodies;	chr1:66607631	chr1:66628485~66628505:+
LUSC	cis	rs4921799	0.618	rs35985354	MIMAT0015020	hsa-miR-548v	-4.2	3.18e-05	-0.23	-0.2	Lung cancer;Adenocarcinoma;	chr8:17680894	chr8:17681588~17681609:-
LUSC	cis	rs4921799	0.662	rs57661227	MIMAT0015020	hsa-miR-548v	-4.2	3.18e-05	-0.23	-0.2	Lung cancer;Adenocarcinoma;	chr8:17680912	chr8:17681588~17681609:-
LUSC	cis	rs546131	0.642	rs561477	MIMAT0019776	hsa-miR-1343-3p	4.2	3.28e-05	0.2	0.2	Lung disease severity in cystic fibrosis;	chr11:34830605	chr11:34941888~34941909:+
LUSC	cis	rs1712517	0.844	rs1163075	MIMAT0022727	hsa-miR-1307-5p	4.19	3.32e-05	0.14	0.2	Migraine;	chr10:103261506	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs12219901	MIMAT0022727	hsa-miR-1307-5p	-4.19	3.33e-05	-0.29	-0.2	Birth weight;	chr10:103081210	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs10458729	MIMAT0022727	hsa-miR-1307-5p	-4.19	3.33e-05	-0.29	-0.2	Birth weight;	chr10:103081722	chr10:103394341~103394361:-
LUSC	cis	rs546131	0.614	rs473885	MIMAT0019776	hsa-miR-1343-3p	4.19	3.33e-05	0.2	0.2	Lung disease severity in cystic fibrosis;	chr11:34830414	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.642	rs473848	MIMAT0019776	hsa-miR-1343-3p	4.19	3.33e-05	0.2	0.2	Lung disease severity in cystic fibrosis;	chr11:34830430	chr11:34941888~34941909:+
LUSC	cis	rs9807989	0.507	rs2287033	MIMAT0019927	hsa-miR-4772-3p	4.19	3.35e-05	0.17	0.2	Asthma;	chr2:102394777	chr2:102432336~102432357:+
LUSC	cis	rs990171	0.644	rs1024798	MIMAT0019926	hsa-miR-4772-5p	4.19	3.35e-05	0.25	0.2	Lymphocyte counts;	chr2:102525192	chr2:102432300~102432321:+
LUSC	cis	rs79387448	0.638	rs11465698	MIMAT0019926	hsa-miR-4772-5p	-4.19	3.39e-05	-0.33	-0.19	Gut microbiota (bacterial taxa);	chr2:102438117	chr2:102432300~102432321:+
LUSC	cis	rs79387448	0.701	rs3752659	MIMAT0019926	hsa-miR-4772-5p	-4.19	3.43e-05	-0.33	-0.19	Gut microbiota (bacterial taxa);	chr2:102385138	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.507	rs11465721	MIMAT0019927	hsa-miR-4772-3p	-4.18	3.48e-05	-0.17	-0.19	Asthma;	chr2:102446780	chr2:102432336~102432357:+
LUSC	cis	rs12554389	0.53	rs1930108	MIMAT0000090	hsa-miR-32-5p	-4.18	3.48e-05	-0.17	-0.19	Lobe attachment (rater-scored or self-reported);	chr9:108605350	chr9:109046272~109046293:-
LUSC	cis	rs12554389	0.53	rs12337383	MIMAT0000090	hsa-miR-32-5p	-4.18	3.5e-05	-0.17	-0.19	Lobe attachment (rater-scored or self-reported);	chr9:108569056	chr9:109046272~109046293:-
LUSC	cis	rs12554389	0.53	rs1930107	MIMAT0000090	hsa-miR-32-5p	-4.18	3.51e-05	-0.17	-0.19	Lobe attachment (rater-scored or self-reported);	chr9:108605784	chr9:109046272~109046293:-
LUSC	cis	rs1712517	0.873	rs7916056	MIMAT0022727	hsa-miR-1307-5p	4.18	3.57e-05	0.14	0.19	Migraine;	chr10:103238157	chr10:103394341~103394361:-
LUSC	cis	rs4493873	0.641	rs4620242	MIMAT0019729	hsa-miR-4661-5p	-4.17	3.64e-05	-0.23	-0.19	Migraine - clinic-based;	chr8:91118861	chr8:91205494~91205515:+
LUSC	cis	rs990171	0.687	rs4851619	MIMAT0019926	hsa-miR-4772-5p	-4.17	3.66e-05	-0.25	-0.19	Lymphocyte counts;	chr2:102559952	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.507	rs6755905	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.7e-05	-0.17	-0.19	Asthma;	chr2:102431747	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.527	rs6756161	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.7e-05	-0.17	-0.19	Asthma (childhood onset);	chr2:102431957	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs6726985	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.7e-05	-0.17	-0.19	Asthma;	chr2:102432120	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs2310300	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.7e-05	-0.17	-0.19	Asthma;	chr2:102432614	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs7581119	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.7e-05	-0.17	-0.19	Asthma;	chr2:102433405	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs3755266	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.71e-05	-0.17	-0.19	Asthma;	chr2:102426252	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs2110659	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.71e-05	-0.17	-0.19	Asthma;	chr2:102427407	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs7605284	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.71e-05	-0.17	-0.19	Asthma;	chr2:102427715	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.584	rs12712149	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.71e-05	-0.17	-0.19	Asthma (childhood onset);	chr2:102428733	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.584	rs7559845	MIMAT0019927	hsa-miR-4772-3p	-4.17	3.71e-05	-0.17	-0.19	Asthma (childhood onset);	chr2:102429754	chr2:102432336~102432357:+
LUSC	cis	rs1355223	0.583	rs2956074	MIMAT0019776	hsa-miR-1343-3p	4.17	3.74e-05	0.18	0.19	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34843333	chr11:34941888~34941909:+
LUSC	cis	rs6681460	0.625	rs2872079	MIMAT0014979	hsa-miR-3117-3p	-4.16	3.75e-05	-0.21	-0.19	Presence of antiphospholipid antibodies;	chr1:66664388	chr1:66628485~66628505:+
LUSC	cis	rs1712517	0.524	rs1712509	MIMAT0005951	hsa-miR-1307-3p	-4.16	3.84e-05	-0.15	-0.19	Migraine;	chr10:103254113	chr10:103394301~103394322:-
LUSC	cis	rs7072216	0.763	rs10883091	MIMAT0026738	hsa-miR-1287-3p	4.15	4.02e-05	0.18	0.19	Metabolite levels;	chr10:98407482	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.763	rs10883092	MIMAT0026738	hsa-miR-1287-3p	4.15	4.02e-05	0.18	0.19	Metabolite levels;	chr10:98407519	chr10:98395232~98395253:-
LUSC	cis	rs7072216	0.727	rs942809	MIMAT0026738	hsa-miR-1287-3p	4.15	4.02e-05	0.18	0.19	Metabolite levels;	chr10:98408244	chr10:98395232~98395253:-
LUSC	cis	rs17036023	1	rs17036023	MIMAT0004985	hsa-miR-942-5p	4.15	4.04e-05	0.3	0.19	Asthma (childhood onset);	chr1:116587089	chr1:117094655~117094676:+
LUSC	cis	rs4493873	0.6	rs12544236	MIMAT0019729	hsa-miR-4661-5p	4.15	4.04e-05	0.22	0.19	Migraine - clinic-based;	chr8:91127026	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.6	rs12546650	MIMAT0019729	hsa-miR-4661-5p	4.15	4.04e-05	0.22	0.19	Migraine - clinic-based;	chr8:91128361	chr8:91205494~91205515:+
LUSC	cis	rs4988958	0.565	rs3755265	MIMAT0019927	hsa-miR-4772-3p	-4.15	4.06e-05	-0.17	-0.19	Asthma (childhood onset);	chr2:102436356	chr2:102432336~102432357:+
LUSC	cis	rs4921799	0.64	rs10112153	MIMAT0015020	hsa-miR-548v	-4.14	4.09e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679023	chr8:17681588~17681609:-
LUSC	cis	rs4921799	0.64	rs10109250	MIMAT0015020	hsa-miR-548v	-4.14	4.09e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679026	chr8:17681588~17681609:-
LUSC	cis	rs12712133	0.514	rs10188022	MIMAT0019927	hsa-miR-4772-3p	4.14	4.11e-05	0.17	0.19	Primary biliary cholangitis;	chr2:102258406	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.873	rs7913461	MIMAT0022727	hsa-miR-1307-5p	-4.14	4.11e-05	-0.14	-0.19	Migraine;	chr10:103241568	chr10:103394341~103394361:-
LUSC	cis	rs10021731	0.577	rs6819048	MIMAT0003242	hsa-miR-577	-4.14	4.11e-05	-0.22	-0.19	Optic disc area;	chr4:114559153	chr4:114656774~114656794:+
LUSC	cis	rs1712517	0.74	rs4293062	MIMAT0022727	hsa-miR-1307-5p	-4.14	4.12e-05	-0.14	-0.19	Migraine;	chr10:103292867	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.744	rs11191641	MIMAT0022727	hsa-miR-1307-5p	-4.14	4.12e-05	-0.14	-0.19	Migraine;	chr10:103293183	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.744	rs4293063	MIMAT0022727	hsa-miR-1307-5p	-4.14	4.12e-05	-0.14	-0.19	Migraine;	chr10:103293219	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs943037	MIMAT0022727	hsa-miR-1307-5p	-4.14	4.14e-05	-0.29	-0.19	Birth weight;	chr10:103076162	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.525	rs7911488	MIMAT0005951	hsa-miR-1307-3p	-4.14	4.14e-05	-0.15	-0.19	Migraine;	chr10:103394332	chr10:103394301~103394322:-
LUSC	cis	rs7210990	0.724	rs7223346	MIMAT0005942	hsa-miR-1288-3p	4.14	4.15e-05	0.21	0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16078560	chr17:16282058~16282078:+
LUSC	cis	rs74233809	1	rs11191519	MIMAT0022727	hsa-miR-1307-5p	-4.14	4.18e-05	-0.27	-0.19	Birth weight;	chr10:103025161	chr10:103394341~103394361:-
LUSC	cis	rs79387448	0.638	rs7600961	MIMAT0019926	hsa-miR-4772-5p	-4.14	4.19e-05	-0.32	-0.19	Gut microbiota (bacterial taxa);	chr2:102418995	chr2:102432300~102432321:+
LUSC	cis	rs74233809	1	rs11191453	MIMAT0022727	hsa-miR-1307-5p	-4.14	4.24e-05	-0.29	-0.19	Birth weight;	chr10:102900095	chr10:103394341~103394361:-
LUSC	cis	rs7851726	0.565	rs10821413	MIMAT0019208	hsa-miR-3074-5p	-4.13	4.25e-05	-0.19	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94907034	chr9:95086063~95086083:-
LUSC	cis	rs1712517	0.835	rs2506961	MIMAT0022727	hsa-miR-1307-5p	4.13	4.25e-05	0.14	0.19	Migraine;	chr10:103248169	chr10:103394341~103394361:-
LUSC	cis	rs1712517	0.873	rs1712510	MIMAT0022727	hsa-miR-1307-5p	4.13	4.25e-05	0.14	0.19	Migraine;	chr10:103249329	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs11191515	MIMAT0022727	hsa-miR-1307-5p	-4.13	4.26e-05	-0.28	-0.19	Birth weight;	chr10:103016770	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs77787671	MIMAT0022727	hsa-miR-1307-5p	-4.13	4.32e-05	-0.27	-0.19	Birth weight;	chr10:103016448	chr10:103394341~103394361:-
LUSC	cis	rs4921799	0.597	rs35034557	MIMAT0015020	hsa-miR-548v	-4.13	4.35e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679136	chr8:17681588~17681609:-
LUSC	cis	rs4921799	0.686	rs10112397	MIMAT0015020	hsa-miR-548v	-4.13	4.35e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679195	chr8:17681588~17681609:-
LUSC	cis	rs4921799	0.513	rs10112412	MIMAT0015020	hsa-miR-548v	-4.13	4.35e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679236	chr8:17681588~17681609:-
LUSC	cis	rs4921799	0.577	rs10112413	MIMAT0015020	hsa-miR-548v	-4.13	4.35e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679238	chr8:17681588~17681609:-
LUSC	cis	rs990171	1	rs7603250	MIMAT0019926	hsa-miR-4772-5p	4.13	4.36e-05	0.24	0.19	Lymphocyte counts;	chr2:102452374	chr2:102432300~102432321:+
LUSC	cis	rs74233809	1	rs75970938	MIMAT0022727	hsa-miR-1307-5p	-4.13	4.37e-05	-0.28	-0.19	Birth weight;	chr10:103033891	chr10:103394341~103394361:-
LUSC	cis	rs74233809	1	rs79668541	MIMAT0022727	hsa-miR-1307-5p	-4.13	4.37e-05	-0.28	-0.19	Birth weight;	chr10:103034147	chr10:103394341~103394361:-
LUSC	cis	rs546131	0.642	rs2915186	MIMAT0019776	hsa-miR-1343-3p	4.13	4.42e-05	0.2	0.19	Lung disease severity in cystic fibrosis;	chr11:34829636	chr11:34941888~34941909:+
LUSC	cis	rs7397861	1	rs7398313	MIMAT0025460	hsa-miR-6502-5p	4.12	4.48e-05	0.24	0.19	Menopause (age at onset);	chr12:66423498	chr12:66251091~66251112:+
LUSC	cis	rs1712517	0.873	rs1163086	MIMAT0022727	hsa-miR-1307-5p	-4.12	4.5e-05	-0.14	-0.19	Migraine;	chr10:103279822	chr10:103394341~103394361:-
LUSC	cis	rs9807989	0.507	rs13021177	MIMAT0019927	hsa-miR-4772-3p	-4.12	4.51e-05	-0.17	-0.19	Asthma;	chr2:102440033	chr2:102432336~102432357:+
LUSC	cis	rs7210990	0.724	rs178827	MIMAT0005942	hsa-miR-1288-3p	4.12	4.52e-05	0.22	0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16180352	chr17:16282058~16282078:+
LUSC	cis	rs990171	0.913	rs1558627	MIMAT0019926	hsa-miR-4772-5p	4.12	4.53e-05	0.25	0.19	Lymphocyte counts;	chr2:102368224	chr2:102432300~102432321:+
LUSC	cis	rs3824488	0.599	rs16909856	MIMAT0019208	hsa-miR-3074-5p	-4.11	4.66e-05	-0.3	-0.19	Neuroticism;	chr9:95442211	chr9:95086063~95086083:-
LUSC	cis	rs74233809	1	rs76752100	MIMAT0022727	hsa-miR-1307-5p	-4.11	4.77e-05	-0.27	-0.19	Birth weight;	chr10:103034329	chr10:103394341~103394361:-
LUSC	cis	rs4921799	0.662	rs10888142	MIMAT0015020	hsa-miR-548v	-4.1	4.82e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679605	chr8:17681588~17681609:-
LUSC	cis	rs4921799	0.662	rs11203898	MIMAT0015020	hsa-miR-548v	-4.1	4.82e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17679823	chr8:17681588~17681609:-
LUSC	cis	rs4921799	0.662	rs11987569	MIMAT0015020	hsa-miR-548v	-4.1	4.82e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17680140	chr8:17681588~17681609:-
LUSC	cis	rs4493873	0.641	rs62526683	MIMAT0019729	hsa-miR-4661-5p	4.1	4.86e-05	0.22	0.19	Migraine - clinic-based;	chr8:91119780	chr8:91205494~91205515:+
LUSC	cis	rs990171	0.644	rs6543158	MIMAT0019926	hsa-miR-4772-5p	4.1	4.96e-05	0.24	0.19	Lymphocyte counts;	chr2:102540893	chr2:102432300~102432321:+
LUSC	cis	rs74233809	1	rs3781285	MIMAT0022727	hsa-miR-1307-5p	-4.1	5e-05	-0.28	-0.19	Birth weight;	chr10:103065908	chr10:103394341~103394361:-
LUSC	cis	rs9807989	0.507	rs4479442	MIMAT0019927	hsa-miR-4772-3p	-4.1	5e-05	-0.17	-0.19	Asthma;	chr2:102437614	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.773	rs1063461	MIMAT0022727	hsa-miR-1307-5p	-4.09	5.03e-05	-0.14	-0.19	Migraine;	chr10:103289348	chr10:103394341~103394361:-
LUSC	cis	rs2284932	0.556	rs6727168	MIMAT0016895	hsa-miR-2355-5p	-4.09	5.05e-05	-0.2	-0.19	Lachrymal/Salivary gland lesion in type 1 autoimmune pancreatitis;	chr2:207124746	chr2:207110043~207110063:-
LUSC	cis	rs74233809	1	rs11191499	MIMAT0022727	hsa-miR-1307-5p	-4.09	5.05e-05	-0.25	-0.19	Birth weight;	chr10:103004514	chr10:103394341~103394361:-
LUSC	cis	rs7210990	0.687	rs178828	MIMAT0005942	hsa-miR-1288-3p	4.09	5.14e-05	0.22	0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16180272	chr17:16282058~16282078:+
LUSC	cis	rs74233809	1	rs11191531	MIMAT0022727	hsa-miR-1307-5p	-4.09	5.14e-05	-0.27	-0.19	Birth weight;	chr10:103047141	chr10:103394341~103394361:-
LUSC	cis	rs7210990	0.699	rs178835	MIMAT0005942	hsa-miR-1288-3p	4.09	5.16e-05	0.22	0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16173802	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.687	rs178833	MIMAT0005942	hsa-miR-1288-3p	4.09	5.16e-05	0.22	0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16175522	chr17:16282058~16282078:+
LUSC	cis	rs1712517	1	rs1712517	MIMAT0022727	hsa-miR-1307-5p	-4.09	5.17e-05	-0.13	-0.19	Migraine;	chr10:103273258	chr10:103394341~103394361:-
LUSC	cis	rs1163656	0.559	rs7136415	MIMAT0003287	hsa-miR-618	-4.08	5.3e-05	-0.36	-0.19	Dental caries;	chr12:80915511	chr12:80935796~80935818:-
LUSC	cis	rs990171	0.649	rs6724322	MIMAT0019926	hsa-miR-4772-5p	4.08	5.31e-05	0.24	0.19	Lymphocyte counts;	chr2:102508723	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs6708949	MIMAT0019926	hsa-miR-4772-5p	-4.08	5.31e-05	-0.24	-0.19	Lymphocyte counts;	chr2:102507506	chr2:102432300~102432321:+
LUSC	cis	rs12712133	0.552	rs10200945	MIMAT0019927	hsa-miR-4772-3p	4.08	5.33e-05	0.17	0.19	Primary biliary cholangitis;	chr2:102268297	chr2:102432336~102432357:+
LUSC	cis	rs2369304	0.627	rs7493192	MIMAT0019214	hsa-miR-3173-5p	4.08	5.34e-05	0.24	0.19	Neutrophil count;	chr14:95759281	chr14:95137961~95137982:-
LUSC	cis	rs9807989	0.507	rs2058659	MIMAT0019927	hsa-miR-4772-3p	4.08	5.41e-05	0.17	0.19	Asthma;	chr2:102438096	chr2:102432336~102432357:+
LUSC	cis	rs990171	0.694	rs12712155	MIMAT0019926	hsa-miR-4772-5p	4.08	5.42e-05	0.24	0.19	Lymphocyte counts;	chr2:102511504	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs4851609	MIMAT0019926	hsa-miR-4772-5p	4.08	5.42e-05	0.24	0.19	Lymphocyte counts;	chr2:102512407	chr2:102432300~102432321:+
LUSC	cis	rs2229238	1	rs2229238	MIMAT0022491	hsa-miR-5698	-4.07	5.45e-05	-0.27	-0.19	Coronary heart disease;	chr1:154465420	chr1:154104562~154104583:-
LUSC	cis	rs4851551	0.619	rs34722443	MIMAT0019926	hsa-miR-4772-5p	4.07	5.46e-05	0.47	0.19	Blood protein levels;	chr2:102223859	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.507	rs6543133	MIMAT0019927	hsa-miR-4772-3p	-4.07	5.52e-05	-0.17	-0.19	Asthma;	chr2:102423717	chr2:102432336~102432357:+
LUSC	cis	rs7397861	1	rs10784534	MIMAT0025460	hsa-miR-6502-5p	4.07	5.52e-05	0.23	0.19	Menopause (age at onset);	chr12:66435946	chr12:66251091~66251112:+
LUSC	cis	rs4851551	0.867	rs2228139	MIMAT0019926	hsa-miR-4772-5p	4.07	5.64e-05	0.47	0.19	Blood protein levels;	chr2:102165189	chr2:102432300~102432321:+
LUSC	cis	rs7851726	0.69	rs4743969	MIMAT0019208	hsa-miR-3074-5p	-4.07	5.65e-05	-0.18	-0.19	Urinary albumin-to-creatinine ratio;	chr9:94836684	chr9:95086063~95086083:-
LUSC	cis	rs990171	0.562	rs6714379	MIMAT0019926	hsa-miR-4772-5p	4.07	5.66e-05	0.24	0.19	Lymphocyte counts;	chr2:102516851	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.649	rs1916307	MIMAT0019926	hsa-miR-4772-5p	4.07	5.66e-05	0.24	0.19	Lymphocyte counts;	chr2:102517721	chr2:102432300~102432321:+
LUSC	cis	rs6681460	0.625	rs6679568	MIMAT0014979	hsa-miR-3117-3p	-4.07	5.67e-05	-0.2	-0.19	Presence of antiphospholipid antibodies;	chr1:66608494	chr1:66628485~66628505:+
LUSC	cis	rs990171	0.65	rs11899041	MIMAT0019926	hsa-miR-4772-5p	4.07	5.68e-05	0.24	0.19	Lymphocyte counts;	chr2:102544594	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.955	rs1573895	MIMAT0019926	hsa-miR-4772-5p	4.06	5.69e-05	0.24	0.19	Lymphocyte counts;	chr2:102366416	chr2:102432300~102432321:+
LUSC	cis	rs74233809	1	rs11191543	MIMAT0022727	hsa-miR-1307-5p	-4.06	5.69e-05	-0.27	-0.19	Birth weight;	chr10:103064630	chr10:103394341~103394361:-
LUSC	cis	rs17730929	0.659	rs1033095	MIMAT0005923	hsa-miR-1269a	4.06	5.73e-05	0.37	0.19	Colorectal cancer (SNP x SNP interaction);	chr4:66366293	chr4:66276890~66276911:+
LUSC	cis	rs4493873	0.582	rs62526682	MIMAT0019729	hsa-miR-4661-5p	4.06	5.78e-05	0.22	0.19	Migraine - clinic-based;	chr8:91117246	chr8:91205494~91205515:+
LUSC	cis	rs1355223	0.752	rs286893	MIMAT0019776	hsa-miR-1343-3p	4.06	5.79e-05	0.18	0.19	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34653335	chr11:34941888~34941909:+
LUSC	cis	rs990171	1	rs1465321	MIMAT0019926	hsa-miR-4772-5p	4.06	5.79e-05	0.24	0.19	Lymphocyte counts;	chr2:102370158	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.724	rs178814	MIMAT0005942	hsa-miR-1288-3p	4.06	5.8e-05	0.22	0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16190841	chr17:16282058~16282078:+
LUSC	cis	rs4493873	0.6	rs55762572	MIMAT0019729	hsa-miR-4661-5p	4.06	5.88e-05	0.22	0.19	Migraine - clinic-based;	chr8:91118088	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.541	rs35606777	MIMAT0019729	hsa-miR-4661-5p	4.06	5.88e-05	0.22	0.19	Migraine - clinic-based;	chr8:91118531	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.641	rs34548877	MIMAT0019729	hsa-miR-4661-5p	4.06	5.88e-05	0.22	0.19	Migraine - clinic-based;	chr8:91118611	chr8:91205494~91205515:+
LUSC	cis	rs7210990	0.724	rs178821	MIMAT0005942	hsa-miR-1288-3p	4.06	5.89e-05	0.22	0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16184821	chr17:16282058~16282078:+
LUSC	cis	rs990171	0.71	rs2310220	MIMAT0019926	hsa-miR-4772-5p	4.06	5.92e-05	0.24	0.19	Lymphocyte counts;	chr2:102335391	chr2:102432300~102432321:+
LUSC	cis	rs12712133	0.552	rs1115281	MIMAT0019927	hsa-miR-4772-3p	4.06	5.92e-05	0.17	0.19	Primary biliary cholangitis;	chr2:102274647	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.873	rs1712516	MIMAT0022727	hsa-miR-1307-5p	-4.05	5.93e-05	-0.14	-0.19	Migraine;	chr10:103273871	chr10:103394341~103394361:-
LUSC	cis	rs990171	1	rs2058622	MIMAT0019926	hsa-miR-4772-5p	4.05	5.96e-05	0.24	0.19	Lymphocyte counts;	chr2:102368964	chr2:102432300~102432321:+
LUSC	cis	rs10993397	0.507	rs10993366	MIMAT0019208	hsa-miR-3074-5p	-4.05	6e-05	-0.18	-0.19	Polycystic ovary syndrome;	chr9:94844308	chr9:95086063~95086083:-
LUSC	cis	rs3824488	0.834	rs79057214	MIMAT0019208	hsa-miR-3074-5p	-4.05	6.03e-05	-0.32	-0.19	Neuroticism;	chr9:95488392	chr9:95086063~95086083:-
LUSC	cis	rs787274	1	rs2153837	MIMAT0019746	hsa-miR-4668-3p	-4.05	6.04e-05	-0.32	-0.19	Age-related hearing impairment (SNP x SNP interaction);	chr9:112700721	chr9:111932147~111932169:+
LUSC	cis	rs4851551	0.543	rs62156407	MIMAT0019926	hsa-miR-4772-5p	4.05	6.09e-05	0.47	0.19	Blood protein levels;	chr2:102208162	chr2:102432300~102432321:+
LUSC	cis	rs8008758	1	rs12435364	MIMAT0003386	hsa-miR-376a-5p	4.04	6.18e-05	0.18	0.19	Body mass index (alcohol intake interaction);	chr14:101223872	chr14:101040788~101040809:+
LUSC	cis	rs79387448	0.638	rs116055209	MIMAT0019926	hsa-miR-4772-5p	-4.04	6.24e-05	-0.31	-0.19	Gut microbiota (bacterial taxa);	chr2:102415729	chr2:102432300~102432321:+
LUSC	cis	rs10021731	0.52	rs10024217	MIMAT0003242	hsa-miR-577	-4.04	6.29e-05	-0.21	-0.19	Optic disc area;	chr4:114536959	chr4:114656774~114656794:+
LUSC	cis	rs990171	0.687	rs1303960	MIMAT0019926	hsa-miR-4772-5p	4.04	6.36e-05	0.24	0.19	Lymphocyte counts;	chr2:102549373	chr2:102432300~102432321:+
LUSC	cis	rs8008758	0.963	rs10132271	MIMAT0003386	hsa-miR-376a-5p	4.04	6.36e-05	0.18	0.19	Body mass index (alcohol intake interaction);	chr14:101222537	chr14:101040788~101040809:+
LUSC	cis	rs4493873	0.641	rs34520902	MIMAT0019729	hsa-miR-4661-5p	4.04	6.41e-05	0.22	0.19	Migraine - clinic-based;	chr8:91119490	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.62	rs56004977	MIMAT0019729	hsa-miR-4661-5p	4.04	6.41e-05	0.22	0.19	Migraine - clinic-based;	chr8:91119901	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.62	rs12540975	MIMAT0019729	hsa-miR-4661-5p	4.04	6.41e-05	0.22	0.19	Migraine - clinic-based;	chr8:91120114	chr8:91205494~91205515:+
LUSC	cis	rs7210990	0.724	rs11658564	MIMAT0005942	hsa-miR-1288-3p	4.03	6.54e-05	0.21	0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16120273	chr17:16282058~16282078:+
LUSC	cis	rs9807989	0.507	rs4851004	MIMAT0019927	hsa-miR-4772-3p	4.03	6.57e-05	0.17	0.19	Asthma;	chr2:102393077	chr2:102432336~102432357:+
LUSC	cis	rs7210990	0.724	rs7222886	MIMAT0005942	hsa-miR-1288-3p	4.03	6.57e-05	0.21	0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16109180	chr17:16282058~16282078:+
LUSC	cis	rs990171	1	rs1468791	MIMAT0019926	hsa-miR-4772-5p	4.03	6.59e-05	0.23	0.19	Lymphocyte counts;	chr2:102475562	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs1403550	MIMAT0019926	hsa-miR-4772-5p	-4.03	6.6e-05	-0.24	-0.19	Lymphocyte counts;	chr2:102519850	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.724	rs9907273	MIMAT0005942	hsa-miR-1288-3p	4.03	6.63e-05	0.21	0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16107445	chr17:16282058~16282078:+
LUSC	cis	rs12712133	0.552	rs10469856	MIMAT0019927	hsa-miR-4772-3p	-4.03	6.65e-05	-0.17	-0.19	Primary biliary cholangitis;	chr2:102272369	chr2:102432336~102432357:+
LUSC	cis	rs4921799	0.662	rs3862096	MIMAT0015020	hsa-miR-548v	-4.03	6.68e-05	-0.22	-0.19	Lung cancer;Adenocarcinoma;	chr8:17686707	chr8:17681588~17681609:-
LUSC	cis	rs7210990	0.77	rs178837	MIMAT0005942	hsa-miR-1288-3p	4.02	6.71e-05	0.22	0.19	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16173584	chr17:16282058~16282078:+
LUSC	cis	rs12712133	0.552	rs11123915	MIMAT0019927	hsa-miR-4772-3p	4.02	6.72e-05	0.17	0.19	Primary biliary cholangitis;	chr2:102264363	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs1420094	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.77e-05	-0.16	-0.19	Asthma;	chr2:102399227	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs6745614	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.78e-05	-0.16	-0.19	Asthma;	chr2:102374753	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs10208196	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.78e-05	-0.16	-0.19	Asthma;	chr2:102379885	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs3213732	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.78e-05	-0.16	-0.19	Asthma;	chr2:102381819	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs10204757	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.78e-05	-0.16	-0.19	Asthma;	chr2:102382514	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.524	rs7591246	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.78e-05	-0.16	-0.19	Asthma;	chr2:102382943	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.565	rs6760621	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.78e-05	-0.16	-0.19	Asthma (childhood onset);	chr2:102383492	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.527	rs11465641	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.78e-05	-0.16	-0.19	Asthma (childhood onset);	chr2:102384408	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.525	rs3771159	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.79e-05	-0.16	-0.19	Asthma (childhood onset);	chr2:102388498	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.501	rs11903946	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.79e-05	-0.16	-0.19	Asthma;	chr2:102388870	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs6706002	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.79e-05	-0.16	-0.19	Asthma;	chr2:102389644	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs6749014	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.79e-05	-0.16	-0.19	Asthma;	chr2:102389988	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.565	rs885088	MIMAT0019927	hsa-miR-4772-3p	-4.02	6.83e-05	-0.16	-0.19	Asthma (childhood onset);	chr2:102422584	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.844	rs1163074	MIMAT0022727	hsa-miR-1307-5p	-4.01	6.99e-05	-0.13	-0.19	Migraine;	chr10:103262005	chr10:103394341~103394361:-
LUSC	cis	rs990171	0.955	rs10197881	MIMAT0019926	hsa-miR-4772-5p	4.01	7.17e-05	0.23	0.19	Lymphocyte counts;	chr2:102475256	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs2192758	MIMAT0019926	hsa-miR-4772-5p	4.01	7.21e-05	0.24	0.19	Lymphocyte counts;	chr2:102515810	chr2:102432300~102432321:+
LUSC	cis	rs4711350	0.723	rs6915136	MIMAT0022975	hsa-miR-3934-3p	4.01	7.23e-05	0.3	0.19	Schizophrenia;	chr6:33683545	chr6:33698191~33698212:+
LUSC	cis	rs74233809	0.901	rs17878846	MIMAT0022727	hsa-miR-1307-5p	-4.01	7.27e-05	-0.28	-0.19	Birth weight;	chr10:102870655	chr10:103394341~103394361:-
LUSC	cis	rs990171	0.687	rs11123935	MIMAT0019926	hsa-miR-4772-5p	4	7.31e-05	0.23	0.19	Lymphocyte counts;	chr2:102523292	chr2:102432300~102432321:+
LUSC	cis	rs1712517	0.873	rs1891292	MIMAT0022727	hsa-miR-1307-5p	4	7.32e-05	0.13	0.19	Migraine;	chr10:103241753	chr10:103394341~103394361:-
LUSC	cis	rs990171	1	rs1861246	MIMAT0019926	hsa-miR-4772-5p	4	7.36e-05	0.24	0.19	Lymphocyte counts;	chr2:102350323	chr2:102432300~102432321:+
LUSC	cis	rs4493873	0.641	rs11783034	MIMAT0019729	hsa-miR-4661-5p	4	7.36e-05	0.22	0.19	Migraine - clinic-based;	chr8:91122587	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.641	rs57771593	MIMAT0019729	hsa-miR-4661-5p	4	7.36e-05	0.22	0.19	Migraine - clinic-based;	chr8:91124078	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.62	rs11777826	MIMAT0019729	hsa-miR-4661-5p	4	7.36e-05	0.22	0.19	Migraine - clinic-based;	chr8:91124337	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.641	rs11785003	MIMAT0019729	hsa-miR-4661-5p	4	7.36e-05	0.22	0.19	Migraine - clinic-based;	chr8:91124500	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.641	rs62526685	MIMAT0019729	hsa-miR-4661-5p	4	7.36e-05	0.22	0.19	Migraine - clinic-based;	chr8:91124791	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.641	rs11778758	MIMAT0019729	hsa-miR-4661-5p	4	7.36e-05	0.22	0.19	Migraine - clinic-based;	chr8:91125218	chr8:91205494~91205515:+
LUSC	cis	rs990171	0.687	rs2005881	MIMAT0019926	hsa-miR-4772-5p	4	7.41e-05	0.24	0.19	Lymphocyte counts;	chr2:102556600	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.955	rs11465583	MIMAT0019926	hsa-miR-4772-5p	4	7.47e-05	0.24	0.19	Lymphocyte counts;	chr2:102366006	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs10197284	MIMAT0019926	hsa-miR-4772-5p	4	7.47e-05	0.24	0.19	Lymphocyte counts;	chr2:102366243	chr2:102432300~102432321:+
LUSC	cis	rs4988958	0.565	rs6732138	MIMAT0019927	hsa-miR-4772-3p	-4	7.55e-05	-0.16	-0.19	Asthma (childhood onset);	chr2:102393202	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs1420096	MIMAT0019927	hsa-miR-4772-3p	-4	7.55e-05	-0.16	-0.19	Asthma;	chr2:102394452	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.565	rs12712146	MIMAT0019927	hsa-miR-4772-3p	-4	7.57e-05	-0.16	-0.19	Asthma (childhood onset);	chr2:102392254	chr2:102432336~102432357:+
LUSC	cis	rs990171	0.77	rs1420103	MIMAT0019926	hsa-miR-4772-5p	4	7.57e-05	0.24	0.19	Lymphocyte counts;	chr2:102332172	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.507	rs7584093	MIMAT0019927	hsa-miR-4772-3p	-3.99	7.72e-05	-0.16	-0.19	Asthma;	chr2:102381261	chr2:102432336~102432357:+
LUSC	cis	rs7397861	1	rs6581689	MIMAT0025460	hsa-miR-6502-5p	3.99	7.79e-05	0.23	0.19	Menopause (age at onset);	chr12:66424336	chr12:66251091~66251112:+
LUSC	cis	rs1048886	0.938	rs12525408	MIMAT0000087	hsa-miR-30a-5p	3.99	7.87e-05	0.27	0.19	Type 2 diabetes;	chr6:70580420	chr6:71403595~71403616:-
LUSC	cis	rs1712517	0.787	rs1163089	MIMAT0022727	hsa-miR-1307-5p	-3.98	7.89e-05	-0.13	-0.19	Migraine;	chr10:103284207	chr10:103394341~103394361:-
LUSC	cis	rs4988958	0.548	rs6543127	MIMAT0019927	hsa-miR-4772-3p	-3.98	8.01e-05	-0.16	-0.19	Asthma (childhood onset);	chr2:102411841	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs1592459	MIMAT0019927	hsa-miR-4772-3p	-3.98	8.01e-05	-0.16	-0.19	Asthma;	chr2:102415109	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs1592458	MIMAT0019927	hsa-miR-4772-3p	-3.98	8.01e-05	-0.16	-0.19	Asthma;	chr2:102415289	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.565	rs1035125	MIMAT0019927	hsa-miR-4772-3p	-3.98	8.01e-05	-0.16	-0.19	Asthma (childhood onset);	chr2:102417379	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs2160201	MIMAT0019927	hsa-miR-4772-3p	-3.98	8.01e-05	-0.16	-0.19	Asthma;	chr2:102417501	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs10203558	MIMAT0019927	hsa-miR-4772-3p	-3.98	8.01e-05	-0.16	-0.19	Asthma;	chr2:102411180	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs10200952	MIMAT0019927	hsa-miR-4772-3p	-3.98	8.01e-05	-0.16	-0.19	Asthma;	chr2:102411191	chr2:102432336~102432357:+
LUSC	cis	rs990171	0.687	rs4851616	MIMAT0019926	hsa-miR-4772-5p	3.98	8.12e-05	0.23	0.19	Lymphocyte counts;	chr2:102535403	chr2:102432300~102432321:+
LUSC	cis	rs4493873	0.641	rs4577919	MIMAT0019729	hsa-miR-4661-5p	3.98	8.17e-05	0.21	0.19	Migraine - clinic-based;	chr8:91128200	chr8:91205494~91205515:+
LUSC	cis	rs9807989	0.507	rs1035129	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.32e-05	-0.16	-0.19	Asthma;	chr2:102403325	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.524	rs2110662	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.32e-05	-0.16	-0.19	Asthma;	chr2:102403679	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.524	rs7594402	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.32e-05	-0.16	-0.19	Asthma;	chr2:102404807	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs6710034	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.32e-05	-0.16	-0.19	Asthma;	chr2:102407218	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.584	rs7589142	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.32e-05	-0.16	-0.19	Asthma (childhood onset);	chr2:102408200	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs1833174	MIMAT0019927	hsa-miR-4772-3p	-3.97	8.32e-05	-0.16	-0.19	Asthma;	chr2:102418383	chr2:102432336~102432357:+
LUSC	cis	rs1712517	0.844	rs1163087	MIMAT0022727	hsa-miR-1307-5p	-3.97	8.37e-05	-0.13	-0.19	Migraine;	chr10:103283532	chr10:103394341~103394361:-
LUSC	cis	rs6681460	0.625	rs2312154	MIMAT0014979	hsa-miR-3117-3p	3.97	8.5e-05	0.2	0.18	Presence of antiphospholipid antibodies;	chr1:66607293	chr1:66628485~66628505:+
LUSC	cis	rs1712517	0.838	rs6584543	MIMAT0022727	hsa-miR-1307-5p	3.97	8.52e-05	0.13	0.18	Migraine;	chr10:103237257	chr10:103394341~103394361:-
LUSC	cis	rs990171	0.77	rs6543116	MIMAT0019926	hsa-miR-4772-5p	3.97	8.55e-05	0.24	0.18	Lymphocyte counts;	chr2:102311266	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.507	rs2041739	MIMAT0019927	hsa-miR-4772-3p	3.97	8.55e-05	0.16	0.18	Asthma;	chr2:102377873	chr2:102432336~102432357:+
LUSC	cis	rs4493873	0.641	rs62526686	MIMAT0019729	hsa-miR-4661-5p	3.96	8.59e-05	0.22	0.18	Migraine - clinic-based;	chr8:91129300	chr8:91205494~91205515:+
LUSC	cis	rs7477	0.619	rs12938397	MIMAT0005942	hsa-miR-1288-3p	-3.96	8.62e-05	-0.2	-0.18	Amyotrophic lateral sclerosis;	chr17:16282786	chr17:16282058~16282078:+
LUSC	cis	rs9807989	0.507	rs6743516	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.65e-05	-0.16	-0.18	Asthma;	chr2:102419875	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.565	rs1420100	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.65e-05	-0.16	-0.18	Asthma (childhood onset);	chr2:102420542	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.527	rs3771155	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.65e-05	-0.16	-0.18	Asthma (childhood onset);	chr2:102421366	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.565	rs10206291	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.65e-05	-0.16	-0.18	Asthma (childhood onset);	chr2:102422403	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs6710528	MIMAT0019927	hsa-miR-4772-3p	3.96	8.66e-05	0.16	0.18	Asthma;	chr2:102399682	chr2:102432336~102432357:+
LUSC	cis	rs4988958	0.565	rs3771154	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.66e-05	-0.16	-0.18	Asthma (childhood onset);	chr2:102422900	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.524	rs6759479	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.66e-05	-0.16	-0.18	Asthma;	chr2:102423587	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs4851571	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.66e-05	-0.16	-0.18	Asthma;	chr2:102402540	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs4851572	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.66e-05	-0.16	-0.18	Asthma;	chr2:102402571	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs2293224	MIMAT0019927	hsa-miR-4772-3p	-3.96	8.66e-05	-0.16	-0.18	Asthma;	chr2:102419319	chr2:102432336~102432357:+
LUSC	cis	rs990171	0.913	rs6718157	MIMAT0019926	hsa-miR-4772-5p	3.96	8.69e-05	0.23	0.18	Lymphocyte counts;	chr2:102463354	chr2:102432300~102432321:+
LUSC	cis	rs2075184	1	rs2075184	MIMAT0019926	hsa-miR-4772-5p	3.96	8.69e-05	0.23	0.18	Pediatric autoimmune diseases;	chr2:102464132	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs917996	MIMAT0019926	hsa-miR-4772-5p	3.96	8.69e-05	0.23	0.18	Lymphocyte counts;	chr2:102465813	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.908	rs731628	MIMAT0019926	hsa-miR-4772-5p	3.96	8.69e-05	0.23	0.18	Lymphocyte counts;	chr2:102466111	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.913	rs1403554	MIMAT0019926	hsa-miR-4772-5p	3.96	8.69e-05	0.23	0.18	Lymphocyte counts;	chr2:102466993	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.955	rs10165460	MIMAT0019926	hsa-miR-4772-5p	3.96	8.69e-05	0.23	0.18	Lymphocyte counts;	chr2:102469171	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs11123931	MIMAT0019926	hsa-miR-4772-5p	3.96	8.69e-05	0.23	0.18	Lymphocyte counts;	chr2:102469200	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs990171	MIMAT0019926	hsa-miR-4772-5p	3.96	8.69e-05	0.23	0.18	Lymphocyte counts;	chr2:102470310	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.955	rs4241210	MIMAT0019926	hsa-miR-4772-5p	3.96	8.74e-05	0.23	0.18	Lymphocyte counts;	chr2:102462280	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.865	rs6717915	MIMAT0019926	hsa-miR-4772-5p	3.96	8.74e-05	0.23	0.18	Lymphocyte counts;	chr2:102463159	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.507	rs3732124	MIMAT0019927	hsa-miR-4772-3p	3.96	8.84e-05	0.16	0.18	Asthma;	chr2:102401592	chr2:102432336~102432357:+
LUSC	cis	rs10021731	0.52	rs11938586	MIMAT0003242	hsa-miR-577	-3.96	8.85e-05	-0.2	-0.18	Optic disc area;	chr4:114536901	chr4:114656774~114656794:+
LUSC	cis	rs73198271	0.74	rs1039911	MIMAT0019728	hsa-miR-4660	-3.95	8.96e-05	-0.23	-0.18	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8790696	chr8:9048453~9048475:+
LUSC	cis	rs9807989	0.524	rs6543126	MIMAT0019927	hsa-miR-4772-3p	-3.95	9.14e-05	-0.16	-0.18	Asthma;	chr2:102410644	chr2:102432336~102432357:+
LUSC	cis	rs990171	0.955	rs6720564	MIMAT0019926	hsa-miR-4772-5p	3.95	9.15e-05	0.23	0.18	Lymphocyte counts;	chr2:102462837	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs13015714	MIMAT0019926	hsa-miR-4772-5p	3.95	9.19e-05	0.23	0.18	Lymphocyte counts;	chr2:102355405	chr2:102432300~102432321:+
LUSC	cis	rs7072216	0.843	rs4400721	MIMAT0026738	hsa-miR-1287-3p	3.95	9.24e-05	0.17	0.18	Metabolite levels;	chr10:98387340	chr10:98395232~98395253:-
LUSC	cis	rs1355223	0.583	rs1553757	MIMAT0019776	hsa-miR-1343-3p	3.94	9.29e-05	0.17	0.18	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34845542	chr11:34941888~34941909:+
LUSC	cis	rs1355223	0.583	rs1549789	MIMAT0019776	hsa-miR-1343-3p	3.94	9.29e-05	0.17	0.18	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34846400	chr11:34941888~34941909:+
LUSC	cis	rs9807989	0.507	rs6758936	MIMAT0019927	hsa-miR-4772-3p	3.94	9.31e-05	0.16	0.18	Asthma;	chr2:102374909	chr2:102432336~102432357:+
LUSC	cis	rs4921799	0.662	rs7462063	MIMAT0015020	hsa-miR-548v	-3.94	9.34e-05	-0.21	-0.18	Lung cancer;Adenocarcinoma;	chr8:17678838	chr8:17681588~17681609:-
LUSC	cis	rs546131	0.642	rs579926	MIMAT0019776	hsa-miR-1343-3p	3.94	9.41e-05	0.19	0.18	Lung disease severity in cystic fibrosis;	chr11:34831608	chr11:34941888~34941909:+
LUSC	cis	rs6584202	0.589	rs10883094	MIMAT0026738	hsa-miR-1287-3p	3.94	9.44e-05	0.18	0.18	Obesity-related traits;	chr10:98428349	chr10:98395232~98395253:-
LUSC	cis	rs7829975	0.535	rs4841005	MIMAT0019728	hsa-miR-4660	-3.94	9.52e-05	-0.21	-0.18	Mood instability;	chr8:8643720	chr8:9048453~9048475:+
LUSC	cis	rs990171	1	rs6727306	MIMAT0019926	hsa-miR-4772-5p	3.94	9.53e-05	0.23	0.18	Lymphocyte counts;	chr2:102365184	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs11685483	MIMAT0019926	hsa-miR-4772-5p	3.94	9.57e-05	0.23	0.18	Lymphocyte counts;	chr2:102542634	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.649	rs6543159	MIMAT0019926	hsa-miR-4772-5p	3.94	9.57e-05	0.23	0.18	Lymphocyte counts;	chr2:102543598	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.605	rs6739426	MIMAT0019926	hsa-miR-4772-5p	3.94	9.57e-05	0.23	0.18	Lymphocyte counts;	chr2:102543984	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.836	rs3785631	MIMAT0005942	hsa-miR-1288-3p	-3.93	9.7e-05	-0.2	-0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16042632	chr17:16282058~16282078:+
LUSC	cis	rs7072216	0.77	rs1061115	MIMAT0026738	hsa-miR-1287-3p	3.93	9.82e-05	0.16	0.18	Metabolite levels;	chr10:98417292	chr10:98395232~98395253:-
LUSC	cis	rs7210990	0.724	rs7207463	MIMAT0005942	hsa-miR-1288-3p	3.93	9.84e-05	0.21	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16100945	chr17:16282058~16282078:+
LUSC	cis	rs7851726	0.652	rs7847277	MIMAT0019208	hsa-miR-3074-5p	-3.92	0.000101	-0.18	-0.18	Urinary albumin-to-creatinine ratio;	chr9:94851146	chr9:95086063~95086083:-
LUSC	cis	rs4493873	0.641	rs61279214	MIMAT0019729	hsa-miR-4661-5p	3.92	0.000102	0.21	0.18	Migraine - clinic-based;	chr8:91132107	chr8:91205494~91205515:+
LUSC	cis	rs6681460	0.932	rs2146904	MIMAT0014979	hsa-miR-3117-3p	3.92	0.000103	0.2	0.18	Presence of antiphospholipid antibodies;	chr1:66694653	chr1:66628485~66628505:+
LUSC	cis	rs7210990	0.724	rs3785628	MIMAT0005942	hsa-miR-1288-3p	-3.92	0.000104	-0.2	-0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16067368	chr17:16282058~16282078:+
LUSC	cis	rs73198271	0.92	rs11781542	MIMAT0019728	hsa-miR-4660	-3.92	0.000104	-0.25	-0.18	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8759671	chr8:9048453~9048475:+
LUSC	cis	rs7072216	0.77	rs1061123	MIMAT0026738	hsa-miR-1287-3p	3.91	0.000105	0.16	0.18	Metabolite levels;	chr10:98417240	chr10:98395232~98395253:-
LUSC	cis	rs7397861	0.932	rs7304118	MIMAT0025460	hsa-miR-6502-5p	3.91	0.000105	0.22	0.18	Menopause (age at onset);	chr12:66448355	chr12:66251091~66251112:+
LUSC	cis	rs9807989	0.524	rs4851576	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.000105	-0.16	-0.18	Asthma;	chr2:102412435	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs4851577	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.000105	-0.16	-0.18	Asthma;	chr2:102412461	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs4851579	MIMAT0019927	hsa-miR-4772-3p	-3.91	0.000105	-0.16	-0.18	Asthma;	chr2:102412524	chr2:102432336~102432357:+
LUSC	cis	rs79387448	0.626	rs80256362	MIMAT0019926	hsa-miR-4772-5p	-3.91	0.000105	-0.31	-0.18	Gut microbiota (bacterial taxa);	chr2:102409041	chr2:102432300~102432321:+
LUSC	cis	rs74233809	0.901	rs12416331	MIMAT0022727	hsa-miR-1307-5p	-3.91	0.000106	-0.26	-0.18	Birth weight;	chr10:103169157	chr10:103394341~103394361:-
LUSC	cis	rs990171	0.687	rs10193407	MIMAT0019926	hsa-miR-4772-5p	3.91	0.000106	0.23	0.18	Lymphocyte counts;	chr2:102522839	chr2:102432300~102432321:+
LUSC	cis	rs8008758	1	rs8008758	MIMAT0003386	hsa-miR-376a-5p	-3.91	0.000108	-0.17	-0.18	Body mass index (alcohol intake interaction);	chr14:101223708	chr14:101040788~101040809:+
LUSC	cis	rs7851726	0.69	rs10821404	MIMAT0019208	hsa-miR-3074-5p	-3.91	0.000108	-0.18	-0.18	Urinary albumin-to-creatinine ratio;	chr9:94834583	chr9:95086063~95086083:-
LUSC	cis	rs990171	1	rs7561487	MIMAT0019926	hsa-miR-4772-5p	3.9	0.00011	0.22	0.18	Lymphocyte counts;	chr2:102461434	chr2:102432300~102432321:+
LUSC	cis	rs1048886	0.872	rs12200777	MIMAT0000087	hsa-miR-30a-5p	3.9	0.00011	0.22	0.18	Type 2 diabetes;	chr6:70577251	chr6:71403595~71403616:-
LUSC	cis	rs73198271	0.813	rs17697237	MIMAT0019728	hsa-miR-4660	3.9	0.000111	0.22	0.18	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8758364	chr8:9048453~9048475:+
LUSC	cis	rs7210990	0.724	rs2324141	MIMAT0005942	hsa-miR-1288-3p	3.9	0.000111	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16130129	chr17:16282058~16282078:+
LUSC	cis	rs3818717	0.538	rs12945601	MIMAT0027454	hsa-miR-6777-5p	3.9	0.000112	0.18	0.18	Lymphocyte counts;	chr17:17750097	chr17:17813518~17813540:-
LUSC	cis	rs9527	0.59	rs1475642	MIMAT0022727	hsa-miR-1307-5p	-3.9	0.000113	-0.14	-0.18	Arsenic metabolism;	chr10:102786426	chr10:103394341~103394361:-
LUSC	cis	rs7397861	1	rs10784531	MIMAT0025460	hsa-miR-6502-5p	3.9	0.000113	0.23	0.18	Menopause (age at onset);	chr12:66421920	chr12:66251091~66251112:+
LUSC	cis	rs7397861	1	rs7487393	MIMAT0025460	hsa-miR-6502-5p	3.9	0.000113	0.23	0.18	Menopause (age at onset);	chr12:66422100	chr12:66251091~66251112:+
LUSC	cis	rs7210990	0.765	rs21180	MIMAT0005942	hsa-miR-1288-3p	3.89	0.000114	0.21	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16184694	chr17:16282058~16282078:+
LUSC	cis	rs6163	0.508	rs12776506	MIMAT0022727	hsa-miR-1307-5p	3.89	0.000114	0.14	0.18	Waist circumference;Hip circumference;	chr10:102773071	chr10:103394341~103394361:-
LUSC	cis	rs990171	0.687	rs12712157	MIMAT0019926	hsa-miR-4772-5p	3.89	0.000116	0.23	0.18	Lymphocyte counts;	chr2:102548670	chr2:102432300~102432321:+
LUSC	cis	rs950880	0.767	rs6710885	MIMAT0019927	hsa-miR-4772-3p	-3.89	0.000116	-0.16	-0.18	Serum protein levels (sST2);	chr2:102361077	chr2:102432336~102432357:+
LUSC	cis	rs9807989	0.507	rs10439410	MIMAT0019927	hsa-miR-4772-3p	3.89	0.000118	0.16	0.18	Asthma;	chr2:102374328	chr2:102432336~102432357:+
LUSC	cis	rs7210990	0.529	rs35799415	MIMAT0005942	hsa-miR-1288-3p	3.88	0.000118	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16127586	chr17:16282058~16282078:+
LUSC	cis	rs1712517	0.844	rs4918003	MIMAT0022727	hsa-miR-1307-5p	-3.88	0.000119	-0.13	-0.18	Migraine;	chr10:103284400	chr10:103394341~103394361:-
LUSC	cis	rs7397861	1	rs7397823	MIMAT0025460	hsa-miR-6502-5p	3.88	0.000119	0.23	0.18	Menopause (age at onset);	chr12:66420243	chr12:66251091~66251112:+
LUSC	cis	rs7851726	0.69	rs4744386	MIMAT0019208	hsa-miR-3074-5p	-3.88	0.00012	-0.18	-0.18	Urinary albumin-to-creatinine ratio;	chr9:94852359	chr9:95086063~95086083:-
LUSC	cis	rs9807989	0.507	rs1420105	MIMAT0019927	hsa-miR-4772-3p	-3.88	0.000121	-0.16	-0.18	Asthma;	chr2:102418659	chr2:102432336~102432357:+
LUSC	cis	rs9876781	0.624	rs12491849	MIMAT0000440	hsa-miR-191-5p	3.88	0.000121	0.13	0.18	Longevity;	chr3:48489975	chr3:49020672~49020694:-
LUSC	cis	rs74233809	1	rs12413409	MIMAT0022727	hsa-miR-1307-5p	-3.88	0.000121	-0.26	-0.18	Birth weight;	chr10:102959339	chr10:103394341~103394361:-
LUSC	cis	rs546131	0.642	rs10836315	MIMAT0019776	hsa-miR-1343-3p	3.88	0.000121	0.2	0.18	Lung disease severity in cystic fibrosis;	chr11:34831799	chr11:34941888~34941909:+
LUSC	cis	rs990171	0.913	rs2075185	MIMAT0019926	hsa-miR-4772-5p	3.88	0.000122	0.22	0.18	Lymphocyte counts;	chr2:102454528	chr2:102432300~102432321:+
LUSC	cis	rs12607903	0.915	rs8099415	MIMAT0025849	hsa-miR-6718-5p	3.88	0.000122	0.21	0.18	Menarche (age at onset);	chr18:3820765	chr18:3885363~3885383:+
LUSC	cis	rs990171	0.913	rs10190555	MIMAT0019926	hsa-miR-4772-5p	3.88	0.000123	0.23	0.18	Lymphocyte counts;	chr2:102377596	chr2:102432300~102432321:+
LUSC	cis	rs74233809	1	rs74233296	MIMAT0022727	hsa-miR-1307-5p	-3.87	0.000123	-0.28	-0.18	Birth weight;	chr10:102895593	chr10:103394341~103394361:-
LUSC	cis	rs17730929	0.659	rs2350805	MIMAT0005923	hsa-miR-1269a	-3.87	0.000124	-0.37	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66361183	chr4:66276890~66276911:+
LUSC	cis	rs73198271	0.74	rs1039910	MIMAT0019728	hsa-miR-4660	-3.87	0.000124	-0.23	-0.18	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8790556	chr8:9048453~9048475:+
LUSC	cis	rs990171	1	rs3755274	MIMAT0019926	hsa-miR-4772-5p	3.87	0.000126	0.23	0.18	Lymphocyte counts;	chr2:102385935	chr2:102432300~102432321:+
LUSC	cis	rs2369304	0.627	rs2369311	MIMAT0019214	hsa-miR-3173-5p	3.87	0.000126	0.22	0.18	Neutrophil count;	chr14:95758123	chr14:95137961~95137982:-
LUSC	cis	rs74233809	0.892	rs11191447	MIMAT0022727	hsa-miR-1307-5p	-3.87	0.000126	-0.28	-0.18	Birth weight;	chr10:102892566	chr10:103394341~103394361:-
LUSC	cis	rs12554389	0.53	rs7022652	MIMAT0000090	hsa-miR-32-5p	-3.87	0.000127	-0.15	-0.18	Lobe attachment (rater-scored or self-reported);	chr9:108594525	chr9:109046272~109046293:-
LUSC	cis	rs7397861	1	rs7397862	MIMAT0025460	hsa-miR-6502-5p	3.86	0.000128	0.22	0.18	Menopause (age at onset);	chr12:66420707	chr12:66251091~66251112:+
LUSC	cis	rs1712517	0.873	rs1163083	MIMAT0022727	hsa-miR-1307-5p	-3.86	0.000128	-0.13	-0.18	Migraine;	chr10:103278698	chr10:103394341~103394361:-
LUSC	cis	rs1048886	0.872	rs9455181	MIMAT0000087	hsa-miR-30a-5p	3.86	0.000129	0.2	0.18	Type 2 diabetes;	chr6:70593014	chr6:71403595~71403616:-
LUSC	cis	rs1048886	0.872	rs10945235	MIMAT0000087	hsa-miR-30a-5p	3.86	0.000129	0.2	0.18	Type 2 diabetes;	chr6:70595342	chr6:71403595~71403616:-
LUSC	cis	rs990171	1	rs917997	MIMAT0019926	hsa-miR-4772-5p	3.86	0.000129	0.22	0.18	Lymphocyte counts;	chr2:102454108	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.913	rs4851587	MIMAT0019926	hsa-miR-4772-5p	3.86	0.000129	0.22	0.18	Lymphocyte counts;	chr2:102457014	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs6705001	MIMAT0019926	hsa-miR-4772-5p	3.86	0.000129	0.22	0.18	Lymphocyte counts;	chr2:102459750	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs6543141	MIMAT0019926	hsa-miR-4772-5p	3.86	0.000129	0.22	0.18	Lymphocyte counts;	chr2:102459891	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs6753717	MIMAT0019926	hsa-miR-4772-5p	3.86	0.000129	0.23	0.18	Lymphocyte counts;	chr2:102376701	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs6750020	MIMAT0019926	hsa-miR-4772-5p	3.86	0.000129	0.23	0.18	Lymphocyte counts;	chr2:102378254	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.913	rs6729638	MIMAT0019926	hsa-miR-4772-5p	3.86	0.000129	0.23	0.18	Lymphocyte counts;	chr2:102379562	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs6750971	MIMAT0019926	hsa-miR-4772-5p	3.86	0.000132	0.22	0.18	Lymphocyte counts;	chr2:102522366	chr2:102432300~102432321:+
LUSC	cis	rs1867631	1	rs1867631	MIMAT0014979	hsa-miR-3117-3p	-3.85	0.000133	-0.21	-0.18	Menopause (age at onset);	chr1:66580443	chr1:66628485~66628505:+
LUSC	cis	rs546131	0.642	rs7946980	MIMAT0019776	hsa-miR-1343-3p	3.85	0.000134	0.19	0.18	Lung disease severity in cystic fibrosis;	chr11:34798891	chr11:34941888~34941909:+
LUSC	cis	rs990171	1	rs4851588	MIMAT0019926	hsa-miR-4772-5p	3.85	0.000135	0.22	0.18	Lymphocyte counts;	chr2:102457045	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.955	rs4070554	MIMAT0019926	hsa-miR-4772-5p	3.85	0.000135	0.22	0.18	Lymphocyte counts;	chr2:102458033	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.955	rs6761825	MIMAT0019926	hsa-miR-4772-5p	3.85	0.000135	0.22	0.18	Lymphocyte counts;	chr2:102459101	chr2:102432300~102432321:+
LUSC	cis	rs3824488	0.92	rs80155616	MIMAT0019208	hsa-miR-3074-5p	-3.85	0.000136	-0.31	-0.18	Neuroticism;	chr9:95481586	chr9:95086063~95086083:-
LUSC	cis	rs3824488	0.92	rs28510415	MIMAT0019208	hsa-miR-3074-5p	-3.85	0.000136	-0.31	-0.18	Neuroticism;	chr9:95482744	chr9:95086063~95086083:-
LUSC	cis	rs6681460	1	rs6681460	MIMAT0014979	hsa-miR-3117-3p	3.85	0.000137	0.19	0.18	Presence of antiphospholipid antibodies;	chr1:66657374	chr1:66628485~66628505:+
LUSC	cis	rs990171	0.721	rs6543115	MIMAT0019926	hsa-miR-4772-5p	3.85	0.000138	0.23	0.18	Lymphocyte counts;	chr2:102311181	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.778	rs9908591	MIMAT0005942	hsa-miR-1288-3p	3.85	0.000138	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16145728	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.724	rs8079969	MIMAT0005942	hsa-miR-1288-3p	3.85	0.000138	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16148130	chr17:16282058~16282078:+
LUSC	cis	rs1712517	0.838	rs1891293	MIMAT0022727	hsa-miR-1307-5p	3.84	0.000139	0.13	0.18	Migraine;	chr10:103242040	chr10:103394341~103394361:-
LUSC	cis	rs9914988	0.943	rs2043032	MIMAT0001631	hsa-miR-451a	-3.84	0.00014	-0.29	-0.18	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28809674	chr17:28861403~28861424:-
LUSC	cis	rs7210990	0.836	rs1126148	MIMAT0005942	hsa-miR-1288-3p	3.84	0.00014	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16112265	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.831	rs35622628	MIMAT0005942	hsa-miR-1288-3p	3.84	0.00014	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16116714	chr17:16282058~16282078:+
LUSC	cis	rs990171	0.687	rs4851613	MIMAT0019926	hsa-miR-4772-5p	3.84	0.000141	0.22	0.18	Lymphocyte counts;	chr2:102521531	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.866	rs12150017	MIMAT0005942	hsa-miR-1288-3p	3.84	0.000142	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16120780	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.831	rs11078332	MIMAT0005942	hsa-miR-1288-3p	3.84	0.000142	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16122754	chr17:16282058~16282078:+
LUSC	cis	rs889398	0.771	rs11075732	MIMAT0004597	hsa-miR-140-3p	3.84	0.000142	0.12	0.18	Body mass index;	chr16:69732135	chr16:69933142~69933162:+
LUSC	cis	rs7210990	0.866	rs11655773	MIMAT0005942	hsa-miR-1288-3p	3.84	0.000142	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16126985	chr17:16282058~16282078:+
LUSC	cis	rs9914988	0.943	rs2242345	MIMAT0001631	hsa-miR-451a	3.83	0.000144	0.26	0.18	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28858809	chr17:28861403~28861424:-
LUSC	cis	rs7210990	0.836	rs178829	MIMAT0005942	hsa-miR-1288-3p	3.83	0.000145	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16179875	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.831	rs178830	MIMAT0005942	hsa-miR-1288-3p	3.83	0.000146	0.21	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16178644	chr17:16282058~16282078:+
LUSC	cis	rs990171	0.954	rs6543137	MIMAT0019926	hsa-miR-4772-5p	3.83	0.000147	0.23	0.18	Lymphocyte counts;	chr2:102449448	chr2:102432300~102432321:+
LUSC	cis	rs4493873	0.507	rs12545986	MIMAT0019729	hsa-miR-4661-5p	3.83	0.000147	0.21	0.18	Migraine - clinic-based;	chr8:91190413	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.507	rs3923174	MIMAT0019729	hsa-miR-4661-5p	3.83	0.000147	0.21	0.18	Migraine - clinic-based;	chr8:91191534	chr8:91205494~91205515:+
LUSC	cis	rs12554389	0.53	rs871424	MIMAT0000090	hsa-miR-32-5p	-3.83	0.000148	-0.16	-0.18	Lobe attachment (rater-scored or self-reported);	chr9:108562322	chr9:109046272~109046293:-
LUSC	cis	rs889398	0.933	rs6499240	MIMAT0004597	hsa-miR-140-3p	-3.83	0.000149	-0.12	-0.18	Body mass index;	chr16:69653009	chr16:69933142~69933162:+
LUSC	cis	rs7072216	0.763	rs2147901	MIMAT0026738	hsa-miR-1287-3p	-3.83	0.000149	-0.17	-0.18	Metabolite levels;	chr10:98405739	chr10:98395232~98395253:-
LUSC	cis	rs74233809	0.901	rs3824754	MIMAT0022727	hsa-miR-1307-5p	-3.83	0.000149	-0.27	-0.18	Birth weight;	chr10:102854593	chr10:103394341~103394361:-
LUSC	cis	rs990171	0.77	rs7562254	MIMAT0019926	hsa-miR-4772-5p	3.82	0.000151	0.23	0.18	Lymphocyte counts;	chr2:102308487	chr2:102432300~102432321:+
LUSC	cis	rs73198271	0.74	rs10113326	MIMAT0019728	hsa-miR-4660	-3.82	0.000152	-0.23	-0.18	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8790120	chr8:9048453~9048475:+
LUSC	cis	rs990171	0.644	rs1523203	MIMAT0019926	hsa-miR-4772-5p	3.82	0.000152	0.22	0.18	Lymphocyte counts;	chr2:102519300	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.649	rs4851611	MIMAT0019926	hsa-miR-4772-5p	3.82	0.000152	0.22	0.18	Lymphocyte counts;	chr2:102519479	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs1403551	MIMAT0019926	hsa-miR-4772-5p	3.82	0.000152	0.22	0.18	Lymphocyte counts;	chr2:102519987	chr2:102432300~102432321:+
LUSC	cis	rs1048886	0.872	rs12191321	MIMAT0000087	hsa-miR-30a-5p	3.82	0.000152	0.22	0.18	Type 2 diabetes;	chr6:70593484	chr6:71403595~71403616:-
LUSC	cis	rs79387448	0.638	rs78123896	MIMAT0019926	hsa-miR-4772-5p	-3.82	0.000153	-0.3	-0.18	Gut microbiota (bacterial taxa);	chr2:102458957	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs6755786	MIMAT0019926	hsa-miR-4772-5p	3.82	0.000154	0.23	0.18	Lymphocyte counts;	chr2:102431643	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs6713618	MIMAT0019926	hsa-miR-4772-5p	3.82	0.000154	0.23	0.18	Lymphocyte counts;	chr2:102431977	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs6716784	MIMAT0019926	hsa-miR-4772-5p	3.82	0.000154	0.23	0.18	Lymphocyte counts;	chr2:102432007	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs6543134	MIMAT0019926	hsa-miR-4772-5p	3.82	0.000154	0.23	0.18	Lymphocyte counts;	chr2:102433998	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.866	rs11650678	MIMAT0005942	hsa-miR-1288-3p	3.82	0.000154	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16124713	chr17:16282058~16282078:+
LUSC	cis	rs546131	0.642	rs12808574	MIMAT0019776	hsa-miR-1343-3p	3.81	0.000156	0.19	0.18	Lung disease severity in cystic fibrosis;	chr11:34830573	chr11:34941888~34941909:+
LUSC	cis	rs7210990	0.866	rs178820	MIMAT0005942	hsa-miR-1288-3p	3.81	0.000157	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16187471	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.831	rs545738	MIMAT0005942	hsa-miR-1288-3p	3.81	0.000157	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16187858	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.612	rs2779212	MIMAT0005942	hsa-miR-1288-3p	-3.81	0.000158	-0.2	-0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:15973341	chr17:16282058~16282078:+
LUSC	cis	rs2229238	0.774	rs4509570	MIMAT0022491	hsa-miR-5698	-3.81	0.000158	-0.23	-0.18	Coronary heart disease;	chr1:154463908	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.774	rs4341355	MIMAT0022491	hsa-miR-5698	-3.81	0.000158	-0.23	-0.18	Coronary heart disease;	chr1:154463928	chr1:154104562~154104583:-
LUSC	cis	rs7210990	0.68	rs178801	MIMAT0005942	hsa-miR-1288-3p	3.81	0.000159	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16205150	chr17:16282058~16282078:+
LUSC	cis	rs73198271	0.773	rs66618176	MIMAT0019728	hsa-miR-4660	-3.81	0.000159	-0.22	-0.18	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8789464	chr8:9048453~9048475:+
LUSC	cis	rs990171	1	rs11694658	MIMAT0019926	hsa-miR-4772-5p	3.81	0.000159	0.23	0.18	Lymphocyte counts;	chr2:102428560	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs2272129	MIMAT0019926	hsa-miR-4772-5p	3.8	0.000162	0.23	0.18	Lymphocyte counts;	chr2:102423789	chr2:102432300~102432321:+
LUSC	cis	rs889398	0.967	rs7359336	MIMAT0004597	hsa-miR-140-3p	-3.8	0.000163	-0.12	-0.18	Body mass index;	chr16:69699557	chr16:69933142~69933162:+
LUSC	cis	rs1355223	0.752	rs17359064	MIMAT0019776	hsa-miR-1343-3p	-3.8	0.000164	-0.17	-0.18	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34652337	chr11:34941888~34941909:+
LUSC	cis	rs7397861	1	rs6581687	MIMAT0025460	hsa-miR-6502-5p	-3.8	0.000165	-0.22	-0.18	Menopause (age at onset);	chr12:66423015	chr12:66251091~66251112:+
LUSC	cis	rs990171	0.77	rs4577297	MIMAT0019926	hsa-miR-4772-5p	3.8	0.000165	0.23	0.18	Lymphocyte counts;	chr2:102301558	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.724	rs2324142	MIMAT0005942	hsa-miR-1288-3p	-3.8	0.000168	-0.2	-0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16137992	chr17:16282058~16282078:+
LUSC	cis	rs990171	0.562	rs12469973	MIMAT0019926	hsa-miR-4772-5p	-3.8	0.000168	-0.23	-0.18	Lymphocyte counts;	chr2:102565814	chr2:102432300~102432321:+
LUSC	cis	rs7072216	0.666	rs11189592	MIMAT0026738	hsa-miR-1287-3p	3.79	0.000169	0.17	0.18	Metabolite levels;	chr10:98395885	chr10:98395232~98395253:-
LUSC	cis	rs2229238	0.774	rs7537291	MIMAT0022491	hsa-miR-5698	-3.79	0.000171	-0.24	-0.18	Coronary heart disease;	chr1:154460931	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.774	rs7546068	MIMAT0022491	hsa-miR-5698	-3.79	0.000171	-0.24	-0.18	Coronary heart disease;	chr1:154460939	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.774	rs7537316	MIMAT0022491	hsa-miR-5698	-3.79	0.000171	-0.24	-0.18	Coronary heart disease;	chr1:154460990	chr1:154104562~154104583:-
LUSC	cis	rs2291447	0.967	rs8069937	MIMAT0027467	hsa-miR-6783-3p	-3.79	0.000171	-0.18	-0.18	Economic and political preferences;	chr17:45131259	chr17:44934618~44934639:-
LUSC	cis	rs2369304	0.736	rs11160288	MIMAT0019214	hsa-miR-3173-5p	-3.79	0.000171	-0.21	-0.18	Neutrophil count;	chr14:95754409	chr14:95137961~95137982:-
LUSC	cis	rs7072216	0.763	rs2147901	MIMAT0005878	hsa-miR-1287-5p	-3.79	0.000172	-0.19	-0.18	Metabolite levels;	chr10:98405739	chr10:98395271~98395292:-
LUSC	cis	rs4493873	0.6	rs4419777	MIMAT0019729	hsa-miR-4661-5p	-3.79	0.000173	-0.21	-0.18	Migraine - clinic-based;	chr8:91174785	chr8:91205494~91205515:+
LUSC	cis	rs7210990	0.724	rs9897388	MIMAT0005942	hsa-miR-1288-3p	3.79	0.000173	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16134312	chr17:16282058~16282078:+
LUSC	cis	rs1355223	0.867	rs1377495	MIMAT0019776	hsa-miR-1343-3p	3.79	0.000173	0.17	0.18	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34661415	chr11:34941888~34941909:+
LUSC	cis	rs12554389	0.53	rs79393974	MIMAT0000090	hsa-miR-32-5p	-3.79	0.000173	-0.15	-0.18	Lobe attachment (rater-scored or self-reported);	chr9:108542231	chr9:109046272~109046293:-
LUSC	cis	rs4493873	0.6	rs5029071	MIMAT0019729	hsa-miR-4661-5p	3.79	0.000174	0.21	0.18	Migraine - clinic-based;	chr8:91140087	chr8:91205494~91205515:+
LUSC	cis	rs73198271	0.74	rs28521727	MIMAT0019728	hsa-miR-4660	-3.79	0.000174	-0.22	-0.18	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8789707	chr8:9048453~9048475:+
LUSC	cis	rs73198271	0.74	rs28402110	MIMAT0019728	hsa-miR-4660	-3.79	0.000174	-0.22	-0.18	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8789739	chr8:9048453~9048475:+
LUSC	cis	rs73198271	0.74	rs10098636	MIMAT0019728	hsa-miR-4660	-3.79	0.000174	-0.22	-0.18	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8789814	chr8:9048453~9048475:+
LUSC	cis	rs73198271	0.74	rs10112989	MIMAT0019728	hsa-miR-4660	-3.79	0.000174	-0.22	-0.18	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8789824	chr8:9048453~9048475:+
LUSC	cis	rs79387448	0.701	rs11465586	MIMAT0019926	hsa-miR-4772-5p	-3.79	0.000175	-0.31	-0.18	Gut microbiota (bacterial taxa);	chr2:102366249	chr2:102432300~102432321:+
LUSC	cis	rs7397861	1	rs7397463	MIMAT0025460	hsa-miR-6502-5p	3.78	0.000177	0.22	0.18	Menopause (age at onset);	chr12:66419391	chr12:66251091~66251112:+
LUSC	cis	rs2369304	0.767	rs8023009	MIMAT0019214	hsa-miR-3173-5p	3.78	0.000177	0.22	0.18	Neutrophil count;	chr14:95740069	chr14:95137961~95137982:-
LUSC	cis	rs990171	1	rs7559479	MIMAT0019926	hsa-miR-4772-5p	3.78	0.000179	0.22	0.18	Lymphocyte counts;	chr2:102452327	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs6746271	MIMAT0019926	hsa-miR-4772-5p	3.77	0.000184	0.22	0.18	Lymphocyte counts;	chr2:102436535	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs2058660	MIMAT0019926	hsa-miR-4772-5p	3.77	0.000184	0.22	0.18	Lymphocyte counts;	chr2:102437989	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.955	rs2058658	MIMAT0019926	hsa-miR-4772-5p	3.77	0.000184	0.22	0.18	Lymphocyte counts;	chr2:102438343	chr2:102432300~102432321:+
LUSC	cis	rs546131	0.642	rs1949048	MIMAT0019776	hsa-miR-1343-3p	-3.77	0.000186	-0.2	-0.18	Lung disease severity in cystic fibrosis;	chr11:34815427	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.642	rs1949046	MIMAT0019776	hsa-miR-1343-3p	-3.77	0.000186	-0.2	-0.18	Lung disease severity in cystic fibrosis;	chr11:34815442	chr11:34941888~34941909:+
LUSC	cis	rs17730929	0.659	rs72643109	MIMAT0005923	hsa-miR-1269a	-3.77	0.000186	-0.37	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66383922	chr4:66276890~66276911:+
LUSC	cis	rs17730929	0.79	rs17087161	MIMAT0005923	hsa-miR-1269a	-3.77	0.000188	-0.39	-0.18	Colorectal cancer (SNP x SNP interaction);	chr4:66430960	chr4:66276890~66276911:+
LUSC	cis	rs4493873	0.641	rs62526707	MIMAT0019729	hsa-miR-4661-5p	3.76	0.000191	0.2	0.18	Migraine - clinic-based;	chr8:91168925	chr8:91205494~91205515:+
LUSC	cis	rs9527	0.59	rs10883839	MIMAT0022727	hsa-miR-1307-5p	3.76	0.000191	0.14	0.18	Arsenic metabolism;	chr10:103160584	chr10:103394341~103394361:-
LUSC	cis	rs2069426	0.591	rs17694493	MIMAT0000089	hsa-miR-31-5p	3.76	0.000194	0.26	0.18	Acute lymphoblastic leukemia (childhood);	chr9:22041999	chr9:21512158~21512178:-
LUSC	cis	rs12554389	0.53	rs17727743	MIMAT0000090	hsa-miR-32-5p	-3.76	0.000194	-0.16	-0.18	Lobe attachment (rater-scored or self-reported);	chr9:108564871	chr9:109046272~109046293:-
LUSC	cis	rs79387448	0.638	rs6741230	MIMAT0019926	hsa-miR-4772-5p	-3.76	0.000195	-0.3	-0.18	Gut microbiota (bacterial taxa);	chr2:102453171	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.955	rs6734736	MIMAT0019926	hsa-miR-4772-5p	3.76	0.000196	0.22	0.18	Lymphocyte counts;	chr2:102446420	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.955	rs6708413	MIMAT0019926	hsa-miR-4772-5p	3.76	0.000196	0.22	0.18	Lymphocyte counts;	chr2:102446909	chr2:102432300~102432321:+
LUSC	cis	rs2369304	0.767	rs1005949	MIMAT0019214	hsa-miR-3173-5p	3.75	2e-04	0.21	0.18	Neutrophil count;	chr14:95746910	chr14:95137961~95137982:-
LUSC	cis	rs7210990	0.866	rs178816	MIMAT0005942	hsa-miR-1288-3p	3.75	2e-04	0.2	0.18	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16189588	chr17:16282058~16282078:+
LUSC	cis	rs7397861	1	rs7397085	MIMAT0025460	hsa-miR-6502-5p	3.75	2e-04	0.22	0.18	Menopause (age at onset);	chr12:66423614	chr12:66251091~66251112:+
LUSC	cis	rs6681460	0.932	rs4655640	MIMAT0014979	hsa-miR-3117-3p	-3.75	0.000201	-0.19	-0.18	Presence of antiphospholipid antibodies;	chr1:66623537	chr1:66628485~66628505:+
LUSC	cis	rs205611	0.769	rs35097565	MIMAT0021020	hsa-miR-5000-3p	-3.75	0.000202	-0.31	-0.18	Iris characteristics;	chr2:74788005	chr2:75090873~75090894:+
LUSC	cis	rs546131	0.642	rs10501136	MIMAT0019776	hsa-miR-1343-3p	3.75	0.000203	0.2	0.18	Lung disease severity in cystic fibrosis;	chr11:34824969	chr11:34941888~34941909:+
LUSC	cis	rs1678618	0.715	rs1613186	MIMAT0019758	hsa-miR-4676-5p	3.75	0.000203	0.2	0.18	Smoking behavior;	chr10:72063982	chr10:72721038~72721058:+
LUSC	cis	rs7397861	1	rs6581688	MIMAT0025460	hsa-miR-6502-5p	3.75	0.000204	0.22	0.17	Menopause (age at onset);	chr12:66424302	chr12:66251091~66251112:+
LUSC	cis	rs1712517	0.844	rs1163081	MIMAT0022727	hsa-miR-1307-5p	-3.74	0.000206	-0.13	-0.17	Migraine;	chr10:103270083	chr10:103394341~103394361:-
LUSC	cis	rs990171	0.913	rs2241117	MIMAT0019926	hsa-miR-4772-5p	3.74	0.000206	0.22	0.17	Lymphocyte counts;	chr2:102386583	chr2:102432300~102432321:+
LUSC	cis	rs11134338	0.517	rs34626780	MIMAT0019693	hsa-miR-4636	-3.74	0.000207	-0.22	-0.17	Obesity-related traits;	chr5:8943227	chr5:9053865~9053886:-
LUSC	cis	rs4493873	0.641	rs56277320	MIMAT0019729	hsa-miR-4661-5p	3.74	0.000208	0.2	0.17	Migraine - clinic-based;	chr8:91160273	chr8:91205494~91205515:+
LUSC	cis	rs12554389	0.53	rs10123779	MIMAT0000090	hsa-miR-32-5p	-3.74	0.000208	-0.15	-0.17	Lobe attachment (rater-scored or self-reported);	chr9:108562371	chr9:109046272~109046293:-
LUSC	cis	rs7072216	0.652	rs11189600	MIMAT0026738	hsa-miR-1287-3p	-3.74	0.000209	-0.16	-0.17	Metabolite levels;	chr10:98419517	chr10:98395232~98395253:-
LUSC	cis	rs990171	1	rs2270297	MIMAT0019926	hsa-miR-4772-5p	3.74	0.000211	0.22	0.17	Lymphocyte counts;	chr2:102376215	chr2:102432300~102432321:+
LUSC	cis	rs73198271	0.74	rs10094270	MIMAT0019728	hsa-miR-4660	-3.74	0.000211	-0.22	-0.17	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8789123	chr8:9048453~9048475:+
LUSC	cis	rs7397861	1	rs6581692	MIMAT0025460	hsa-miR-6502-5p	3.74	0.000211	0.22	0.17	Menopause (age at onset);	chr12:66428840	chr12:66251091~66251112:+
LUSC	cis	rs2291447	0.905	rs11652187	MIMAT0027467	hsa-miR-6783-3p	-3.74	0.000212	-0.18	-0.17	Economic and political preferences;	chr17:45122537	chr17:44934618~44934639:-
LUSC	cis	rs990171	0.802	rs1558650	MIMAT0019926	hsa-miR-4772-5p	3.73	0.000212	0.22	0.17	Lymphocyte counts;	chr2:102443564	chr2:102432300~102432321:+
LUSC	cis	rs75358501	0.636	rs725980	MIMAT0014994	hsa-miR-3130-3p	3.73	0.000212	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783245~206783265:-
LUSC	cis	rs75358501	0.636	rs725980	MIMAT0014994_1	hsa-miR-3130-3p	3.73	0.000212	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206773856	chr2:206783277~206783297:+
LUSC	cis	rs75358501	0.636	rs10199766	MIMAT0014994	hsa-miR-3130-3p	3.73	0.000212	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783245~206783265:-
LUSC	cis	rs75358501	0.636	rs10199766	MIMAT0014994_1	hsa-miR-3130-3p	3.73	0.000212	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206777144	chr2:206783277~206783297:+
LUSC	cis	rs4493873	0.641	rs58037018	MIMAT0019729	hsa-miR-4661-5p	3.73	0.000212	0.2	0.17	Migraine - clinic-based;	chr8:91160686	chr8:91205494~91205515:+
LUSC	cis	rs74233809	1	rs11191548	MIMAT0022727	hsa-miR-1307-5p	3.73	0.000213	0.24	0.17	Birth weight;	chr10:103086421	chr10:103394341~103394361:-
LUSC	cis	rs1048886	0.872	rs113350471	MIMAT0000087	hsa-miR-30a-5p	3.73	0.000213	0.25	0.17	Type 2 diabetes;	chr6:70433373	chr6:71403595~71403616:-
LUSC	cis	rs75358501	0.688	rs2287629	MIMAT0014994	hsa-miR-3130-3p	-3.73	0.000214	-0.24	-0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783245~206783265:-
LUSC	cis	rs75358501	0.688	rs2287629	MIMAT0014994_1	hsa-miR-3130-3p	-3.73	0.000214	-0.24	-0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785690	chr2:206783277~206783297:+
LUSC	cis	rs12554389	0.53	rs7020966	MIMAT0000090	hsa-miR-32-5p	-3.73	0.000214	-0.14	-0.17	Lobe attachment (rater-scored or self-reported);	chr9:108552079	chr9:109046272~109046293:-
LUSC	cis	rs11134338	0.627	rs2962650	MIMAT0019693	hsa-miR-4636	-3.73	0.000215	-0.21	-0.17	Obesity-related traits;	chr5:8937053	chr5:9053865~9053886:-
LUSC	cis	rs11134338	0.602	rs2963376	MIMAT0019693	hsa-miR-4636	-3.73	0.000215	-0.21	-0.17	Obesity-related traits;	chr5:8942752	chr5:9053865~9053886:-
LUSC	cis	rs3824488	0.92	rs10512249	MIMAT0019208	hsa-miR-3074-5p	-3.73	0.000216	-0.27	-0.17	Neuroticism;	chr9:95494027	chr9:95086063~95086083:-
LUSC	cis	rs7851726	1	rs7866848	MIMAT0019208	hsa-miR-3074-5p	-3.73	0.000217	-0.17	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94743326	chr9:95086063~95086083:-
LUSC	cis	rs6681460	1	rs6659968	MIMAT0014979	hsa-miR-3117-3p	-3.73	0.000217	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66657776	chr1:66628485~66628505:+
LUSC	cis	rs6681460	1	rs2031478	MIMAT0014979	hsa-miR-3117-3p	-3.73	0.000217	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66658059	chr1:66628485~66628505:+
LUSC	cis	rs889398	0.967	rs7359336	MIMAT0000431	hsa-miR-140-5p	-3.73	0.000218	-0.15	-0.17	Body mass index;	chr16:69699557	chr16:69933103~69933124:+
LUSC	cis	rs889398	0.967	rs35967356	MIMAT0004597	hsa-miR-140-3p	3.73	0.000219	0.12	0.17	Body mass index;	chr16:69547451	chr16:69933142~69933162:+
LUSC	cis	rs4493873	0.641	rs4524748	MIMAT0019729	hsa-miR-4661-5p	3.73	0.000219	0.2	0.17	Migraine - clinic-based;	chr8:91146870	chr8:91205494~91205515:+
LUSC	cis	rs546131	0.6	rs7946699	MIMAT0019776	hsa-miR-1343-3p	3.73	0.00022	0.18	0.17	Lung disease severity in cystic fibrosis;	chr11:34798522	chr11:34941888~34941909:+
LUSC	cis	rs4713675	0.565	rs4713670	MIMAT0022975	hsa-miR-3934-3p	3.72	0.000221	0.18	0.17	Plateletcrit;	chr6:33732105	chr6:33698191~33698212:+
LUSC	cis	rs11134338	0.517	rs13189384	MIMAT0019693	hsa-miR-4636	-3.72	0.000222	-0.22	-0.17	Obesity-related traits;	chr5:8943209	chr5:9053865~9053886:-
LUSC	cis	rs7210990	0.699	rs178836	MIMAT0005942	hsa-miR-1288-3p	3.72	0.000223	0.2	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16173684	chr17:16282058~16282078:+
LUSC	cis	rs990171	1	rs3860444	MIMAT0019926	hsa-miR-4772-5p	3.72	0.000224	0.22	0.17	Lymphocyte counts;	chr2:102391163	chr2:102432300~102432321:+
LUSC	cis	rs2229238	0.774	rs4240872	MIMAT0022491	hsa-miR-5698	3.72	0.000225	0.23	0.17	Coronary heart disease;	chr1:154463719	chr1:154104562~154104583:-
LUSC	cis	rs889398	0.802	rs12925700	MIMAT0004597	hsa-miR-140-3p	3.72	0.000228	0.12	0.17	Body mass index;	chr16:69759560	chr16:69933142~69933162:+
LUSC	cis	rs74233809	1	rs35125602	MIMAT0022727	hsa-miR-1307-5p	-3.72	0.000229	-0.26	-0.17	Birth weight;	chr10:102896282	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.77	rs7896828	MIMAT0026738	hsa-miR-1287-3p	3.71	0.000231	0.15	0.17	Metabolite levels;	chr10:98410750	chr10:98395232~98395253:-
LUSC	cis	rs17660992	0.519	rs34200125	MIMAT0000689	hsa-miR-99b-5p	3.71	0.000232	0.15	0.17	Blood protein levels;	chr19:51659849	chr19:51692618~51692639:+
LUSC	cis	rs990171	1	rs2160232	MIMAT0019926	hsa-miR-4772-5p	3.71	0.000232	0.22	0.17	Lymphocyte counts;	chr2:102430420	chr2:102432300~102432321:+
LUSC	cis	rs10197862	0.518	rs35181686	MIMAT0019927	hsa-miR-4772-3p	3.71	0.000233	0.19	0.17	Asthma and hay fever;Asthma;	chr2:102476125	chr2:102432336~102432357:+
LUSC	cis	rs990171	0.837	rs1568681	MIMAT0019926	hsa-miR-4772-5p	3.71	0.000233	0.22	0.17	Lymphocyte counts;	chr2:102398236	chr2:102432300~102432321:+
LUSC	cis	rs7072216	0.666	rs11598689	MIMAT0005878	hsa-miR-1287-5p	3.71	0.000235	0.2	0.17	Metabolite levels;	chr10:98396270	chr10:98395271~98395292:-
LUSC	cis	rs990171	0.695	rs759382	MIMAT0019926	hsa-miR-4772-5p	3.71	0.000238	0.22	0.17	Lymphocyte counts;	chr2:102477754	chr2:102432300~102432321:+
LUSC	cis	rs75358501	0.636	rs13427002	MIMAT0014994	hsa-miR-3130-3p	3.71	0.000238	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783245~206783265:-
LUSC	cis	rs75358501	0.636	rs13427002	MIMAT0014994_1	hsa-miR-3130-3p	3.71	0.000238	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206778949	chr2:206783277~206783297:+
LUSC	cis	rs17749155	0.58	rs957240	MIMAT0003266	hsa-miR-598-3p	3.7	0.00024	0.27	0.17	Barrett's esophagus  or Esophageal adenocarcinoma;Barrett's esophagus;	chr8:10205998	chr8:11035221~11035242:-
LUSC	cis	rs4332037	0.552	rs11773627	MIMAT0000764	hsa-miR-339-5p	-3.7	0.00024	-0.19	-0.17	Bipolar disorder;	chr7:1963098	chr7:1022990~1023012:-
LUSC	cis	rs4493873	0.641	rs10956794	MIMAT0019729	hsa-miR-4661-5p	-3.7	0.000241	-0.2	-0.17	Migraine - clinic-based;	chr8:91116612	chr8:91205494~91205515:+
LUSC	cis	rs990171	0.687	rs6761871	MIMAT0019926	hsa-miR-4772-5p	3.7	0.000242	0.22	0.17	Lymphocyte counts;	chr2:102560338	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.724	rs11870608	MIMAT0005942	hsa-miR-1288-3p	3.7	0.000245	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16122356	chr17:16282058~16282078:+
LUSC	cis	rs205611	0.709	rs12151610	MIMAT0021020	hsa-miR-5000-3p	-3.7	0.000245	-0.31	-0.17	Iris characteristics;	chr2:74798726	chr2:75090873~75090894:+
LUSC	cis	rs2887399	0.572	rs7492479	MIMAT0019214	hsa-miR-3173-5p	3.7	0.000247	0.3	0.17	Mosaic loss of chromosome Y;	chr14:95740509	chr14:95137961~95137982:-
LUSC	cis	rs7397861	1	rs10748045	MIMAT0025460	hsa-miR-6502-5p	-3.69	0.00025	-0.21	-0.17	Menopause (age at onset);	chr12:66422359	chr12:66251091~66251112:+
LUSC	cis	rs4713675	0.584	rs560111	MIMAT0022975	hsa-miR-3934-3p	-3.69	0.000251	-0.18	-0.17	Plateletcrit;	chr6:33738500	chr6:33698191~33698212:+
LUSC	cis	rs1048886	0.872	rs79339185	MIMAT0000087	hsa-miR-30a-5p	3.69	0.000252	0.21	0.17	Type 2 diabetes;	chr6:70572379	chr6:71403595~71403616:-
LUSC	cis	rs11134338	0.517	rs13168801	MIMAT0019693	hsa-miR-4636	-3.69	0.000252	-0.22	-0.17	Obesity-related traits;	chr5:8943200	chr5:9053865~9053886:-
LUSC	cis	rs1355223	0.867	rs11821793	MIMAT0019776	hsa-miR-1343-3p	-3.69	0.000252	-0.16	-0.17	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34659915	chr11:34941888~34941909:+
LUSC	cis	rs1355223	0.867	rs7925421	MIMAT0019776	hsa-miR-1343-3p	-3.69	0.000252	-0.16	-0.17	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34660130	chr11:34941888~34941909:+
LUSC	cis	rs2369304	0.767	rs1006942	MIMAT0019214	hsa-miR-3173-5p	3.69	0.000253	0.21	0.17	Neutrophil count;	chr14:95744686	chr14:95137961~95137982:-
LUSC	cis	rs12607903	0.824	rs3850801	MIMAT0025849	hsa-miR-6718-5p	-3.69	0.000253	-0.2	-0.17	Menarche (age at onset);	chr18:3807349	chr18:3885363~3885383:+
LUSC	cis	rs11134338	0.557	rs2963380	MIMAT0019693	hsa-miR-4636	-3.69	0.000254	-0.2	-0.17	Obesity-related traits;	chr5:8945082	chr5:9053865~9053886:-
LUSC	cis	rs1048886	0.872	rs12525538	MIMAT0000087	hsa-miR-30a-5p	3.69	0.000256	0.21	0.17	Type 2 diabetes;	chr6:70575198	chr6:71403595~71403616:-
LUSC	cis	rs1048886	0.872	rs34246525	MIMAT0000087	hsa-miR-30a-5p	3.69	0.000256	0.21	0.17	Type 2 diabetes;	chr6:70575239	chr6:71403595~71403616:-
LUSC	cis	rs75358501	0.636	rs12471008	MIMAT0014994	hsa-miR-3130-3p	3.68	0.000259	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783245~206783265:-
LUSC	cis	rs75358501	0.636	rs12471008	MIMAT0014994_1	hsa-miR-3130-3p	3.68	0.000259	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206775059	chr2:206783277~206783297:+
LUSC	cis	rs75358501	0.636	rs768533	MIMAT0014994	hsa-miR-3130-3p	3.68	0.000259	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783245~206783265:-
LUSC	cis	rs75358501	0.636	rs768533	MIMAT0014994_1	hsa-miR-3130-3p	3.68	0.000259	0.24	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206776113	chr2:206783277~206783297:+
LUSC	cis	rs2369304	0.767	rs2008175	MIMAT0019214	hsa-miR-3173-5p	3.68	0.000259	0.2	0.17	Neutrophil count;	chr14:95746700	chr14:95137961~95137982:-
LUSC	cis	rs7851726	0.668	rs10761361	MIMAT0019208	hsa-miR-3074-5p	-3.68	0.000259	-0.17	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94882260	chr9:95086063~95086083:-
LUSC	cis	rs990171	1	rs1035127	MIMAT0019926	hsa-miR-4772-5p	-3.68	0.000261	-0.22	-0.17	Lymphocyte counts;	chr2:102403459	chr2:102432300~102432321:+
LUSC	cis	rs9527	1	rs4919690	MIMAT0022727	hsa-miR-1307-5p	-3.68	0.000261	-0.13	-0.17	Arsenic metabolism;	chr10:102856743	chr10:103394341~103394361:-
LUSC	cis	rs7210990	0.766	rs2779211	MIMAT0005942	hsa-miR-1288-3p	-3.68	0.000261	-0.2	-0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:15972621	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.766	rs10491104	MIMAT0005942	hsa-miR-1288-3p	3.68	0.000261	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:15981247	chr17:16282058~16282078:+
LUSC	cis	rs7851726	0.668	rs7862219	MIMAT0019208	hsa-miR-3074-5p	-3.68	0.000263	-0.17	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94889948	chr9:95086063~95086083:-
LUSC	cis	rs7210990	0.866	rs1160109	MIMAT0005942	hsa-miR-1288-3p	3.68	0.000263	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16129818	chr17:16282058~16282078:+
LUSC	cis	rs4921799	0.64	rs11203894	MIMAT0015020	hsa-miR-548v	-3.68	0.000263	-0.19	-0.17	Lung cancer;Adenocarcinoma;	chr8:17677953	chr8:17681588~17681609:-
LUSC	cis	rs7851726	0.628	rs4744412	MIMAT0019208	hsa-miR-3074-5p	3.68	0.000265	0.17	0.17	Urinary albumin-to-creatinine ratio;	chr9:94928219	chr9:95086063~95086083:-
LUSC	cis	rs79387448	0.638	rs6759588	MIMAT0019926	hsa-miR-4772-5p	-3.68	0.000265	-0.3	-0.17	Gut microbiota (bacterial taxa);	chr2:102423699	chr2:102432300~102432321:+
LUSC	cis	rs11693697	1	rs11693697	MIMAT0019927	hsa-miR-4772-3p	3.68	0.000265	0.2	0.17	Serum protein levels (sST2);	chr2:102299202	chr2:102432336~102432357:+
LUSC	cis	rs6681460	1	rs4655647	MIMAT0014979	hsa-miR-3117-3p	-3.67	0.00027	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66640394	chr1:66628485~66628505:+
LUSC	cis	rs1355223	1	rs11604069	MIMAT0019776	hsa-miR-1343-3p	-3.67	0.000271	-0.17	-0.17	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34742704	chr11:34941888~34941909:+
LUSC	cis	rs2887399	0.505	rs10143585	MIMAT0019214	hsa-miR-3173-5p	3.67	0.000271	0.28	0.17	Mosaic loss of chromosome Y;	chr14:95755290	chr14:95137961~95137982:-
LUSC	cis	rs7210990	0.701	rs178802	MIMAT0005942	hsa-miR-1288-3p	3.67	0.000271	0.2	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16203731	chr17:16282058~16282078:+
LUSC	cis	rs990171	1	rs4851575	MIMAT0019926	hsa-miR-4772-5p	3.67	0.000272	0.21	0.17	Lymphocyte counts;	chr2:102408743	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs2110735	MIMAT0019926	hsa-miR-4772-5p	3.67	0.000273	0.22	0.17	Lymphocyte counts;	chr2:102434465	chr2:102432300~102432321:+
LUSC	cis	rs990171	1	rs2110734	MIMAT0019926	hsa-miR-4772-5p	3.67	0.000273	0.22	0.17	Lymphocyte counts;	chr2:102435746	chr2:102432300~102432321:+
LUSC	cis	rs889398	0.9	rs4783722	MIMAT0004597	hsa-miR-140-3p	3.67	0.000273	0.11	0.17	Body mass index;	chr16:69548009	chr16:69933142~69933162:+
LUSC	cis	rs2871473	0.951	rs1030025	MIMAT0019926	hsa-miR-4772-5p	-3.67	0.000274	-0.25	-0.17	Blood protein levels;	chr2:102489152	chr2:102432300~102432321:+
LUSC	cis	rs11134338	0.627	rs2963363	MIMAT0019693	hsa-miR-4636	-3.67	0.000277	-0.21	-0.17	Obesity-related traits;	chr5:8928781	chr5:9053865~9053886:-
LUSC	cis	rs889398	0.616	rs35808754	MIMAT0004597	hsa-miR-140-3p	3.66	0.000279	0.12	0.17	Body mass index;	chr16:69737807	chr16:69933142~69933162:+
LUSC	cis	rs7397861	1	rs7312836	MIMAT0025460	hsa-miR-6502-5p	3.66	0.00028	0.21	0.17	Menopause (age at onset);	chr12:66429522	chr12:66251091~66251112:+
LUSC	cis	rs6755560	1	rs35311487	MIMAT0014995	hsa-miR-3130-5p	3.66	0.000281	0.19	0.17	QT interval (drug interaction);	chr2:206848647	chr2:206783276~206783296:-
LUSC	cis	rs6755560	1	rs35311487	MIMAT0014995_1	hsa-miR-3130-5p	3.66	0.000281	0.19	0.17	QT interval (drug interaction);	chr2:206848647	chr2:206783246~206783266:+
LUSC	cis	rs7210990	0.866	rs178659	MIMAT0005942	hsa-miR-1288-3p	3.66	0.000281	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16153128	chr17:16282058~16282078:+
LUSC	cis	rs7851726	0.676	rs10821398	MIMAT0019208	hsa-miR-3074-5p	-3.66	0.000282	-0.16	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94815277	chr9:95086063~95086083:-
LUSC	cis	rs2369304	0.767	rs17093352	MIMAT0019214	hsa-miR-3173-5p	3.66	0.000282	0.2	0.17	Neutrophil count;	chr14:95743694	chr14:95137961~95137982:-
LUSC	cis	rs990171	0.649	rs2058657	MIMAT0019926	hsa-miR-4772-5p	3.66	0.000283	0.22	0.17	Lymphocyte counts;	chr2:102520556	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.764	rs9907313	MIMAT0005942	hsa-miR-1288-3p	3.66	0.000283	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16145776	chr17:16282058~16282078:+
LUSC	cis	rs11134338	0.68	rs13163334	MIMAT0019693	hsa-miR-4636	-3.66	0.000285	-0.21	-0.17	Obesity-related traits;	chr5:8962550	chr5:9053865~9053886:-
LUSC	cis	rs1048886	0.872	rs10945231	MIMAT0000087	hsa-miR-30a-5p	3.66	0.000287	0.21	0.17	Type 2 diabetes;	chr6:70588060	chr6:71403595~71403616:-
LUSC	cis	rs6755560	0.889	rs7597011	MIMAT0014995	hsa-miR-3130-5p	3.66	0.000287	0.19	0.17	QT interval (drug interaction);	chr2:206855115	chr2:206783276~206783296:-
LUSC	cis	rs6755560	0.889	rs7597011	MIMAT0014995_1	hsa-miR-3130-5p	3.66	0.000287	0.19	0.17	QT interval (drug interaction);	chr2:206855115	chr2:206783246~206783266:+
LUSC	cis	rs6681460	0.932	rs523956	MIMAT0014979	hsa-miR-3117-3p	3.66	0.000287	0.18	0.17	Presence of antiphospholipid antibodies;	chr1:66722593	chr1:66628485~66628505:+
LUSC	cis	rs6681460	0.837	rs6669023	MIMAT0014979	hsa-miR-3117-3p	-3.66	0.000287	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66706185	chr1:66628485~66628505:+
LUSC	cis	rs74233809	0.901	rs11191425	MIMAT0022727	hsa-miR-1307-5p	-3.66	0.000287	-0.26	-0.17	Birth weight;	chr10:102866213	chr10:103394341~103394361:-
LUSC	cis	rs12554389	0.53	rs7859551	MIMAT0000090	hsa-miR-32-5p	-3.66	0.000288	-0.15	-0.17	Lobe attachment (rater-scored or self-reported);	chr9:108566828	chr9:109046272~109046293:-
LUSC	cis	rs3824488	0.92	rs28418339	MIMAT0019208	hsa-miR-3074-5p	-3.65	0.00029	-0.28	-0.17	Neuroticism;	chr9:95491194	chr9:95086063~95086083:-
LUSC	cis	rs546131	0.642	rs836950	MIMAT0019776	hsa-miR-1343-3p	-3.65	0.000291	-0.18	-0.17	Lung disease severity in cystic fibrosis;	chr11:34830473	chr11:34941888~34941909:+
LUSC	cis	rs990171	0.649	rs2192757	MIMAT0019926	hsa-miR-4772-5p	3.65	0.000292	0.21	0.17	Lymphocyte counts;	chr2:102515919	chr2:102432300~102432321:+
LUSC	cis	rs9346455	0.764	rs9354996	MIMAT0000088	hsa-miR-30a-3p	3.65	0.000293	0.28	0.17	Antipsychotic drug-induced weight gain;Antipsychotic drug-induced weight gain (time interaction);	chr6:71325489	chr6:71403554~71403575:-
LUSC	cis	rs7210990	0.699	rs178838	MIMAT0005942	hsa-miR-1288-3p	3.65	0.000293	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16172587	chr17:16282058~16282078:+
LUSC	cis	rs2887399	0.505	rs7141057	MIMAT0019214	hsa-miR-3173-5p	3.65	0.000293	0.28	0.17	Mosaic loss of chromosome Y;	chr14:95757742	chr14:95137961~95137982:-
LUSC	cis	rs546131	0.515	rs731727	MIMAT0019776	hsa-miR-1343-3p	-3.65	0.000295	-0.18	-0.17	Lung disease severity in cystic fibrosis;	chr11:34836287	chr11:34941888~34941909:+
LUSC	cis	rs7210990	0.83	rs178806	MIMAT0005942	hsa-miR-1288-3p	3.65	0.000295	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16197297	chr17:16282058~16282078:+
LUSC	cis	rs546131	0.642	rs11605381	MIMAT0019776	hsa-miR-1343-3p	-3.65	0.000297	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34825646	chr11:34941888~34941909:+
LUSC	cis	rs7851726	0.714	rs1867102	MIMAT0019208	hsa-miR-3074-5p	-3.65	0.000298	-0.17	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94865485	chr9:95086063~95086083:-
LUSC	cis	rs6681460	0.966	rs1325261	MIMAT0014979	hsa-miR-3117-3p	-3.65	0.000298	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66644833	chr1:66628485~66628505:+
LUSC	cis	rs990171	0.913	rs4851009	MIMAT0019926	hsa-miR-4772-5p	3.64	0.000299	0.22	0.17	Lymphocyte counts;	chr2:102439184	chr2:102432300~102432321:+
LUSC	cis	rs1048886	0.872	rs77665410	MIMAT0000087	hsa-miR-30a-5p	3.64	3e-04	0.2	0.17	Type 2 diabetes;	chr6:70569676	chr6:71403595~71403616:-
LUSC	cis	rs889398	0.802	rs9940315	MIMAT0004597	hsa-miR-140-3p	-3.64	0.000301	-0.11	-0.17	Body mass index;	chr16:69842261	chr16:69933142~69933162:+
LUSC	cis	rs2072510	0.683	rs2540487	MIMAT0000760	hsa-miR-331-3p	3.64	0.000303	0.13	0.17	Metabolite levels (small molecules and protein measures);	chr12:96036005	chr12:95308480~95308500:+
LUSC	cis	rs889398	0.874	rs2917677	MIMAT0004597	hsa-miR-140-3p	3.64	0.000303	0.12	0.17	Body mass index;	chr16:69716946	chr16:69933142~69933162:+
LUSC	cis	rs10197862	0.518	rs13018263	MIMAT0019927	hsa-miR-4772-3p	3.64	0.000306	0.18	0.17	Asthma and hay fever;Asthma;	chr2:102475811	chr2:102432336~102432357:+
LUSC	cis	rs2229238	0.662	rs35699331	MIMAT0022491	hsa-miR-5698	-3.64	0.000306	-0.23	-0.17	Coronary heart disease;	chr1:154460428	chr1:154104562~154104583:-
LUSC	cis	rs2229238	0.774	rs6698040	MIMAT0022491	hsa-miR-5698	-3.64	0.000306	-0.23	-0.17	Coronary heart disease;	chr1:154460472	chr1:154104562~154104583:-
LUSC	cis	rs4921799	0.64	rs10503602	MIMAT0015020	hsa-miR-548v	3.64	0.000309	0.19	0.17	Lung cancer;Adenocarcinoma;	chr8:17677549	chr8:17681588~17681609:-
LUSC	cis	rs2369304	0.767	rs6575539	MIMAT0019214	hsa-miR-3173-5p	3.64	0.00031	0.2	0.17	Neutrophil count;	chr14:95745805	chr14:95137961~95137982:-
LUSC	cis	rs79387448	0.576	rs11902044	MIMAT0019926	hsa-miR-4772-5p	-3.63	0.000311	-0.3	-0.17	Gut microbiota (bacterial taxa);	chr2:102356074	chr2:102432300~102432321:+
LUSC	cis	rs79387448	0.701	rs10515921	MIMAT0019926	hsa-miR-4772-5p	-3.63	0.000311	-0.3	-0.17	Gut microbiota (bacterial taxa);	chr2:102364558	chr2:102432300~102432321:+
LUSC	cis	rs79387448	0.701	rs11465584	MIMAT0019926	hsa-miR-4772-5p	-3.63	0.000311	-0.3	-0.17	Gut microbiota (bacterial taxa);	chr2:102366169	chr2:102432300~102432321:+
LUSC	cis	rs9527	0.662	rs10786714	MIMAT0022727	hsa-miR-1307-5p	3.63	0.000311	0.13	0.17	Arsenic metabolism;	chr10:102838849	chr10:103394341~103394361:-
LUSC	cis	rs6681460	0.966	rs11208932	MIMAT0014979	hsa-miR-3117-3p	-3.63	0.000312	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66632170	chr1:66628485~66628505:+
LUSC	cis	rs11134338	0.557	rs2963324	MIMAT0019693	hsa-miR-4636	-3.63	0.000312	-0.2	-0.17	Obesity-related traits;	chr5:8933018	chr5:9053865~9053886:-
LUSC	cis	rs6681460	0.966	rs10889642	MIMAT0014979	hsa-miR-3117-3p	-3.63	0.000314	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66677651	chr1:66628485~66628505:+
LUSC	cis	rs7851726	0.69	rs10821392	MIMAT0019208	hsa-miR-3074-5p	-3.63	0.000317	-0.16	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94746625	chr9:95086063~95086083:-
LUSC	cis	rs79387448	0.701	rs76943877	MIMAT0019926	hsa-miR-4772-5p	-3.63	0.000318	-0.3	-0.17	Gut microbiota (bacterial taxa);	chr2:102354217	chr2:102432300~102432321:+
LUSC	cis	rs4493873	0.6	rs10111106	MIMAT0019729	hsa-miR-4661-5p	3.63	0.000319	0.2	0.17	Migraine - clinic-based;	chr8:91110512	chr8:91205494~91205515:+
LUSC	cis	rs4493873	0.641	rs28372564	MIMAT0019729	hsa-miR-4661-5p	3.63	0.000319	0.2	0.17	Migraine - clinic-based;	chr8:91111112	chr8:91205494~91205515:+
LUSC	cis	rs990171	1	rs12712145	MIMAT0019926	hsa-miR-4772-5p	3.63	0.000319	0.21	0.17	Lymphocyte counts;	chr2:102392250	chr2:102432300~102432321:+
LUSC	cis	rs1867631	0.959	rs11208914	MIMAT0014979	hsa-miR-3117-3p	-3.63	0.00032	-0.2	-0.17	Menopause (age at onset);	chr1:66584045	chr1:66628485~66628505:+
LUSC	cis	rs6681460	0.932	rs618093	MIMAT0014979	hsa-miR-3117-3p	-3.62	0.000323	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66712745	chr1:66628485~66628505:+
LUSC	cis	rs73198271	0.74	rs10092600	MIMAT0019728	hsa-miR-4660	-3.62	0.000323	-0.21	-0.17	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8791513	chr8:9048453~9048475:+
LUSC	cis	rs73198271	0.74	rs10105690	MIMAT0019728	hsa-miR-4660	-3.62	0.000328	-0.21	-0.17	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8791722	chr8:9048453~9048475:+
LUSC	cis	rs7210990	0.612	rs2286796	MIMAT0005942	hsa-miR-1288-3p	3.62	0.000328	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:15980913	chr17:16282058~16282078:+
LUSC	cis	rs6681460	1	rs6696927	MIMAT0014979	hsa-miR-3117-3p	-3.62	0.00033	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66604698	chr1:66628485~66628505:+
LUSC	cis	rs6681460	0.966	rs6588215	MIMAT0014979	hsa-miR-3117-3p	-3.62	0.00033	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66676266	chr1:66628485~66628505:+
LUSC	cis	rs28452995	0.825	rs12347366	MIMAT0000090	hsa-miR-32-5p	3.62	0.00033	0.14	0.17	Lobe attachment (rater-scored or self-reported);	chr9:108627243	chr9:109046272~109046293:-
LUSC	cis	rs6681460	0.966	rs10889643	MIMAT0014979	hsa-miR-3117-3p	-3.62	0.000331	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66677685	chr1:66628485~66628505:+
LUSC	cis	rs2369304	0.767	rs2369305	MIMAT0019214	hsa-miR-3173-5p	3.62	0.000334	0.21	0.17	Neutrophil count;	chr14:95739948	chr14:95137961~95137982:-
LUSC	cis	rs11134338	0.653	rs13359910	MIMAT0019693	hsa-miR-4636	-3.61	0.000335	-0.2	-0.17	Obesity-related traits;	chr5:8960805	chr5:9053865~9053886:-
LUSC	cis	rs9807989	0.839	rs1362348	MIMAT0019926	hsa-miR-4772-5p	3.61	0.000336	0.2	0.17	Asthma;	chr2:102368164	chr2:102432300~102432321:+
LUSC	cis	rs7397861	1	rs7397861	MIMAT0025460	hsa-miR-6502-5p	3.61	0.000337	0.21	0.17	Menopause (age at onset);	chr12:66420686	chr12:66251091~66251112:+
LUSC	cis	rs889398	0.933	rs6499240	MIMAT0000431	hsa-miR-140-5p	-3.61	0.000338	-0.15	-0.17	Body mass index;	chr16:69653009	chr16:69933103~69933124:+
LUSC	cis	rs7072216	0.922	rs59667296	MIMAT0026738	hsa-miR-1287-3p	3.61	0.000338	0.15	0.17	Metabolite levels;	chr10:98386556	chr10:98395232~98395253:-
LUSC	cis	rs1048886	0.872	rs12201029	MIMAT0000087	hsa-miR-30a-5p	3.61	0.000341	0.2	0.17	Type 2 diabetes;	chr6:70599019	chr6:71403595~71403616:-
LUSC	cis	rs990171	1	rs2041756	MIMAT0019926	hsa-miR-4772-5p	-3.61	0.000341	-0.21	-0.17	Lymphocyte counts;	chr2:102433450	chr2:102432300~102432321:+
LUSC	cis	rs9914988	1	rs6803	MIMAT0001631	hsa-miR-451a	3.61	0.000342	0.24	0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28860771	chr17:28861403~28861424:-
LUSC	cis	rs11134338	0.68	rs9313264	MIMAT0019693	hsa-miR-4636	-3.61	0.000346	-0.2	-0.17	Obesity-related traits;	chr5:8961449	chr5:9053865~9053886:-
LUSC	cis	rs2369304	0.781	rs11160287	MIMAT0019214	hsa-miR-3173-5p	3.61	0.000347	0.19	0.17	Neutrophil count;	chr14:95754301	chr14:95137961~95137982:-
LUSC	cis	rs9914988	0.887	rs62066838	MIMAT0001631	hsa-miR-451a	3.6	0.000352	0.24	0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28857515	chr17:28861403~28861424:-
LUSC	cis	rs73198271	0.74	rs10092720	MIMAT0019728	hsa-miR-4660	-3.6	0.000353	-0.21	-0.17	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8791607	chr8:9048453~9048475:+
LUSC	cis	rs9807989	0.839	rs13392100	MIMAT0019926	hsa-miR-4772-5p	3.6	0.000353	0.2	0.17	Asthma;	chr2:102365634	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.839	rs3771166	MIMAT0019926	hsa-miR-4772-5p	3.6	0.000353	0.2	0.17	Asthma;	chr2:102369762	chr2:102432300~102432321:+
LUSC	cis	rs4493873	0.507	rs12549426	MIMAT0019729	hsa-miR-4661-5p	3.6	0.000354	0.2	0.17	Migraine - clinic-based;	chr8:91213004	chr8:91205494~91205515:+
LUSC	cis	rs1048886	0.872	rs9455177	MIMAT0000087	hsa-miR-30a-5p	3.6	0.000356	0.19	0.17	Type 2 diabetes;	chr6:70591822	chr6:71403595~71403616:-
LUSC	cis	rs990171	1	rs3755267	MIMAT0019926	hsa-miR-4772-5p	-3.6	0.000356	-0.21	-0.17	Lymphocyte counts;	chr2:102422127	chr2:102432300~102432321:+
LUSC	cis	rs7851726	0.628	rs12344211	MIMAT0019208	hsa-miR-3074-5p	3.6	0.000356	0.17	0.17	Urinary albumin-to-creatinine ratio;	chr9:94928822	chr9:95086063~95086083:-
LUSC	cis	rs546131	0.642	rs61881103	MIMAT0019776	hsa-miR-1343-3p	-3.6	0.000357	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34816717	chr11:34941888~34941909:+
LUSC	cis	rs6681460	0.899	rs1280280	MIMAT0014979	hsa-miR-3117-3p	-3.6	0.000357	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66708220	chr1:66628485~66628505:+
LUSC	cis	rs6681460	0.899	rs499263	MIMAT0014979	hsa-miR-3117-3p	-3.6	0.000359	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66714254	chr1:66628485~66628505:+
LUSC	cis	rs6681460	0.966	rs7524851	MIMAT0014979	hsa-miR-3117-3p	-3.6	0.000359	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66627335	chr1:66628485~66628505:+
LUSC	cis	rs6681460	0.966	rs4655646	MIMAT0014979	hsa-miR-3117-3p	-3.6	0.000359	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66628653	chr1:66628485~66628505:+
LUSC	cis	rs2369304	0.736	rs1998686	MIMAT0019214	hsa-miR-3173-5p	3.6	0.000359	0.19	0.17	Neutrophil count;	chr14:95752707	chr14:95137961~95137982:-
LUSC	cis	rs9914988	0.943	rs7211502	MIMAT0001631	hsa-miR-451a	-3.59	0.000363	-0.24	-0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28836277	chr17:28861403~28861424:-
LUSC	cis	rs1355223	0.966	rs11602318	MIMAT0019776	hsa-miR-1343-3p	3.59	0.000363	0.16	0.17	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34745436	chr11:34941888~34941909:+
LUSC	cis	rs7210990	0.724	rs178822	MIMAT0005942	hsa-miR-1288-3p	3.59	0.000363	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16184155	chr17:16282058~16282078:+
LUSC	cis	rs9807989	0.839	rs1974675	MIMAT0019926	hsa-miR-4772-5p	3.59	0.000364	0.2	0.17	Asthma;	chr2:102369915	chr2:102432300~102432321:+
LUSC	cis	rs546131	0.614	rs35953213	MIMAT0019776	hsa-miR-1343-3p	-3.59	0.000365	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34827222	chr11:34941888~34941909:+
LUSC	cis	rs9807989	0.839	rs4988955	MIMAT0019926	hsa-miR-4772-5p	3.59	0.000366	0.19	0.17	Asthma;	chr2:102351468	chr2:102432300~102432321:+
LUSC	cis	rs7397861	0.896	rs1472216	MIMAT0025460	hsa-miR-6502-5p	-3.59	0.000366	-0.2	-0.17	Menopause (age at onset);	chr12:66441196	chr12:66251091~66251112:+
LUSC	cis	rs4493873	0.6	rs62526730	MIMAT0019729	hsa-miR-4661-5p	3.59	0.000366	0.2	0.17	Migraine - clinic-based;	chr8:91179676	chr8:91205494~91205515:+
LUSC	cis	rs990171	0.955	rs3755268	MIMAT0019926	hsa-miR-4772-5p	3.59	0.000366	0.21	0.17	Lymphocyte counts;	chr2:102422067	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.559	rs178839	MIMAT0005942	hsa-miR-1288-3p	3.59	0.000366	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16170557	chr17:16282058~16282078:+
LUSC	cis	rs9807989	0.729	rs10170583	MIMAT0019926	hsa-miR-4772-5p	3.59	0.000367	0.19	0.17	Asthma;	chr2:102358304	chr2:102432300~102432321:+
LUSC	cis	rs72991	0.607	rs10790445	MIMAT0000423	hsa-miR-125b-5p	-3.59	0.000367	-0.17	-0.17	Response to tocilizumab in rheumatoid arthritis;	chr11:121366663	chr11:122099809~122099830:-
LUSC	cis	rs72991	0.607	rs10790445	MIMAT0000423_1	hsa-miR-125b-5p	-3.59	0.000367	-0.17	-0.17	Response to tocilizumab in rheumatoid arthritis;	chr11:121366663	chr21:16590253~16590274:+
LUSC	cis	rs1163656	0.527	rs1402347	MIMAT0003287	hsa-miR-618	3.59	0.000369	0.31	0.17	Dental caries;	chr12:80913217	chr12:80935796~80935818:-
LUSC	cis	rs7210990	0.866	rs11078333	MIMAT0005942	hsa-miR-1288-3p	3.59	0.00037	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16146312	chr17:16282058~16282078:+
LUSC	cis	rs2871473	1	rs2871473	MIMAT0019926	hsa-miR-4772-5p	-3.59	0.00037	-0.24	-0.17	Blood protein levels;	chr2:102490821	chr2:102432300~102432321:+
LUSC	cis	rs11134338	0.68	rs16881756	MIMAT0019693	hsa-miR-4636	3.59	0.000371	0.2	0.17	Obesity-related traits;	chr5:8976747	chr5:9053865~9053886:-
LUSC	cis	rs79387448	0.592	rs6728945	MIMAT0019926	hsa-miR-4772-5p	-3.59	0.000372	-0.29	-0.17	Gut microbiota (bacterial taxa);	chr2:102370011	chr2:102432300~102432321:+
LUSC	cis	rs546131	0.642	rs61881107	MIMAT0019776	hsa-miR-1343-3p	-3.59	0.000374	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34826473	chr11:34941888~34941909:+
LUSC	cis	rs4921799	0.662	rs35211928	MIMAT0015020	hsa-miR-548v	-3.59	0.000374	-0.19	-0.17	Lung cancer;Adenocarcinoma;	chr8:17677494	chr8:17681588~17681609:-
LUSC	cis	rs4921799	0.662	rs12680944	MIMAT0015020	hsa-miR-548v	-3.59	0.000374	-0.19	-0.17	Lung cancer;Adenocarcinoma;	chr8:17677530	chr8:17681588~17681609:-
LUSC	cis	rs546131	0.642	rs35833762	MIMAT0019776	hsa-miR-1343-3p	-3.58	0.000376	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34824311	chr11:34941888~34941909:+
LUSC	cis	rs6681460	0.901	rs1570815	MIMAT0014979	hsa-miR-3117-3p	-3.58	0.000376	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66673984	chr1:66628485~66628505:+
LUSC	cis	rs9807989	0.801	rs10173193	MIMAT0019926	hsa-miR-4772-5p	3.58	0.000377	0.19	0.17	Asthma;	chr2:102358590	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.801	rs10176664	MIMAT0019926	hsa-miR-4772-5p	3.58	0.000377	0.19	0.17	Asthma;	chr2:102359712	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.839	rs6543123	MIMAT0019926	hsa-miR-4772-5p	3.58	0.000377	0.19	0.17	Asthma;	chr2:102360736	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.801	rs11123925	MIMAT0019926	hsa-miR-4772-5p	3.58	0.000377	0.19	0.17	Asthma;	chr2:102361051	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.839	rs10204837	MIMAT0019926	hsa-miR-4772-5p	3.58	0.000377	0.19	0.17	Asthma;	chr2:102361270	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.839	rs3755276	MIMAT0019926	hsa-miR-4772-5p	3.58	0.000377	0.19	0.17	Asthma;	chr2:102361999	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.839	rs9308857	MIMAT0019926	hsa-miR-4772-5p	3.58	0.000377	0.19	0.17	Asthma;	chr2:102363164	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.839	rs1420099	MIMAT0019926	hsa-miR-4772-5p	3.58	0.000377	0.19	0.17	Asthma;	chr2:102364083	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.839	rs10182710	MIMAT0019926	hsa-miR-4772-5p	3.58	0.000377	0.19	0.17	Asthma;	chr2:102364846	chr2:102432300~102432321:+
LUSC	cis	rs4493873	0.507	rs4596614	MIMAT0019729	hsa-miR-4661-5p	-3.58	0.000378	-0.19	-0.17	Migraine - clinic-based;	chr8:91216289	chr8:91205494~91205515:+
LUSC	cis	rs990171	0.687	rs9989842	MIMAT0019926	hsa-miR-4772-5p	3.58	0.00038	0.21	0.17	Lymphocyte counts;	chr2:102507174	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs9989749	MIMAT0019926	hsa-miR-4772-5p	3.58	0.00038	0.21	0.17	Lymphocyte counts;	chr2:102507183	chr2:102432300~102432321:+
LUSC	cis	rs7851726	0.646	rs10739983	MIMAT0019208	hsa-miR-3074-5p	-3.58	0.000381	-0.16	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94764002	chr9:95086063~95086083:-
LUSC	cis	rs1048886	0.872	rs9455182	MIMAT0000087	hsa-miR-30a-5p	3.58	0.000385	0.19	0.17	Type 2 diabetes;	chr6:70593212	chr6:71403595~71403616:-
LUSC	cis	rs2369304	0.736	rs17093383	MIMAT0019214	hsa-miR-3173-5p	3.58	0.000385	0.2	0.17	Neutrophil count;	chr14:95754226	chr14:95137961~95137982:-
LUSC	cis	rs546131	0.614	rs35264793	MIMAT0019776	hsa-miR-1343-3p	-3.58	0.000386	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34813297	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.614	rs7106579	MIMAT0019776	hsa-miR-1343-3p	-3.58	0.000386	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34813955	chr11:34941888~34941909:+
LUSC	cis	rs7851726	0.69	rs7027708	MIMAT0019208	hsa-miR-3074-5p	-3.58	0.000387	-0.16	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94748390	chr9:95086063~95086083:-
LUSC	cis	rs7851726	0.646	rs10821393	MIMAT0019208	hsa-miR-3074-5p	-3.58	0.000387	-0.16	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94754478	chr9:95086063~95086083:-
LUSC	cis	rs6681460	0.966	rs10789215	MIMAT0014979	hsa-miR-3117-3p	3.57	0.000392	0.18	0.17	Presence of antiphospholipid antibodies;	chr1:66685502	chr1:66628485~66628505:+
LUSC	cis	rs3925158	0.51	rs6767007	MIMAT0004499	hsa-miR-26a-1-3p	-3.57	0.000395	-0.28	-0.17	Gut microbiota (bacterial taxa);	chr3:38170766	chr3:37969452~37969473:+
LUSC	cis	rs546131	0.642	rs11603640	MIMAT0019776	hsa-miR-1343-3p	-3.57	0.000396	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34811360	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.642	rs1039841	MIMAT0019776	hsa-miR-1343-3p	-3.57	0.000396	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34811592	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.642	rs1594425	MIMAT0019776	hsa-miR-1343-3p	-3.57	0.000396	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34811775	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.642	rs1594426	MIMAT0019776	hsa-miR-1343-3p	-3.57	0.000396	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34811912	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.642	rs12793173	MIMAT0019776	hsa-miR-1343-3p	-3.57	0.000396	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34812657	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.614	rs12791769	MIMAT0019776	hsa-miR-1343-3p	-3.57	0.000396	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34812721	chr11:34941888~34941909:+
LUSC	cis	rs889398	0.77	rs8052225	MIMAT0004597	hsa-miR-140-3p	-3.57	0.000399	-0.11	-0.17	Body mass index;	chr16:69849750	chr16:69933142~69933162:+
LUSC	cis	rs2274459	0.722	rs10947443	MIMAT0004567	hsa-miR-219a-1-3p	3.57	0.000399	0.23	0.17	Obesity (extreme);	chr6:33823453	chr6:33207896~33207917:+
LUSC	cis	rs12554389	0.53	rs944672	MIMAT0000090	hsa-miR-32-5p	-3.57	4e-04	-0.14	-0.17	Lobe attachment (rater-scored or self-reported);	chr9:108552936	chr9:109046272~109046293:-
LUSC	cis	rs6681460	1	rs6670378	MIMAT0014979	hsa-miR-3117-3p	-3.57	0.000401	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66660902	chr1:66628485~66628505:+
LUSC	cis	rs453301	0.592	rs4841084	MIMAT0019728	hsa-miR-4660	3.57	0.000401	0.19	0.17	Joint mobility (Beighton score);	chr8:9026395	chr8:9048453~9048475:+
LUSC	cis	rs9807989	0.708	rs6543124	MIMAT0019926	hsa-miR-4772-5p	3.57	0.000401	0.2	0.17	Asthma;	chr2:102370999	chr2:102432300~102432321:+
LUSC	cis	rs1355223	0.752	rs896856	MIMAT0019776	hsa-miR-1343-3p	-3.57	0.000402	-0.16	-0.17	Systemic lupus erythematosus and Systemic sclerosis;	chr11:34655295	chr11:34941888~34941909:+
LUSC	cis	rs7072216	0.666	rs2274248	MIMAT0026738	hsa-miR-1287-3p	3.57	0.000402	0.16	0.17	Metabolite levels;	chr10:98388785	chr10:98395232~98395253:-
LUSC	cis	rs9914988	0.943	rs59461345	MIMAT0001631	hsa-miR-451a	-3.57	0.000402	-0.24	-0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28824834	chr17:28861403~28861424:-
LUSC	cis	rs9914988	0.943	rs11656256	MIMAT0001631	hsa-miR-451a	-3.57	0.000402	-0.24	-0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28826535	chr17:28861403~28861424:-
LUSC	cis	rs9914988	0.887	rs12947735	MIMAT0001631	hsa-miR-451a	-3.57	0.000402	-0.24	-0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28829848	chr17:28861403~28861424:-
LUSC	cis	rs9914988	0.832	rs12946132	MIMAT0001631	hsa-miR-451a	-3.57	0.000402	-0.24	-0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28830344	chr17:28861403~28861424:-
LUSC	cis	rs9914988	0.832	rs34267753	MIMAT0001631	hsa-miR-451a	-3.57	0.000402	-0.24	-0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28830568	chr17:28861403~28861424:-
LUSC	cis	rs9914988	0.943	rs2874253	MIMAT0001631	hsa-miR-451a	-3.57	0.000402	-0.24	-0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28830845	chr17:28861403~28861424:-
LUSC	cis	rs7072216	0.922	rs6584191	MIMAT0026738	hsa-miR-1287-3p	3.57	0.000403	0.15	0.17	Metabolite levels;	chr10:98392298	chr10:98395232~98395253:-
LUSC	cis	rs6681460	1	rs7521111	MIMAT0014979	hsa-miR-3117-3p	-3.57	0.000403	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66655951	chr1:66628485~66628505:+
LUSC	cis	rs6681460	1	rs7521123	MIMAT0014979	hsa-miR-3117-3p	-3.57	0.000403	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66655980	chr1:66628485~66628505:+
LUSC	cis	rs11134338	0.709	rs6871960	MIMAT0019693	hsa-miR-4636	-3.56	0.000404	-0.2	-0.17	Obesity-related traits;	chr5:8963759	chr5:9053865~9053886:-
LUSC	cis	rs11134338	0.68	rs10512999	MIMAT0019693	hsa-miR-4636	-3.56	0.000404	-0.2	-0.17	Obesity-related traits;	chr5:8963773	chr5:9053865~9053886:-
LUSC	cis	rs11134338	0.68	rs9313265	MIMAT0019693	hsa-miR-4636	-3.56	0.000404	-0.2	-0.17	Obesity-related traits;	chr5:8963957	chr5:9053865~9053886:-
LUSC	cis	rs11134338	0.635	rs10056871	MIMAT0019693	hsa-miR-4636	-3.56	0.000404	-0.2	-0.17	Obesity-related traits;	chr5:8964206	chr5:9053865~9053886:-
LUSC	cis	rs11134338	0.628	rs10058520	MIMAT0019693	hsa-miR-4636	-3.56	0.000404	-0.2	-0.17	Obesity-related traits;	chr5:8964245	chr5:9053865~9053886:-
LUSC	cis	rs11134338	0.664	rs13188103	MIMAT0019693	hsa-miR-4636	-3.56	0.000404	-0.2	-0.17	Obesity-related traits;	chr5:8964407	chr5:9053865~9053886:-
LUSC	cis	rs11134338	0.664	rs4431316	MIMAT0019693	hsa-miR-4636	-3.56	0.000404	-0.2	-0.17	Obesity-related traits;	chr5:8964666	chr5:9053865~9053886:-
LUSC	cis	rs7210990	0.645	rs178653	MIMAT0005942	hsa-miR-1288-3p	3.56	0.000405	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16162163	chr17:16282058~16282078:+
LUSC	cis	rs9807989	0.708	rs6543124	MIMAT0019927	hsa-miR-4772-3p	-3.56	0.000407	-0.15	-0.17	Asthma;	chr2:102370999	chr2:102432336~102432357:+
LUSC	cis	rs11134338	0.515	rs2962651	MIMAT0019693	hsa-miR-4636	-3.56	0.000407	-0.19	-0.17	Obesity-related traits;	chr5:8935759	chr5:9053865~9053886:-
LUSC	cis	rs11134338	0.579	rs2963370	MIMAT0019693	hsa-miR-4636	-3.56	0.000407	-0.19	-0.17	Obesity-related traits;	chr5:8940426	chr5:9053865~9053886:-
LUSC	cis	rs11134338	0.557	rs2963371	MIMAT0019693	hsa-miR-4636	-3.56	0.000407	-0.19	-0.17	Obesity-related traits;	chr5:8940589	chr5:9053865~9053886:-
LUSC	cis	rs73198271	0.74	rs1039912	MIMAT0019728	hsa-miR-4660	-3.56	0.000407	-0.23	-0.17	Bone ultrasound measurement (broadband ultrasound attenuation);	chr8:8790719	chr8:9048453~9048475:+
LUSC	cis	rs990171	0.52	rs10195948	MIMAT0019926	hsa-miR-4772-5p	3.56	0.000408	0.21	0.17	Lymphocyte counts;	chr2:102509277	chr2:102432300~102432321:+
LUSC	cis	rs7210990	0.724	rs178815	MIMAT0005942	hsa-miR-1288-3p	3.56	0.000409	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16189615	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.75	rs178810	MIMAT0005942	hsa-miR-1288-3p	3.56	0.000409	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16194116	chr17:16282058~16282078:+
LUSC	cis	rs75358501	0.636	rs2287628	MIMAT0014994	hsa-miR-3130-3p	3.56	0.000411	0.23	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783245~206783265:-
LUSC	cis	rs75358501	0.636	rs2287628	MIMAT0014994_1	hsa-miR-3130-3p	3.56	0.000411	0.23	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206785809	chr2:206783277~206783297:+
LUSC	cis	rs6681460	0.966	rs10749765	MIMAT0014979	hsa-miR-3117-3p	-3.56	0.000411	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66684597	chr1:66628485~66628505:+
LUSC	cis	rs79387448	0.655	rs3771167	MIMAT0019926	hsa-miR-4772-5p	-3.56	0.000411	-0.29	-0.17	Gut microbiota (bacterial taxa);	chr2:102369728	chr2:102432300~102432321:+
LUSC	cis	rs546131	0.515	rs7128804	MIMAT0019776	hsa-miR-1343-3p	-3.56	0.000415	-0.18	-0.17	Lung disease severity in cystic fibrosis;	chr11:34836401	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.642	rs12291580	MIMAT0019776	hsa-miR-1343-3p	-3.56	0.000416	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34825185	chr11:34941888~34941909:+
LUSC	cis	rs990171	0.538	rs6543154	MIMAT0019926	hsa-miR-4772-5p	3.55	0.000421	0.21	0.17	Lymphocyte counts;	chr2:102497875	chr2:102432300~102432321:+
LUSC	cis	rs4921799	0.64	rs11203895	MIMAT0015020	hsa-miR-548v	-3.55	0.000421	-0.19	-0.17	Lung cancer;Adenocarcinoma;	chr8:17678085	chr8:17681588~17681609:-
LUSC	cis	rs7210990	0.724	rs178824	MIMAT0005942	hsa-miR-1288-3p	3.55	0.000421	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16183093	chr17:16282058~16282078:+
LUSC	cis	rs990171	0.566	rs1523199	MIMAT0019926	hsa-miR-4772-5p	3.55	0.000421	0.21	0.17	Lymphocyte counts;	chr2:102481732	chr2:102432300~102432321:+
LUSC	cis	rs11134338	0.58	rs6861103	MIMAT0019693	hsa-miR-4636	-3.55	0.000421	-0.2	-0.17	Obesity-related traits;	chr5:8928269	chr5:9053865~9053886:-
LUSC	cis	rs75358501	0.636	rs7576591	MIMAT0014994	hsa-miR-3130-3p	3.55	0.000422	0.23	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783245~206783265:-
LUSC	cis	rs75358501	0.636	rs7576591	MIMAT0014994_1	hsa-miR-3130-3p	3.55	0.000422	0.23	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206784502	chr2:206783277~206783297:+
LUSC	cis	rs7210990	0.724	rs545755	MIMAT0005942	hsa-miR-1288-3p	3.55	0.000423	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16187856	chr17:16282058~16282078:+
LUSC	cis	rs9807989	0.811	rs11688559	MIMAT0019926	hsa-miR-4772-5p	3.55	0.000423	0.19	0.17	Asthma;	chr2:102353453	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.811	rs11688568	MIMAT0019926	hsa-miR-4772-5p	3.55	0.000423	0.19	0.17	Asthma;	chr2:102353489	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.811	rs11688573	MIMAT0019926	hsa-miR-4772-5p	3.55	0.000423	0.19	0.17	Asthma;	chr2:102353511	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.811	rs11689730	MIMAT0019926	hsa-miR-4772-5p	3.55	0.000423	0.19	0.17	Asthma;	chr2:102353524	chr2:102432300~102432321:+
LUSC	cis	rs1867631	0.585	rs4655639	MIMAT0014979	hsa-miR-3117-3p	-3.55	0.000423	-0.18	-0.17	Menopause (age at onset);	chr1:66623407	chr1:66628485~66628505:+
LUSC	cis	rs6681460	0.934	rs10889635	MIMAT0014979	hsa-miR-3117-3p	-3.55	0.000423	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66609892	chr1:66628485~66628505:+
LUSC	cis	rs7210990	0.831	rs178809	MIMAT0005942	hsa-miR-1288-3p	3.55	0.000426	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16196459	chr17:16282058~16282078:+
LUSC	cis	rs7210990	0.866	rs178805	MIMAT0005942	hsa-miR-1288-3p	3.55	0.000426	0.19	0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16197814	chr17:16282058~16282078:+
LUSC	cis	rs6681460	1	rs6680944	MIMAT0014979	hsa-miR-3117-3p	-3.55	0.000427	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66656882	chr1:66628485~66628505:+
LUSC	cis	rs75358501	0.636	rs2241347	MIMAT0014994	hsa-miR-3130-3p	3.55	0.000428	0.23	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783245~206783265:-
LUSC	cis	rs75358501	0.636	rs2241347	MIMAT0014994_1	hsa-miR-3130-3p	3.55	0.000428	0.23	0.17	3-hydroxy-1-methylpropylmercapturic acid levels in smokers;	chr2:206783257	chr2:206783277~206783297:+
LUSC	cis	rs7072216	0.77	rs1061115	MIMAT0005878	hsa-miR-1287-5p	3.55	0.000431	0.17	0.17	Metabolite levels;	chr10:98417292	chr10:98395271~98395292:-
LUSC	cis	rs889398	0.802	rs8050414	MIMAT0004597	hsa-miR-140-3p	-3.55	0.000432	-0.11	-0.17	Body mass index;	chr16:69852910	chr16:69933142~69933162:+
LUSC	cis	rs7851726	0.69	rs11788697	MIMAT0019208	hsa-miR-3074-5p	-3.55	0.000432	-0.16	-0.17	Urinary albumin-to-creatinine ratio;	chr9:94823083	chr9:95086063~95086083:-
LUSC	cis	rs2369304	0.767	rs8022018	MIMAT0019214	hsa-miR-3173-5p	3.55	0.000432	0.2	0.17	Neutrophil count;	chr14:95745504	chr14:95137961~95137982:-
LUSC	cis	rs9426935	0.505	rs12032914	MIMAT0022491	hsa-miR-5698	-3.55	0.000432	-0.21	-0.17	Lentiform nucleus volume;	chr1:153914286	chr1:154104562~154104583:-
LUSC	cis	rs7072216	0.652	rs11189600	MIMAT0005878	hsa-miR-1287-5p	-3.55	0.000433	-0.17	-0.17	Metabolite levels;	chr10:98419517	chr10:98395271~98395292:-
LUSC	cis	rs74233809	0.901	rs11191416	MIMAT0022727	hsa-miR-1307-5p	3.55	0.000434	0.22	0.17	Birth weight;	chr10:102845159	chr10:103394341~103394361:-
LUSC	cis	rs7072216	0.77	rs1061123	MIMAT0005878	hsa-miR-1287-5p	3.54	0.000435	0.17	0.17	Metabolite levels;	chr10:98417240	chr10:98395271~98395292:-
LUSC	cis	rs79387448	0.638	rs76255660	MIMAT0019926	hsa-miR-4772-5p	-3.54	0.000435	-0.29	-0.17	Gut microbiota (bacterial taxa);	chr2:102474569	chr2:102432300~102432321:+
LUSC	cis	rs6681460	1	rs6656550	MIMAT0014979	hsa-miR-3117-3p	-3.54	0.000435	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66656869	chr1:66628485~66628505:+
LUSC	cis	rs4745062	0.738	rs11142767	MIMAT0000265	hsa-miR-204-5p	3.54	0.000436	0.18	0.17	Longevity;	chr9:71270998	chr9:70810031~70810052:-
LUSC	cis	rs6681460	0.966	rs7519747	MIMAT0014979	hsa-miR-3117-3p	-3.54	0.000436	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66675040	chr1:66628485~66628505:+
LUSC	cis	rs4493873	0.641	rs6471268	MIMAT0019729	hsa-miR-4661-5p	-3.54	0.000437	-0.19	-0.17	Migraine - clinic-based;	chr8:91167737	chr8:91205494~91205515:+
LUSC	cis	rs990171	0.874	rs6419573	MIMAT0019926	hsa-miR-4772-5p	3.54	0.000437	0.21	0.17	Lymphocyte counts;	chr2:102410643	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs13019784	MIMAT0019926	hsa-miR-4772-5p	-3.54	0.000438	-0.21	-0.17	Lymphocyte counts;	chr2:102506842	chr2:102432300~102432321:+
LUSC	cis	rs9914988	0.943	rs4313850	MIMAT0001631	hsa-miR-451a	-3.54	0.000439	-0.24	-0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28753750	chr17:28861403~28861424:-
LUSC	cis	rs546131	0.642	rs12278295	MIMAT0019776	hsa-miR-1343-3p	-3.54	0.00044	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34824707	chr11:34941888~34941909:+
LUSC	cis	rs2369304	0.736	rs11160289	MIMAT0019214	hsa-miR-3173-5p	3.54	0.000441	0.2	0.17	Neutrophil count;	chr14:95754429	chr14:95137961~95137982:-
LUSC	cis	rs546131	0.6	rs502857	MIMAT0019776	hsa-miR-1343-3p	3.54	0.000442	0.17	0.17	Lung disease severity in cystic fibrosis;	chr11:34833115	chr11:34941888~34941909:+
LUSC	cis	rs2069426	0.591	rs17694493	MIMAT0004504	hsa-miR-31-3p	3.54	0.000442	0.25	0.17	Acute lymphoblastic leukemia (childhood);	chr9:22041999	chr9:21512121~21512142:-
LUSC	cis	rs941898	0.625	rs6575763	MIMAT0000722	hsa-miR-370-3p	-3.54	0.000445	-0.12	-0.17	White matter hyperintensity burden;	chr14:100105425	chr14:100911186~100911207:+
LUSC	cis	rs7072216	0.77	rs3830020	MIMAT0026738	hsa-miR-1287-3p	-3.54	0.000446	-0.15	-0.17	Metabolite levels;	chr10:98416858	chr10:98395232~98395253:-
LUSC	cis	rs9807989	0.773	rs72823661	MIMAT0019926	hsa-miR-4772-5p	3.54	0.000446	0.19	0.17	Asthma;	chr2:102352256	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.801	rs72823663	MIMAT0019926	hsa-miR-4772-5p	3.54	0.000446	0.19	0.17	Asthma;	chr2:102352278	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.811	rs67088699	MIMAT0019926	hsa-miR-4772-5p	3.54	0.000446	0.19	0.17	Asthma;	chr2:102352291	chr2:102432300~102432321:+
LUSC	cis	rs546131	0.642	rs58210900	MIMAT0019776	hsa-miR-1343-3p	-3.54	0.000446	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34816500	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.642	rs61881104	MIMAT0019776	hsa-miR-1343-3p	-3.54	0.000446	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34816836	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.571	rs4351790	MIMAT0019776	hsa-miR-1343-3p	-3.54	0.000446	-0.18	-0.17	Lung disease severity in cystic fibrosis;	chr11:34835344	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.571	rs4593984	MIMAT0019776	hsa-miR-1343-3p	-3.54	0.000446	-0.18	-0.17	Lung disease severity in cystic fibrosis;	chr11:34835387	chr11:34941888~34941909:+
LUSC	cis	rs546131	0.571	rs2421741	MIMAT0019776	hsa-miR-1343-3p	-3.54	0.000446	-0.18	-0.17	Lung disease severity in cystic fibrosis;	chr11:34835429	chr11:34941888~34941909:+
LUSC	cis	rs9914988	0.887	rs2070265	MIMAT0001631	hsa-miR-451a	3.54	0.000448	0.24	0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28748405	chr17:28861403~28861424:-
LUSC	cis	rs4921799	0.662	rs34105101	MIMAT0015020	hsa-miR-548v	-3.54	0.000448	-0.19	-0.17	Lung cancer;Adenocarcinoma;	chr8:17675909	chr8:17681588~17681609:-
LUSC	cis	rs1163656	1	rs1163656	MIMAT0003287	hsa-miR-618	-3.54	0.000448	-0.23	-0.17	Dental caries;	chr12:80943679	chr12:80935796~80935818:-
LUSC	cis	rs9527	0.662	rs743575	MIMAT0022727	hsa-miR-1307-5p	3.54	0.00045	0.13	0.17	Arsenic metabolism;	chr10:102835149	chr10:103394341~103394361:-
LUSC	cis	rs2887399	0.572	rs1107727	MIMAT0019214	hsa-miR-3173-5p	3.53	0.000451	0.27	0.17	Mosaic loss of chromosome Y;	chr14:95740492	chr14:95137961~95137982:-
LUSC	cis	rs2871473	1	rs1030024	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000451	0.24	0.17	Blood protein levels;	chr2:102489310	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.773	rs5010059	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000452	0.19	0.17	Asthma;	chr2:102352366	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.839	rs11695627	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000452	0.19	0.17	Asthma;	chr2:102353645	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.801	rs7558339	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000452	0.19	0.17	Asthma;	chr2:102353783	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.811	rs7608638	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000452	0.19	0.17	Asthma;	chr2:102353829	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.811	rs4485584	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000452	0.19	0.17	Asthma;	chr2:102354290	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.811	rs4485585	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000452	0.19	0.17	Asthma;	chr2:102354299	chr2:102432300~102432321:+
LUSC	cis	rs9807989	1	rs9807989	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000452	0.19	0.17	Asthma;	chr2:102354740	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.839	rs9808453	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000452	0.19	0.17	Asthma;	chr2:102354846	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.839	rs4851565	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000452	0.19	0.17	Asthma;	chr2:102355021	chr2:102432300~102432321:+
LUSC	cis	rs9807989	0.765	rs9807962	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000452	0.19	0.17	Asthma;	chr2:102355204	chr2:102432300~102432321:+
LUSC	cis	rs11134338	0.557	rs2963337	MIMAT0019693	hsa-miR-4636	-3.53	0.000452	-0.19	-0.17	Obesity-related traits;	chr5:8935520	chr5:9053865~9053886:-
LUSC	cis	rs9807989	0.801	rs4851566	MIMAT0019926	hsa-miR-4772-5p	3.53	0.000452	0.19	0.17	Asthma;	chr2:102356339	chr2:102432300~102432321:+
LUSC	cis	rs2887399	0.505	rs744439	MIMAT0019214	hsa-miR-3173-5p	-3.53	0.000453	-0.27	-0.17	Mosaic loss of chromosome Y;	chr14:95741453	chr14:95137961~95137982:-
LUSC	cis	rs9914988	0.945	rs9279	MIMAT0001631	hsa-miR-451a	3.53	0.000455	0.24	0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28860618	chr17:28861403~28861424:-
LUSC	cis	rs1048886	0.872	rs55639214	MIMAT0000087	hsa-miR-30a-5p	3.53	0.000455	0.2	0.17	Type 2 diabetes;	chr6:70577494	chr6:71403595~71403616:-
LUSC	cis	rs1048886	0.872	rs56114703	MIMAT0000087	hsa-miR-30a-5p	3.53	0.000455	0.2	0.17	Type 2 diabetes;	chr6:70577594	chr6:71403595~71403616:-
LUSC	cis	rs1048886	0.872	rs12203089	MIMAT0000087	hsa-miR-30a-5p	3.53	0.000455	0.2	0.17	Type 2 diabetes;	chr6:70578956	chr6:71403595~71403616:-
LUSC	cis	rs2369304	0.767	rs28473040	MIMAT0019214	hsa-miR-3173-5p	3.53	0.000458	0.19	0.17	Neutrophil count;	chr14:95743850	chr14:95137961~95137982:-
LUSC	cis	rs7210990	0.836	rs1079533	MIMAT0005942	hsa-miR-1288-3p	-3.53	0.000458	-0.19	-0.17	Neutrophil percentage of white cells;Lymphocyte percentage of white cells;	chr17:16046884	chr17:16282058~16282078:+
LUSC	cis	rs6681460	1	rs1325263	MIMAT0014979	hsa-miR-3117-3p	-3.53	0.000459	-0.18	-0.17	Presence of antiphospholipid antibodies;	chr1:66664108	chr1:66628485~66628505:+
LUSC	cis	rs9527	0.59	rs10883843	MIMAT0022727	hsa-miR-1307-5p	3.53	0.000462	0.12	0.17	Arsenic metabolism;	chr10:103187736	chr10:103394341~103394361:-
LUSC	cis	rs9914988	0.943	rs9303621	MIMAT0001631	hsa-miR-451a	-3.53	0.000463	-0.24	-0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28834120	chr17:28861403~28861424:-
LUSC	cis	rs9914988	1	rs901975	MIMAT0001631	hsa-miR-451a	3.53	0.000464	0.24	0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28862756	chr17:28861403~28861424:-
LUSC	cis	rs9914988	0.559	rs1109024	MIMAT0001631	hsa-miR-451a	3.53	0.000464	0.24	0.17	Glycated hemoglobin levels;High light scatter reticulocyte percentage of red cells;High light scatter reticulocyte count;	chr17:28862953	chr17:28861403~28861424:-
LUSC	cis	rs10980607	0.526	rs531003	MIMAT0030017	hsa-miR-7702	-3.53	0.000464	-0.17	-0.17	Eosinophil percentage of granulocytes;Neutrophil percentage of granulocytes;	chr9:110850339	chr9:111271193~111271214:-
LUSC	cis	rs9527	1	rs4919690	MIMAT0005951	hsa-miR-1307-3p	-3.53	0.000466	-0.13	-0.17	Arsenic metabolism;	chr10:102856743	chr10:103394301~103394322:-
LUSC	cis	rs546131	0.642	rs7131074	MIMAT0019776	hsa-miR-1343-3p	-3.53	0.000466	-0.19	-0.17	Lung disease severity in cystic fibrosis;	chr11:34817558	chr11:34941888~34941909:+
LUSC	cis	rs2369304	0.736	rs2887454	MIMAT0019214	hsa-miR-3173-5p	3.53	0.000467	0.19	0.17	Neutrophil count;	chr14:95756060	chr14:95137961~95137982:-
LUSC	cis	rs4921799	0.662	rs34285970	MIMAT0015020	hsa-miR-548v	-3.52	0.000468	-0.18	-0.16	Lung cancer;Adenocarcinoma;	chr8:17677418	chr8:17681588~17681609:-
LUSC	cis	rs6681460	0.966	rs10889644	MIMAT0014979	hsa-miR-3117-3p	-3.52	0.000469	-0.18	-0.16	Presence of antiphospholipid antibodies;	chr1:66679639	chr1:66628485~66628505:+
LUSC	cis	rs889398	0.802	rs8051168	MIMAT0004597	hsa-miR-140-3p	-3.52	0.000469	-0.11	-0.16	Body mass index;	chr16:69853371	chr16:69933142~69933162:+
LUSC	cis	rs990171	0.687	rs6751949	MIMAT0019926	hsa-miR-4772-5p	3.52	0.000473	0.21	0.16	Lymphocyte counts;	chr2:102508679	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs6739301	MIMAT0019926	hsa-miR-4772-5p	3.52	0.000473	0.21	0.16	Lymphocyte counts;	chr2:102508998	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs6742381	MIMAT0019926	hsa-miR-4772-5p	3.52	0.000473	0.21	0.16	Lymphocyte counts;	chr2:102509007	chr2:102432300~102432321:+
LUSC	cis	rs6971499	1	rs10248190	MIMAT0004503	hsa-miR-29a-5p	-3.52	0.000479	-0.2	-0.16	Pancreatic cancer;	chr7:131005149	chr7:130876786~130876807:-
LUSC	cis	rs990171	0.687	rs10210680	MIMAT0019926	hsa-miR-4772-5p	3.52	0.000483	0.21	0.16	Lymphocyte counts;	chr2:102511223	chr2:102432300~102432321:+
LUSC	cis	rs990171	0.687	rs11676371	MIMAT0019926	hsa-miR-4772-5p	3.52	0.000483	0.21	0.16	Lymphocyte counts;	chr2:102513233	chr2:102432300~102432321:+
LUSC	cis	rs4713675	0.604	rs791902	MIMAT0022975	hsa-miR-3934-3p	3.51	0.000487	0.17	0.16	Plateletcrit;	chr6:33734840	chr6:33698191~33698212:+
LUSC	trans	rs17730929	0.659	rs1033095	MIMAT0019059	hsa-miR-1269b	-7.93	1.83e-14	-0.69	-0.35	Colorectal cancer (SNP x SNP interaction);	chr4:66366293	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.659	rs2350805	MIMAT0019059	hsa-miR-1269b	7.86	2.91e-14	0.71	0.35	Colorectal cancer (SNP x SNP interaction);	chr4:66361183	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.659	rs72643109	MIMAT0019059	hsa-miR-1269b	7.21	2.42e-12	0.69	0.32	Colorectal cancer (SNP x SNP interaction);	chr4:66383922	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs55770221	MIMAT0019059	hsa-miR-1269b	6.88	2.04e-11	0.81	0.31	Colorectal cancer (SNP x SNP interaction);	chr4:66406304	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs10517974	MIMAT0019059	hsa-miR-1269b	-6.66	7.95e-11	-0.77	-0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66263513	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs35028404	MIMAT0019059	hsa-miR-1269b	6.66	8.22e-11	0.82	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66263128	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs35749355	MIMAT0019059	hsa-miR-1269b	6.66	8.22e-11	0.82	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66263160	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs34908018	MIMAT0019059	hsa-miR-1269b	6.66	8.22e-11	0.82	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66263222	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs35358552	MIMAT0019059	hsa-miR-1269b	6.66	8.22e-11	0.82	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66267628	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs34134312	MIMAT0019059	hsa-miR-1269b	6.66	8.22e-11	0.82	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66267647	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs36044013	MIMAT0019059	hsa-miR-1269b	6.66	8.22e-11	0.82	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66267679	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13148783	MIMAT0019059	hsa-miR-1269b	6.66	8.22e-11	0.82	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66267739	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13122552	MIMAT0019059	hsa-miR-1269b	6.66	8.22e-11	0.82	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66267818	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13148985	MIMAT0019059	hsa-miR-1269b	6.66	8.22e-11	0.82	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66267827	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs11930224	MIMAT0019059	hsa-miR-1269b	6.63	9.88e-11	0.78	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66410437	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs72641620	MIMAT0019059	hsa-miR-1269b	6.63	1e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66265652	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13141975	MIMAT0019059	hsa-miR-1269b	6.62	1.03e-10	0.82	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266997	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs10517972	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66263635	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs10517970	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66263813	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs10517969	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66263852	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.591	rs72641615	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66263912	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.591	rs72641616	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66263923	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs17838961	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66264579	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13107500	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66265657	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13139833	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66265742	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13107954	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66265877	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13113516	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266094	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13111921	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266095	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13145575	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266161	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13113894	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266216	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13112620	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266350	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.656	rs13115053	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266794	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13113717	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266893	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13147393	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266945	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13147401	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266956	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13113927	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266990	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13119186	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66267060	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13119418	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66267145	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs35943387	MIMAT0019059	hsa-miR-1269b	6.61	1.08e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66267443	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13101728	MIMAT0019059	hsa-miR-1269b	6.59	1.22e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66289547	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.656	rs61224431	MIMAT0019059	hsa-miR-1269b	6.59	1.22e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66290047	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs67668930	MIMAT0019059	hsa-miR-1269b	6.59	1.22e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66290585	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643154	MIMAT0019059	hsa-miR-1269b	6.59	1.28e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66420531	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs55771742	MIMAT0019059	hsa-miR-1269b	6.59	1.28e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66423079	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.72	rs72643159	MIMAT0019059	hsa-miR-1269b	6.59	1.28e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66423924	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.72	rs72643160	MIMAT0019059	hsa-miR-1269b	6.59	1.28e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66423989	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs1512959	MIMAT0019059	hsa-miR-1269b	6.59	1.28e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66430238	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs17785798	MIMAT0019059	hsa-miR-1269b	6.59	1.28e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66432794	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13140283	MIMAT0019059	hsa-miR-1269b	6.58	1.31e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66265990	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.656	rs13111848	MIMAT0019059	hsa-miR-1269b	6.58	1.31e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66266020	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs112955418	MIMAT0019059	hsa-miR-1269b	6.58	1.34e-10	0.78	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66413317	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643164	MIMAT0019059	hsa-miR-1269b	6.56	1.46e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66425792	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643167	MIMAT0019059	hsa-miR-1269b	6.56	1.46e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66427428	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643168	MIMAT0019059	hsa-miR-1269b	6.56	1.46e-10	0.77	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66429006	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs72643139	MIMAT0019059	hsa-miR-1269b	6.56	1.48e-10	0.8	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66410401	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs115579433	MIMAT0019059	hsa-miR-1269b	6.56	1.48e-10	0.8	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66414070	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.656	rs13106117	MIMAT0019059	hsa-miR-1269b	-6.56	1.5e-10	-0.8	-0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66295169	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs114518531	MIMAT0019059	hsa-miR-1269b	6.54	1.66e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66269990	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.656	rs72641630	MIMAT0019059	hsa-miR-1269b	6.54	1.66e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66270256	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs74482402	MIMAT0019059	hsa-miR-1269b	6.54	1.66e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66270874	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs17784894	MIMAT0019059	hsa-miR-1269b	6.54	1.67e-10	0.79	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66391928	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs6852720	MIMAT0019059	hsa-miR-1269b	6.54	1.67e-10	0.79	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66403907	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs17087157	MIMAT0019059	hsa-miR-1269b	6.52	1.92e-10	0.75	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66417252	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs17714933	MIMAT0019059	hsa-miR-1269b	6.51	2.03e-10	0.81	0.3	Colorectal cancer (SNP x SNP interaction);	chr4:66273140	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs55677631	MIMAT0019059	hsa-miR-1269b	6.5	2.12e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66422324	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643155	MIMAT0019059	hsa-miR-1269b	6.5	2.12e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66422772	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643157	MIMAT0019059	hsa-miR-1269b	6.5	2.12e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66423249	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.72	rs72643161	MIMAT0019059	hsa-miR-1269b	6.5	2.12e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66424092	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs56257983	MIMAT0019059	hsa-miR-1269b	6.5	2.12e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66430756	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643169	MIMAT0019059	hsa-miR-1269b	6.5	2.12e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66432508	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs35827885	MIMAT0019059	hsa-miR-1269b	6.5	2.21e-10	0.77	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66263658	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643165	MIMAT0019059	hsa-miR-1269b	6.47	2.53e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66426954	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs116808105	MIMAT0019059	hsa-miR-1269b	6.47	2.53e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66429223	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs17785566	MIMAT0019059	hsa-miR-1269b	6.47	2.53e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66429490	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs17729112	MIMAT0019059	hsa-miR-1269b	6.47	2.53e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66429748	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs34110728	MIMAT0019059	hsa-miR-1269b	6.47	2.53e-10	0.8	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66290892	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs35096368	MIMAT0019059	hsa-miR-1269b	6.46	2.72e-10	0.81	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66290884	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13151607	MIMAT0019059	hsa-miR-1269b	6.46	2.72e-10	0.81	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66294789	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs34810172	MIMAT0019059	hsa-miR-1269b	6.46	2.72e-10	0.81	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66297781	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs35618975	MIMAT0019059	hsa-miR-1269b	6.46	2.72e-10	0.81	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66297883	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs35630788	MIMAT0019059	hsa-miR-1269b	6.46	2.72e-10	0.81	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66298031	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643131	MIMAT0019059	hsa-miR-1269b	6.45	2.9e-10	0.79	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66404222	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643112	MIMAT0019059	hsa-miR-1269b	6.45	3e-10	0.79	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66384382	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs35759060	MIMAT0019059	hsa-miR-1269b	6.45	3.01e-10	0.81	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66280452	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs11933206	MIMAT0019059	hsa-miR-1269b	6.44	3.1e-10	0.72	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66415854	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs35755819	MIMAT0019059	hsa-miR-1269b	6.43	3.34e-10	0.82	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66300275	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs17087106	MIMAT0019059	hsa-miR-1269b	6.42	3.58e-10	0.81	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66374848	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.72	rs72643158	MIMAT0019059	hsa-miR-1269b	6.4	4.01e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66423819	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs17729362	MIMAT0019059	hsa-miR-1269b	6.4	4.01e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66432869	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643170	MIMAT0019059	hsa-miR-1269b	6.4	4.06e-10	0.75	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66433069	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs72643138	MIMAT0019059	hsa-miR-1269b	6.39	4.21e-10	0.76	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66408685	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13141988	MIMAT0019059	hsa-miR-1269b	6.39	4.21e-10	0.78	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66263266	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs17728801	MIMAT0019059	hsa-miR-1269b	6.38	4.47e-10	0.77	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66410084	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643166	MIMAT0019059	hsa-miR-1269b	6.38	4.58e-10	0.76	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66427128	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs10517979	MIMAT0019059	hsa-miR-1269b	-6.37	4.7e-10	-0.74	-0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66390363	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs1355435	MIMAT0019059	hsa-miR-1269b	6.36	4.89e-10	0.8	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66355410	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs1154969	MIMAT0019059	hsa-miR-1269b	6.36	4.98e-10	0.76	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66408205	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72641701	MIMAT0019059	hsa-miR-1269b	6.35	5.21e-10	0.79	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66375156	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs6823582	MIMAT0019059	hsa-miR-1269b	6.35	5.47e-10	0.78	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66381578	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs13122515	MIMAT0019059	hsa-miR-1269b	6.35	5.49e-10	0.79	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66355679	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643140	MIMAT0019059	hsa-miR-1269b	6.33	5.86e-10	0.77	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66411109	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs116430396	MIMAT0019059	hsa-miR-1269b	6.33	5.86e-10	0.77	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66413102	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643145	MIMAT0019059	hsa-miR-1269b	6.33	5.86e-10	0.77	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66413131	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs116275903	MIMAT0019059	hsa-miR-1269b	6.33	5.86e-10	0.77	0.29	Colorectal cancer (SNP x SNP interaction);	chr4:66414052	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs72641691	MIMAT0019059	hsa-miR-1269b	6.26	8.94e-10	0.78	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66356406	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs111281713	MIMAT0019059	hsa-miR-1269b	6.25	9.79e-10	0.74	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66433382	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs17728992	MIMAT0019059	hsa-miR-1269b	6.21	1.19e-09	0.68	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66420866	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs11934326	MIMAT0019059	hsa-miR-1269b	6.21	1.22e-09	0.76	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66359839	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs11943327	MIMAT0019059	hsa-miR-1269b	6.2	1.28e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66391549	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs56352425	MIMAT0019059	hsa-miR-1269b	6.2	1.29e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66389476	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643117	MIMAT0019059	hsa-miR-1269b	6.2	1.29e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66392344	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs1511277	MIMAT0019059	hsa-miR-1269b	6.2	1.29e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66394608	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs34841981	MIMAT0019059	hsa-miR-1269b	6.19	1.36e-09	0.71	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66403566	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643132	MIMAT0019059	hsa-miR-1269b	6.19	1.36e-09	0.71	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66404580	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs868976	MIMAT0019059	hsa-miR-1269b	6.19	1.37e-09	0.7	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66429774	chr17:12917313~12917334:-
LUSC	trans	rs12210905	1	rs6917419	MIMAT0001080	hsa-miR-196b-5p	-6.14	1.87e-09	-0.49	-0.28	Hip circumference adjusted for BMI;	chr6:27275701	chr7:27169528~27169549:-
LUSC	trans	rs17730929	0.79	rs17716638	MIMAT0019059	hsa-miR-1269b	6.13	1.9e-09	0.74	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66361741	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs55890046	MIMAT0019059	hsa-miR-1269b	6.12	2e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66389575	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs10517978	MIMAT0019059	hsa-miR-1269b	6.12	2e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66389902	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs56332155	MIMAT0019059	hsa-miR-1269b	6.12	2e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66393688	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643119	MIMAT0019059	hsa-miR-1269b	6.12	2e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66395027	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs6816747	MIMAT0019059	hsa-miR-1269b	6.12	2e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66395615	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643120	MIMAT0019059	hsa-miR-1269b	6.12	2e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66396089	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643122	MIMAT0019059	hsa-miR-1269b	6.12	2e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66396603	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643123	MIMAT0019059	hsa-miR-1269b	6.12	2e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66396694	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643124	MIMAT0019059	hsa-miR-1269b	6.12	2e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66397194	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643125	MIMAT0019059	hsa-miR-1269b	6.12	2e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66398058	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643126	MIMAT0019059	hsa-miR-1269b	6.12	2e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66398856	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs35707449	MIMAT0019059	hsa-miR-1269b	6.12	2.01e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66357396	chr17:12917313~12917334:-
LUSC	trans	rs12200782	0.79	rs72840194	MIMAT0001080	hsa-miR-196b-5p	-6.12	2.07e-09	-0.54	-0.28	Small cell lung carcinoma;	chr6:26361141	chr7:27169528~27169549:-
LUSC	trans	rs17730929	0.79	rs72643121	MIMAT0019059	hsa-miR-1269b	6.06	2.93e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66396420	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs17784079	MIMAT0019059	hsa-miR-1269b	6.05	3.1e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66364590	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.722	rs13108964	MIMAT0019059	hsa-miR-1269b	6.04	3.21e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66362275	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs13114529	MIMAT0019059	hsa-miR-1269b	6.04	3.21e-09	0.72	0.28	Colorectal cancer (SNP x SNP interaction);	chr4:66362297	chr17:12917313~12917334:-
LUSC	trans	rs12210905	0.92	rs9393802	MIMAT0001080	hsa-miR-196b-5p	-6.03	3.46e-09	-0.49	-0.28	Hip circumference adjusted for BMI;	chr6:27275326	chr7:27169528~27169549:-
LUSC	trans	rs17730929	0.79	rs72643110	MIMAT0019059	hsa-miR-1269b	6.03	3.53e-09	0.71	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66384109	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643115	MIMAT0019059	hsa-miR-1269b	6.03	3.53e-09	0.71	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66385989	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs36083664	MIMAT0019059	hsa-miR-1269b	6.02	3.71e-09	0.72	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66356907	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.929	rs17787189	MIMAT0019059	hsa-miR-1269b	5.98	4.59e-09	0.72	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66486574	chr17:12917313~12917334:-
LUSC	trans	rs73173548	0.502	rs6865693	MIMAT0022258	hsa-miR-5571-3p	5.97	4.86e-09	0.32	0.27	Macular telangiectasia type 2;	chr5:88419422	chr22:22886331~22886349:+
LUSC	trans	rs17730929	0.527	rs115852023	MIMAT0019059	hsa-miR-1269b	5.96	5.04e-09	0.69	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66366023	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs13142032	MIMAT0019059	hsa-miR-1269b	5.96	5.27e-09	0.69	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66358367	chr17:12917313~12917334:-
LUSC	trans	rs73173548	0.502	rs6452789	MIMAT0022258	hsa-miR-5571-3p	5.95	5.29e-09	0.32	0.27	Macular telangiectasia type 2;	chr5:88429498	chr22:22886331~22886349:+
LUSC	trans	rs17730929	0.79	rs116645654	MIMAT0019059	hsa-miR-1269b	5.95	5.38e-09	0.69	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66405576	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs114186485	MIMAT0019059	hsa-miR-1269b	5.95	5.38e-09	0.69	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66405578	chr17:12917313~12917334:-
LUSC	trans	rs36093844	0.626	rs12278260	MIMAT0000073	hsa-miR-19a-3p	-5.95	5.42e-09	-0.16	-0.27	IgG response to Plasmodium falciparum antigens (GLURP, MSP2 FC27, MSP2 3D7);	chr11:85955961	chr13:91350939~91350961:+
LUSC	trans	rs17730929	0.722	rs35980427	MIMAT0019059	hsa-miR-1269b	5.95	5.46e-09	0.74	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66262645	chr17:12917313~12917334:-
LUSC	trans	rs61270009	0.738	rs73171756	MIMAT0022258	hsa-miR-5571-3p	5.94	5.69e-09	0.32	0.27	Depressive symptoms;	chr5:88446454	chr22:22886331~22886349:+
LUSC	trans	rs17730929	0.858	rs17729886	MIMAT0019059	hsa-miR-1269b	5.93	6.11e-09	0.7	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66448534	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs17728252	MIMAT0019059	hsa-miR-1269b	5.93	6.16e-09	0.71	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66376967	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643107	MIMAT0019059	hsa-miR-1269b	5.93	6.21e-09	0.71	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66381920	chr17:12917313~12917334:-
LUSC	trans	rs73173548	0.502	rs10505857	MIMAT0022258	hsa-miR-5571-3p	5.93	6.22e-09	0.33	0.27	Macular telangiectasia type 2;	chr5:88420376	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs34634636	MIMAT0022258	hsa-miR-5571-3p	5.93	6.24e-09	0.33	0.27	Macular telangiectasia type 2;	chr5:88435989	chr22:22886331~22886349:+
LUSC	trans	rs17730929	0.722	rs10517975	MIMAT0019059	hsa-miR-1269b	5.93	6.26e-09	0.68	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66263472	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs6552006	MIMAT0019059	hsa-miR-1269b	5.92	6.43e-09	0.66	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66388039	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643116	MIMAT0019059	hsa-miR-1269b	5.92	6.43e-09	0.66	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66388719	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs72643118	MIMAT0019059	hsa-miR-1269b	5.92	6.43e-09	0.66	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66393297	chr17:12917313~12917334:-
LUSC	trans	rs73173548	0.502	rs13185071	MIMAT0022258	hsa-miR-5571-3p	5.9	7.23e-09	0.33	0.27	Macular telangiectasia type 2;	chr5:88429895	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs4601863	MIMAT0022258	hsa-miR-5571-3p	5.9	7.23e-09	0.33	0.27	Macular telangiectasia type 2;	chr5:88433804	chr22:22886331~22886349:+
LUSC	trans	rs11711311	1	rs12631232	MIMAT0004569	hsa-miR-222-5p	-5.9	7.37e-09	-0.28	-0.27	IgG glycosylation;	chr3:113778539	chrX:45747073~45747094:-
LUSC	trans	rs73173548	0.502	rs34743961	MIMAT0022258	hsa-miR-5571-3p	5.9	7.42e-09	0.32	0.27	Macular telangiectasia type 2;	chr5:88435952	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.528	rs13161403	MIMAT0022258	hsa-miR-5571-3p	5.89	7.84e-09	0.34	0.27	Macular telangiectasia type 2;	chr5:88471144	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.528	rs68019847	MIMAT0022258	hsa-miR-5571-3p	5.88	8.02e-09	0.32	0.27	Macular telangiectasia type 2;	chr5:88446795	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs6867204	MIMAT0022258	hsa-miR-5571-3p	5.88	8.04e-09	0.33	0.27	Macular telangiectasia type 2;	chr5:88446423	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs34933255	MIMAT0022258	hsa-miR-5571-3p	5.88	8.04e-09	0.33	0.27	Macular telangiectasia type 2;	chr5:88446492	chr22:22886331~22886349:+
LUSC	trans	rs12200782	1	rs12200782	MIMAT0001080	hsa-miR-196b-5p	-5.87	8.71e-09	-0.51	-0.27	Small cell lung carcinoma;	chr6:26402808	chr7:27169528~27169549:-
LUSC	trans	rs73173548	0.502	rs71639110	MIMAT0022258	hsa-miR-5571-3p	5.86	8.85e-09	0.33	0.27	Macular telangiectasia type 2;	chr5:88422222	chr22:22886331~22886349:+
LUSC	trans	rs6438234	0.961	rs952384	MIMAT0014995	hsa-miR-3130-5p	-5.86	8.92e-09	-0.31	-0.27	Type 2 diabetes;	chr3:115186394	chr2:206783276~206783296:-
LUSC	trans	rs6438234	0.961	rs952384	MIMAT0014995_1	hsa-miR-3130-5p	-5.86	8.92e-09	-0.31	-0.27	Type 2 diabetes;	chr3:115186394	chr2:206783246~206783266:+
LUSC	trans	rs73173548	0.502	rs12188494	MIMAT0022258	hsa-miR-5571-3p	5.85	9.32e-09	0.32	0.27	Macular telangiectasia type 2;	chr5:88447747	chr22:22886331~22886349:+
LUSC	trans	rs12210905	1	rs6938397	MIMAT0001080	hsa-miR-196b-5p	-5.84	1.01e-08	-0.48	-0.27	Hip circumference adjusted for BMI;	chr6:27263445	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs67310631	MIMAT0001080	hsa-miR-196b-5p	-5.84	1.01e-08	-0.48	-0.27	Hip circumference adjusted for BMI;	chr6:27265464	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs9379967	MIMAT0001080	hsa-miR-196b-5p	-5.84	1.01e-08	-0.48	-0.27	Hip circumference adjusted for BMI;	chr6:27265648	chr7:27169528~27169549:-
LUSC	trans	rs73173548	0.502	rs10452479	MIMAT0022258	hsa-miR-5571-3p	5.84	1.01e-08	0.31	0.27	Macular telangiectasia type 2;	chr5:88445131	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs34394411	MIMAT0022258	hsa-miR-5571-3p	5.84	1.03e-08	0.32	0.27	Macular telangiectasia type 2;	chr5:88436903	chr22:22886331~22886349:+
LUSC	trans	rs12210905	1	rs9368494	MIMAT0001080	hsa-miR-196b-5p	-5.83	1.07e-08	-0.48	-0.27	Hip circumference adjusted for BMI;	chr6:27269522	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs9368492	MIMAT0001080	hsa-miR-196b-5p	-5.83	1.09e-08	-0.48	-0.27	Hip circumference adjusted for BMI;	chr6:27253739	chr7:27169528~27169549:-
LUSC	trans	rs12200782	1	rs3927423	MIMAT0001080	hsa-miR-196b-5p	-5.82	1.11e-08	-0.52	-0.27	Small cell lung carcinoma;	chr6:26393259	chr7:27169528~27169549:-
LUSC	trans	rs12200782	1	rs12201802	MIMAT0001080	hsa-miR-196b-5p	-5.82	1.11e-08	-0.52	-0.27	Small cell lung carcinoma;	chr6:26398436	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs6902012	MIMAT0001080	hsa-miR-196b-5p	5.82	1.16e-08	0.56	0.27	Hip circumference adjusted for BMI;	chr6:27275988	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs9393796	MIMAT0001080	hsa-miR-196b-5p	-5.82	1.16e-08	-0.48	-0.27	Hip circumference adjusted for BMI;	chr6:27259186	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs9379965	MIMAT0001080	hsa-miR-196b-5p	-5.82	1.16e-08	-0.48	-0.27	Hip circumference adjusted for BMI;	chr6:27259282	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs12198077	MIMAT0001080	hsa-miR-196b-5p	-5.81	1.18e-08	-0.55	-0.27	Hip circumference adjusted for BMI;	chr6:27201528	chr7:27169528~27169549:-
LUSC	trans	rs73173548	0.502	rs71639111	MIMAT0022258	hsa-miR-5571-3p	5.81	1.19e-08	0.32	0.27	Macular telangiectasia type 2;	chr5:88428788	chr22:22886331~22886349:+
LUSC	trans	rs61270009	0.731	rs13189022	MIMAT0022258	hsa-miR-5571-3p	5.81	1.19e-08	0.32	0.27	Depressive symptoms;	chr5:88445017	chr22:22886331~22886349:+
LUSC	trans	rs17730929	0.858	rs7693354	MIMAT0019059	hsa-miR-1269b	5.8	1.25e-08	0.66	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66461109	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.79	rs58788152	MIMAT0019059	hsa-miR-1269b	5.79	1.3e-08	0.66	0.27	Colorectal cancer (SNP x SNP interaction);	chr4:66477494	chr17:12917313~12917334:-
LUSC	trans	rs12210905	1	rs1062834	MIMAT0001080	hsa-miR-196b-5p	-5.79	1.32e-08	-0.52	-0.27	Hip circumference adjusted for BMI;	chr6:27254760	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs12205628	MIMAT0001080	hsa-miR-196b-5p	-5.79	1.32e-08	-0.52	-0.27	Hip circumference adjusted for BMI;	chr6:27258180	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs72843643	MIMAT0001080	hsa-miR-196b-5p	-5.79	1.32e-08	-0.52	-0.27	Hip circumference adjusted for BMI;	chr6:27243468	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs72843644	MIMAT0001080	hsa-miR-196b-5p	-5.79	1.32e-08	-0.52	-0.27	Hip circumference adjusted for BMI;	chr6:27243822	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs3800310	MIMAT0001080	hsa-miR-196b-5p	-5.79	1.33e-08	-0.51	-0.27	Hip circumference adjusted for BMI;	chr6:27239064	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs5030955	MIMAT0001080	hsa-miR-196b-5p	-5.79	1.33e-08	-0.51	-0.27	Hip circumference adjusted for BMI;	chr6:27246088	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs5030958	MIMAT0001080	hsa-miR-196b-5p	-5.79	1.33e-08	-0.51	-0.27	Hip circumference adjusted for BMI;	chr6:27246478	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs12214930	MIMAT0001080	hsa-miR-196b-5p	-5.79	1.33e-08	-0.54	-0.26	Hip circumference adjusted for BMI;	chr6:27125936	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs9368493	MIMAT0001080	hsa-miR-196b-5p	-5.79	1.33e-08	-0.48	-0.26	Hip circumference adjusted for BMI;	chr6:27260521	chr7:27169528~27169549:-
LUSC	trans	rs73173548	0.502	rs10505856	MIMAT0022258	hsa-miR-5571-3p	5.79	1.34e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88440636	chr22:22886331~22886349:+
LUSC	trans	rs12210905	1	rs9357034	MIMAT0001080	hsa-miR-196b-5p	-5.79	1.37e-08	-0.52	-0.26	Hip circumference adjusted for BMI;	chr6:27275646	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs12209393	MIMAT0001080	hsa-miR-196b-5p	-5.78	1.38e-08	-0.54	-0.26	Hip circumference adjusted for BMI;	chr6:27117294	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs12192320	MIMAT0001080	hsa-miR-196b-5p	-5.78	1.38e-08	-0.54	-0.26	Hip circumference adjusted for BMI;	chr6:27122526	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs3531	MIMAT0001080	hsa-miR-196b-5p	-5.78	1.38e-08	-0.54	-0.26	Hip circumference adjusted for BMI;	chr6:27127534	chr7:27169528~27169549:-
LUSC	trans	rs73173548	0.502	rs13180798	MIMAT0022258	hsa-miR-5571-3p	5.78	1.45e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88425633	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs13163266	MIMAT0022258	hsa-miR-5571-3p	5.78	1.45e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88425703	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs13180932	MIMAT0022258	hsa-miR-5571-3p	5.78	1.45e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88425720	chr22:22886331~22886349:+
LUSC	trans	rs17730929	0.858	rs77846903	MIMAT0019059	hsa-miR-1269b	5.77	1.46e-08	0.66	0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66456430	chr17:12917313~12917334:-
LUSC	trans	rs17730929	0.858	rs72902537	MIMAT0019059	hsa-miR-1269b	5.77	1.46e-08	0.66	0.26	Colorectal cancer (SNP x SNP interaction);	chr4:66463193	chr17:12917313~12917334:-
LUSC	trans	rs13089785	0.788	rs2280422	MIMAT0002890	hsa-miR-299-5p	5.77	1.5e-08	0.23	0.26	Intelligence (multi-trait analysis);	chr3:123978083	chr14:101023800~101023821:+
LUSC	trans	rs73173548	0.502	rs4144466	MIMAT0022258	hsa-miR-5571-3p	5.77	1.53e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88412379	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs13165211	MIMAT0022258	hsa-miR-5571-3p	5.76	1.55e-08	0.31	0.26	Macular telangiectasia type 2;	chr5:88443772	chr22:22886331~22886349:+
LUSC	trans	rs113835537	0.935	rs79496339	MIMAT0018968	hsa-miR-4449	5.76	1.56e-08	0.43	0.26	Airway imaging phenotypes;	chr11:66700298	chr4:52712720~52712741:+
LUSC	trans	rs12210905	1	rs9348756	MIMAT0001080	hsa-miR-196b-5p	-5.76	1.59e-08	-0.53	-0.26	Hip circumference adjusted for BMI;	chr6:27260480	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs10946906	MIMAT0001080	hsa-miR-196b-5p	-5.76	1.59e-08	-0.56	-0.26	Hip circumference adjusted for BMI;	chr6:27285001	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs12209456	MIMAT0001080	hsa-miR-196b-5p	-5.74	1.73e-08	-0.54	-0.26	Hip circumference adjusted for BMI;	chr6:27117446	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs12209800	MIMAT0001080	hsa-miR-196b-5p	5.74	1.75e-08	0.53	0.26	Hip circumference adjusted for BMI;	chr6:27221738	chr7:27169528~27169549:-
LUSC	trans	rs73173548	0.502	rs36077166	MIMAT0022258	hsa-miR-5571-3p	5.74	1.76e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88441770	chr22:22886331~22886349:+
LUSC	trans	rs12210905	0.92	rs6911234	MIMAT0001080	hsa-miR-196b-5p	-5.73	1.82e-08	-0.53	-0.26	Hip circumference adjusted for BMI;	chr6:27119080	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs4636015	MIMAT0001080	hsa-miR-196b-5p	-5.73	1.82e-08	-0.53	-0.26	Hip circumference adjusted for BMI;	chr6:27129537	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs41269245	MIMAT0001080	hsa-miR-196b-5p	-5.73	1.82e-08	-0.53	-0.26	Hip circumference adjusted for BMI;	chr6:27132317	chr7:27169528~27169549:-
LUSC	trans	rs73173548	0.502	rs12659818	MIMAT0022258	hsa-miR-5571-3p	5.72	1.92e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88451964	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs4129236	MIMAT0022258	hsa-miR-5571-3p	5.72	1.94e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88441542	chr22:22886331~22886349:+
LUSC	trans	rs12210905	0.841	rs12206996	MIMAT0001080	hsa-miR-196b-5p	-5.71	2.09e-08	-0.54	-0.26	Hip circumference adjusted for BMI;	chr6:27098636	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs72842200	MIMAT0001080	hsa-miR-196b-5p	-5.71	2.09e-08	-0.54	-0.26	Hip circumference adjusted for BMI;	chr6:27100257	chr7:27169528~27169549:-
LUSC	trans	rs1597595	0.817	rs13432683	MIMAT0014990	hsa-miR-3127-5p	5.71	2.12e-08	0.27	0.26	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes;	chr2:147110401	chr2:96798288~96798310:+
LUSC	trans	rs61270009	0.955	rs12515274	MIMAT0022258	hsa-miR-5571-3p	5.7	2.17e-08	0.31	0.26	Depressive symptoms;	chr5:88359845	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.528	rs34182576	MIMAT0022258	hsa-miR-5571-3p	5.7	2.18e-08	0.31	0.26	Macular telangiectasia type 2;	chr5:88438321	chr22:22886331~22886349:+
LUSC	trans	rs12210905	1	rs12196084	MIMAT0001080	hsa-miR-196b-5p	-5.7	2.18e-08	-0.5	-0.26	Hip circumference adjusted for BMI;	chr6:27230425	chr7:27169528~27169549:-
LUSC	trans	rs11711311	1	rs9288982	MIMAT0004569	hsa-miR-222-5p	-5.69	2.37e-08	-0.27	-0.26	IgG glycosylation;	chr3:113751302	chrX:45747073~45747094:-
LUSC	trans	rs73173548	0.502	rs10505855	MIMAT0022258	hsa-miR-5571-3p	5.68	2.41e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88440962	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs4129235	MIMAT0022258	hsa-miR-5571-3p	5.68	2.41e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88441465	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs34969608	MIMAT0022258	hsa-miR-5571-3p	5.67	2.58e-08	0.31	0.26	Macular telangiectasia type 2;	chr5:88448606	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs12516483	MIMAT0022258	hsa-miR-5571-3p	5.66	2.67e-08	0.31	0.26	Macular telangiectasia type 2;	chr5:88454718	chr22:22886331~22886349:+
LUSC	trans	rs12210905	1	rs12208534	MIMAT0001080	hsa-miR-196b-5p	-5.66	2.78e-08	-0.53	-0.26	Hip circumference adjusted for BMI;	chr6:27098980	chr7:27169528~27169549:-
LUSC	trans	rs73173548	0.502	rs7726289	MIMAT0022258	hsa-miR-5571-3p	5.65	2.89e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88437392	chr22:22886331~22886349:+
LUSC	trans	rs703108	0.731	rs7898954	MIMAT0000067	hsa-let-7f-5p	-5.65	2.94e-08	-0.28	-0.26	Monocyte percentage of white cells;	chr10:22034717	chr9:94176353~94176374:+
LUSC	trans	rs703108	0.731	rs7898954	MIMAT0000067_1	hsa-let-7f-5p	-5.65	2.94e-08	-0.28	-0.26	Monocyte percentage of white cells;	chr10:22034717	chrX:53557246~53557267:-
LUSC	trans	rs12210905	1	rs6931711	MIMAT0001080	hsa-miR-196b-5p	-5.64	3.01e-08	-0.53	-0.26	Hip circumference adjusted for BMI;	chr6:27177807	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs72843615	MIMAT0001080	hsa-miR-196b-5p	-5.64	3.01e-08	-0.53	-0.26	Hip circumference adjusted for BMI;	chr6:27182790	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs12210905	MIMAT0001080	hsa-miR-196b-5p	-5.64	3.01e-08	-0.53	-0.26	Hip circumference adjusted for BMI;	chr6:27183530	chr7:27169528~27169549:-
LUSC	trans	rs1597595	0.948	rs1083478	MIMAT0014990	hsa-miR-3127-5p	-5.64	3.05e-08	-0.27	-0.26	HDL cholesterol change in response to fenofibrate in statin-treated type 2 diabetes;	chr2:147183774	chr2:96798288~96798310:+
LUSC	trans	rs73173548	0.502	rs4423262	MIMAT0022258	hsa-miR-5571-3p	5.64	3.06e-08	0.3	0.26	Macular telangiectasia type 2;	chr5:88438609	chr22:22886331~22886349:+
LUSC	trans	rs12210905	1	rs72843629	MIMAT0001080	hsa-miR-196b-5p	-5.63	3.16e-08	-0.5	-0.26	Hip circumference adjusted for BMI;	chr6:27207436	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs12189835	MIMAT0001080	hsa-miR-196b-5p	-5.63	3.18e-08	-0.49	-0.26	Hip circumference adjusted for BMI;	chr6:27230492	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs72843640	MIMAT0001080	hsa-miR-196b-5p	-5.63	3.18e-08	-0.49	-0.26	Hip circumference adjusted for BMI;	chr6:27234314	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs72843641	MIMAT0001080	hsa-miR-196b-5p	-5.63	3.18e-08	-0.49	-0.26	Hip circumference adjusted for BMI;	chr6:27235556	chr7:27169528~27169549:-
LUSC	trans	rs73173548	0.502	rs6885165	MIMAT0022258	hsa-miR-5571-3p	5.63	3.29e-08	0.31	0.26	Macular telangiectasia type 2;	chr5:88449705	chr22:22886331~22886349:+
LUSC	trans	rs61270009	0.955	rs2305104	MIMAT0022258	hsa-miR-5571-3p	-5.62	3.34e-08	-0.29	-0.26	Depressive symptoms;	chr5:88324853	chr22:22886331~22886349:+
LUSC	trans	rs6748734	0.553	rs7340215	MIMAT0004506	hsa-miR-33a-3p	5.62	3.41e-08	0.27	0.26	Urinary metabolites;	chr2:240866434	chr22:41900989~41901010:+
LUSC	trans	rs73173548	0.502	rs12653074	MIMAT0022258	hsa-miR-5571-3p	5.62	3.45e-08	0.31	0.26	Macular telangiectasia type 2;	chr5:88452920	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs12187348	MIMAT0022258	hsa-miR-5571-3p	5.61	3.56e-08	0.3	0.26	Macular telangiectasia type 2;	chr5:88424724	chr22:22886331~22886349:+
LUSC	trans	rs12200782	0.79	rs72836480	MIMAT0001080	hsa-miR-196b-5p	-5.6	3.67e-08	-0.52	-0.26	Small cell lung carcinoma;	chr6:26358368	chr7:27169528~27169549:-
LUSC	trans	rs4427176	0.507	rs7010270	MIMAT0000067	hsa-let-7f-5p	-5.6	3.73e-08	-0.23	-0.26	Mosquito bite size;	chr8:9699337	chr9:94176353~94176374:+
LUSC	trans	rs4427176	0.507	rs7010270	MIMAT0000067_1	hsa-let-7f-5p	-5.6	3.73e-08	-0.23	-0.26	Mosquito bite size;	chr8:9699337	chrX:53557246~53557267:-
LUSC	trans	rs61270009	0.955	rs11748798	MIMAT0022258	hsa-miR-5571-3p	5.6	3.82e-08	0.3	0.26	Depressive symptoms;	chr5:88354925	chr22:22886331~22886349:+
LUSC	trans	rs61270009	0.955	rs11740836	MIMAT0022258	hsa-miR-5571-3p	5.6	3.82e-08	0.3	0.26	Depressive symptoms;	chr5:88356311	chr22:22886331~22886349:+
LUSC	trans	rs61270009	0.913	rs13154590	MIMAT0022258	hsa-miR-5571-3p	5.6	3.82e-08	0.3	0.26	Depressive symptoms;	chr5:88357208	chr22:22886331~22886349:+
LUSC	trans	rs61270009	0.687	rs10942530	MIMAT0022258	hsa-miR-5571-3p	5.59	3.91e-08	0.32	0.26	Depressive symptoms;	chr5:88414221	chr22:22886331~22886349:+
LUSC	trans	rs73173548	0.502	rs10942531	MIMAT0022258	hsa-miR-5571-3p	5.59	3.91e-08	0.32	0.26	Macular telangiectasia type 2;	chr5:88414280	chr22:22886331~22886349:+
LUSC	trans	rs12210905	1	rs12213361	MIMAT0001080	hsa-miR-196b-5p	-5.59	3.95e-08	-0.52	-0.26	Hip circumference adjusted for BMI;	chr6:27170608	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs72843613	MIMAT0001080	hsa-miR-196b-5p	-5.59	3.95e-08	-0.52	-0.26	Hip circumference adjusted for BMI;	chr6:27170688	chr7:27169528~27169549:-
LUSC	trans	rs12210905	1	rs1102557	MIMAT0001080	hsa-miR-196b-5p	5.59	3.95e-08	0.52	0.26	Hip circumference adjusted for BMI;	chr6:27182015	chr7:27169528~27169549:-
LUSC	trans	rs6748734	0.625	rs7598309	MIMAT0004506	hsa-miR-33a-3p	5.59	3.97e-08	0.28	0.26	Urinary metabolites;	chr2:240885459	chr22:41900989~41901010:+
LUSC	trans	rs73173548	0.502	rs6865869	MIMAT0022258	hsa-miR-5571-3p	5.59	4e-08	0.31	0.26	Macular telangiectasia type 2;	chr5:88449645	chr22:22886331~22886349:+